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Abstract  
Introduction 
The B vitamin folate has an essential role in many biological processes, such as one-
carbon metabolism, protein synthesis and DNA synthesis1.   Due to its wide range of 
roles in the human body, low folate status has been implicated in many diseases, 
including cardiovascular disease, some cancers and cognitive decline, as well as 
folate’s well-established roles in decreasing risk of Neural Tube Defects and 
megaloblastic anaemia1,2. With its important role in human health, research into 
environmental factors that may impact folate status, such as solar ultraviolet (UV) 
radiation, are of great health significance. In vitro studies have shown the ability for 
UV radiation to degrade folate and folic acid (its synthetic derivative) in human 
blood and recent population studies have pointed to a potentially significant link for 
solar UV degradation of folic acid in humans3-5. This is a particularly important area 
of research from an Australian point of view due to the high personal UV radiation 
exposures experienced by much of the population and the recent introduction of 
mandatory folic acid fortification to the food supply6,7. Folic acid food fortification, 
combined with folic acid supplementation for vulnerable populations, such as 
conception age women, has resulted in a significant proportion of our folate needs 
being provided by folic acid7. However, despite the importance of this area, there is 
a dearth of epidemiological research that has been conducted into investigating the 
relationship between folate status and solar UV radiation exposure. 
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Aim 
To investigate the association between sun exposure and folate degradation in a 
population of women of childbearing age in South East Queensland 
Method 
A longitudinal study was conducted to investigate the association between folate 
degradation and sun exposure. Forty-six (N=46) conception age females aged 18-47 
years were recruited for the study. Participants received 500 µg folic acid 
supplementation daily for two weeks, followed by a one week assessment of sun 
exposure. Serum and red cell folate was tested via a blood test at baseline, 
following folic acid supplementation and at the end of the study following the 
completion of one week of sun exposure data collection. Solar UV radiation 
exposure was tested using a sun diary and activity questionnaire, while data for 
dietary intake of folate were collected using a validated questionnaire.  
Results 
Chapter 4 describes the demographics of the sample and the variation in 
participants’ serum and red cell folate status over the study period. Average 
participant serum folate significantly increased from baseline by 8.8 nmol/L, 
following the two weeks of folic acid supplementation (p=<0.01). Serum folate then 
decreased in the week following cessation of supplementation by 4.0 nmol/L 
(p=<0.01).  In contrast, no significant changes in red cell folate were observed over 
the course of the study. 
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Chapter 5 reports on the dietary intake of folate in participants. Median dietary 
folate intake, measured as Dietary Folate Equivalents was 354 µg/day. The range of 
intakes (75.9-1048.9 µg/d) revealed the wide variation of dietary folate intakes 
within the sample. Significant correlations with dietary intake and both serum 
(r=.52; p=<0.01) and red cell folate (r=.41; p=<0.01) status were observed at 
baseline. The major sources of dietary folate for participants in this sample were 
fruit and vegetables (45%), followed by breads and cereals (25%). 
Chapter 6 explored the sun exposure and sun protection characteristics within the 
sample. Following cessation of folic acid supplementation, the median daily outdoor 
time in minutes for the sample was 92 minutes, while median daily environmental 
UV exposure was 456 J/m2. The percentage of skin exposed was strongly correlated 
with the amount of sun exposure, with participants with higher sun exposures 
observed to have an increased percentage of skin exposed. This was reported both 
for average time outdoors in minutes (r=.57; p=<0.01) and J/m2 (r=.55; p=<0.01).  In 
contrast to percentage of skin exposed, sunscreen use was not associated with sun 
exposure. Due to the importance of percentage of skin exposed for calculating 
participants’ total sun exposure, a variable integrating both environmental UV 
exposure and percentage skin exposed was developed, the daily personal UV 
exposure. Median daily personal UV exposure for participants’ was 290 J.  
Chapter 7 aimed to address whether there was an association between sun 
exposure and change in folate status, with the dependent variable, change in folate 
status, defined as the difference between the collection of blood following 
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cessation of folic acid supplementation and the final blood collection one week 
later. Significant inverse correlations were observed between change in serum 
folate and daily personal UV exposure (Spearman’s rho=-.44; p=<0.01) as well as 
average time outdoors (Spearman’s rho=-.44; p=<0.01). Significant associations 
were also observed between non-smoking (p=.015) and lower physical activity 
levels (p=.019) and increased change in serum folate status. There were no 
significant correlations between change in red cell folate and the independent 
variables, including the sun exposure measures. Multiple linear regression was 
undertaken to assess the relationship between change in serum folate status and 
independent variables showing significance or trends (p=<0.2). Multivariable 
models showed daily personal UV radiation exposure in Joules (Standardised B=-
.454, p=<0.01) and outdoor exposure in minutes (Standardised B=-.410, p=.003) 
were both significantly associated with change in serum folate. The models 
explained 32.8% and 28.8% of the variation in change of serum folate, respectively. 
Other significant independent variables were physical activity and week of 
recruitment.  
Conclusions 
The results from this study suggest a strong association exists between degree of 
sun exposure measured as both time outdoors in minutes and personal UV 
radiation exposure in Joules, and decrease in serum folate status. This project adds 
significantly to evidence suggesting that people whose folate levels have been 
raised by folic acid are at increased risk of a higher degree of folate degradation 
following high levels of sun exposure, potentially reducing the efficacy of folic acid 
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supplementation. The public health consequences of this association may be most 
pronounced for individuals with high sun exposure and poor sun protection 
measure usage. 
This thesis adds significantly to the literature and the research field, being the first 
population study to investigate the effects of UV radiation exposure on folate levels 
in a sample of participants in Australia. It also builds on international research by 
being the first population study to investigate the association of natural outdoor UV 
radiation exposure (as opposed to artificial sources of UV radiation) and folate 
degradation in free-living conception age females. The present thesis provides a 
strong case for continued investigation in this field with a larger sample or the 
establishment of a small well designed randomized controlled trial to provide data 
on the casual association between UV radiation exposure and folate degradation in 
the human body. 
  
7 | P a g e  
 
Statement of original authorship 
The work contained in this thesis has not been previously submitted to meet 
requirements for an award at this or any other higher education institution. To the 
best of my knowledge and belief, the thesis contains no material previously 
published or written by another person except where due reference is made. 
 
Name:      David Borradale 
 
Signature: 
 
Date:      4/12/2013 
 
 
  
QUT Verified Signature
8 | P a g e  
 
List of Abbreviations 
BSA  Body Surface Area 
DFE  Dietary Folate Equivalents 
EAR  Estimated Average Requirements 
FFQ  Food Frequency Questionnaire 
FSANZ  Food Standards Australia and New Zealand 
J  Joules 
J/m2  Joules per meter square 
NHANES National Health and Nutrition Examination Survey 
NNS  National Nutrition Survey 
NTD  Neural Tube Defects 
RDI  Recommended Daily Intake 
ROS  Reactive Oxygen Species 
SPSS  Statistical Package for the Social Sciences 
UV  Ultraviolet 
UVA  Ultraviolet A 
UVB  Ultraviolet B 
5-MTHF 5-Methyltetrahydrofolate 
 
 
 
 
 
 
 
 
 
 
9 | P a g e  
 
Acknowledgements 
Due acknowledgement must be made to the participants of this study who 
generously provided their time (and blood!) for the data collection phase of this 
project. 
All members of my supervisory team have provided excellent support and direction 
throughout my PhD project. My primary supervisor, Prof. Michael Kimlin, has 
provided key insight and supervision for the overall project. Michael’s experience 
and passion for research have helped inspire me towards a career based in 
research. 
Dr. Elizabeth Isenring, has been of enormous assistance with the nutrition elements 
of the project as well as providing important feedback during the thesis writing. 
Liz’s research experience and leadership in the field nutrition and dietetics has 
benefitted the project greatly. 
Dr. Elke Hacker has provided important insight regarding measurement of the sun 
protection and exposure elements of the project. Additionally, Elke has provided 
advice that has been of great assistance during the thesis writing process and she 
has been of immense value as a mentor during this time. 
Also special mention must be made to the members of the AusSun laboratory with 
whom I have worked with over the last five years, first with my Masters and now 
with my PhD. My colleagues have generously given their time to assist with my data 
collection and have provided support throughout my project, I doubt you could find 
10 | P a g e  
 
a more helpful and generous group of people. 
And last, but certainly not least, to my wife who has put up with my late nights, 
practice presentations and family who have put up with my busy nights and days 
throughout my PhD project, and provided enormous support throughout the 
process. 
 
 
 
 
 
 
 
 
 
 
11 | P a g e  
 
Table of contents 
Key Words .................................................................................................................... 1 
Abstract ........................................................................................................................ 2 
Introduction ............................................................................................................. 2 
Aim ........................................................................................................................... 3 
Method ..................................................................................................................... 3 
Results ...................................................................................................................... 3 
Conclusions .............................................................................................................. 5 
Statement of original authorship ............................................................................. 7 
List of Abbreviations ................................................................................................ 8 
Table of contents ....................................................................................................... 11 
List of Tables ............................................................................................................... 17 
List of Figures ............................................................................................................. 19 
Chapter 1: Introduction.............................................................................................. 21 
1.1 Overview of research ....................................................................................... 21 
1.2 Contributions of thesis to public health research ............................................ 22 
1.3 Publications and presentations associated with thesis ................................... 23 
1.4 Structure of thesis content .............................................................................. 23 
Chapter 2: Literature Review ..................................................................................... 26 
2.1 Overview .......................................................................................................... 26 
12 | P a g e  
 
2.2 Folate and Folic acid ......................................................................................... 26 
2.2.1 Folates in food and folic acid .................................................................... 26 
2.2.2 Folate metabolism .................................................................................... 30 
2.2.3 Determination of folate levels .................................................................. 32 
2.3 Folate and disease ............................................................................................ 34 
2.3.1 Folate and disease: Neural Tube Defects .................................................. 34 
2.3.2 Folate and disease: Cardiovascular disease .............................................. 37 
2.3.3 Folate and disease: Cancer ....................................................................... 38 
2.3.4 Folate and disease: Cognitive Decline ...................................................... 41 
2.3.5 Folate and disease: Seasonal effects ........................................................ 42 
2.4 Folate and UV radiation: Overview .................................................................. 44 
2.4.1 Folate and UV radiation: Laboratory studies ............................................ 45 
2.4.2 Folate and UV radiation:  Sunbed and solar UV studies ........................... 50 
2.5 Limitations in previous research and current research needs ........................ 57 
2.6 Current project’s role in addressing research needs ....................................... 60 
2.7 Aims, research questions and hypotheses for project .................................... 61 
Chapter 3: Methodology ............................................................................................ 62 
3.1 Research design ............................................................................................... 62 
3.1.1 Recruitment and screening ....................................................................... 62 
3.1.2 Project design ............................................................................................ 63 
13 | P a g e  
 
3.1.3 Study dependent variable ......................................................................... 67 
3.1.4 Study setting ............................................................................................. 67 
3.2 Study components and measures .................................................................... 68 
3.2.1 Part A: General Information Questionnaire .............................................. 68 
3.2.2 Part B: Sun Exposure Questionnaire ......................................................... 69 
3.2.3 Part C: Folate Food Frequency Questionnaire .......................................... 70 
3.2.4 Calculation of Dietary Folate Equivalents (DFEs) ...................................... 71 
3.2.5 Sun and Physical Activity Diary ................................................................. 73 
3.2.6 Estimation of participant’s personal outdoor and UV  
radiation exposure ............................................................................................. 74 
3.2.7 Weather data ............................................................................................ 78 
3.2.8 Anthropometry ......................................................................................... 78 
3.2.9 Phlebotomy ............................................................................................... 79 
3.2.10 Blood transport ....................................................................................... 79 
3.2.11 Serum and red cell folate blood analysis ................................................ 80 
3.3 Data storage and security ................................................................................ 81 
3.3.1 Security of electronic and paper results ................................................... 81 
3.3.2 Serum folate storage ................................................................................. 81 
3.4 Ethics ................................................................................................................ 82 
3.5 Statistical analysis ............................................................................................ 83 
3.5.1 Data entry and verification ....................................................................... 83 
14 | P a g e  
 
3.5.2 Data cleaning ............................................................................................. 83 
3.5.3 Exploratory analysis of the data and descriptive statistics ....................... 84 
3.5.4 Analysis of Research Questions ................................................................ 84 
3.5.5 Statistical assumptions .............................................................................. 87 
3.5.6 Sample size calculation ............................................................................. 89 
Chapter 4: Participant demographics and folate status ............................................ 90 
4.1 Introduction ..................................................................................................... 90 
4.2 Methodology overview .................................................................................... 91 
4.3 Results .............................................................................................................. 91 
4.3.1 Participant demographics ......................................................................... 91 
4.3.2 Folate status of participants ..................................................................... 95 
4.4 Discussion ......................................................................................................... 97 
Chapter 5: Dietary intake of folate and effect of supplementation on  
blood folates ............................................................................................................ 102 
5.1 Introduction ................................................................................................... 102 
5.2 Methodology Overview .................................................................................. 102 
5.3 Results ............................................................................................................ 103 
5.4 Discussion ....................................................................................................... 108 
Chapter 6: Sun exposure, sun protection behaviours and clothing ........................ 112 
6.1 Introduction ................................................................................................... 112 
6.2 Methodological overview .............................................................................. 113 
15 | P a g e  
 
6.3 Results ............................................................................................................ 113 
6.3.1 Weather conditions during the study period ......................................... 113 
6.3.2 Description of time outdoors and UV radiation exposure ..................... 115 
6.3.3 Outdoor time and environmental UV radiation by time of day ............. 118 
6.3.4 Sun protection behaviours and association with outdoor time and 
environmental UV radiation exposure ............................................................. 120 
6.3.5 Estimated UV radiation exposure and percentage of skin exposed as an 
integrated variable ........................................................................................... 122 
6.3.6 Summary of sun exposure measures and association with demographic 
variables ........................................................................................................... 124 
6.4 Discussion ....................................................................................................... 127 
Chapter 7: Associations between outdoor exposure and folate status in conception 
age females .............................................................................................................. 135 
7.1 Introduction ................................................................................................... 135 
7.2 Methodological overview .............................................................................. 136 
7.3 Results ............................................................................................................ 136 
7.3.1 Description of the change (Δ) in serum and red cell folate status over  
sun exposure measurement period (Time 2 to Time 3). ................................. 136 
7.3.2 Bivariate relationship between change in blood folate and outdoor 
exposure measures-correlations. .................................................................... 139 
7.3.3 Bivariate associations between dependent variables (change in serum 
and red cell folate) and independent variables ............................................... 140 
16 | P a g e  
 
7.3.4 Multivariable linear regression analysis of association between 
dependent variables (change in serum and red cell folate) and independent 
variables ........................................................................................................... 144 
7.4 Discussion ....................................................................................................... 152 
Chapter 8: Conclusions............................................................................................. 164 
8.1 Overview of findings ...................................................................................... 164 
8.2 Conclusion and significance of the Thesis ...................................................... 167 
8.3 Strengths and Limitations of project .............................................................. 170 
8.4 Future research directions ............................................................................. 173 
References ................................................................................................................ 175 
Appendices ............................................................................................................... 186 
 
  
17 | P a g e  
 
List of Tables 
Table: 2.1: Dietary Folate Equivalents (DFEs) of selected foods and supplements ... 28 
Table 2.2: Dietary recommendations and mandatory fortification in Australia ....... 29 
Table 2.3: Classification of low and normal serum and erythrocyte folate levels..... 33 
Table 2.4: Published in vivo studies in folate degradation and ultraviolet (UV) 
radiation exposure ..................................................................................................... 55 
Table 2.5: Aims, research questions and hypotheses for the research project ........ 61 
Table 4.1: Aim and research question for Chapter 4 ................................................. 90 
Table 4.2: Selected participant demographics  .......................................................... 93 
Table 4.3: Participant dependent variables ............................................................... 96 
Table 5.1: Aim and research question for Chapter 4 ............................................... 102 
Table 5.2: Dietary Folate Equivalents (DFEs), intake of sample before and during 
folic acid supplementation. ...................................................................................... 104 
Table 5.3: Correlations of blood folate at three time points with Dietary  
Folate Equivalents .................................................................................................... 106 
Table 6.1: Table of definitions .................................................................................. 112 
Table 6.2: Summary of weather conditions over study period  
(17th Oct-16th Nov 2012) .......................................................................................... 114 
18 | P a g e  
 
Table 6.3: Participants’ average time outdoors and environmental UV radiation 
exposure ................................................................................................................... 115 
Table 6.4: Percentage contributions of environmental UV radiation (J/m2)  
over week ................................................................................................................. 117 
Table 6.5: Sunscreen use and association with average time outdoors and  
average environmental UV radiation exposure (J/m2) ............................................ 120 
Table 7.1: Aim and research question for Chapter 7 ............................................... 136 
Table 7.2: Description of change in serum and red cell folate (over 1 week 
measurement period) .............................................................................................. 137 
Table 7.3: Correlations between change in serum and red cell folate and sun 
exposure measures of Personal UV radiation exposure (Joules) and time outdoors 
(minutes) .................................................................................................................. 140 
Table 7.4 Associations between change in serum and red cell folate and 
independent variables ............................................................................................. 142 
Table 7.5: Multivariable regression model: change in serum folate (personal UV 
radiation exposure as sun exposure variable) ......................................................... 149 
Table 7.6: Multivariable regression model: change in serum folate (outdoor time 
exposure as sun exposure variable) ......................................................................... 150 
Table 7.7 Multivariable regression model: change in red blood cell folate ............ 151 
Table 8.1: Summary of key findings for the research questions in thesis ............... 166 
19 | P a g e  
 
List of Figures 
Figure 2.1: Diagram of folic acid showing major structural components .................. 27 
Figure 2.2: Folate absorption and metabolism pathway ........................................... 31 
Figure 2.3: Homocysteine metabolism in the cell (Simplified) .................................. 37 
Figure 2.4: Absorbance’s for UVA and UVB radiation in 5-MTHF and folic acid ....... 46 
Figure 2.5: Proposed pathways to folate degradation by UV radiation .................... 49 
Figure 2.6:  Flowchart illustrating need for improved epidemiological data on  
UV radiation’s role in folate degradation .................................................................. 59 
Figure 3.1: Flow chart of study design ....................................................................... 66 
Figure 3.2: Data collection phase of project .............................................................. 67 
Figure 5.1 Average Dietary Folate Equivalent (DFE) intake of participants prior to 
supplementation  ..................................................................................................... 104 
Figure 5.2: Contribution of foods to average Daily DFEs ......................................... 105 
Figure 5.3: Total DFEs and correlation with serum folate (Baseline) ...................... 107 
Figure 5.4: Total DFEs and correlation with RBC folate (Baseline) .......................... 107 
Figure 6.1: Description of daily sun in hours and maximum temperatures over  
study period ............................................................................................................. 114 
 
20 | P a g e  
 
Figure 6.2: Average daily participant UV radiation exposures ................................ 116 
Figure 6.3: Average daily outdoor exposure (minutes) for each time period of day 
during measurement week ...................................................................................... 119 
Figure 6.4: Average environmental UV radiation exposure (J/m2) for each time 
period of day during measurement week ............................................................... 119 
Figure 6.5: Correlation between percentage of skin exposed and average daily time 
outdoors ................................................................................................................... 121 
Figure 6.6: Correlation between average percentage skin of exposed and average 
daily environmental UV............................................................................................ 122 
Figure 6.7: Frequency of estimated daily UV radiation exposure in Joules............. 123 
Figure 7.1: Histogram of change in serum folate (nmol/L) over  
measurement week  ................................................................................................ 138 
Figure 7.2: Histogram of change in red cell folate (nmol/L) over  
measurement week ................................................................................................. 138 
  
21 | P a g e  
 
Chapter 1: Introduction 
1.1 Overview of research 
Folate is a water soluble B vitamin that plays an essential role in human health. 
Classically, folate deficiency is associated with an increased risk of neural tube birth 
defects (NTDs), such as Spina Bifida, for mothers with poor folate status and 
megaloblastic anaemia1,2. Low folate status may also be a risk factor for some 
cancers and cardiovascular disease, although the role of folate in these diseases is a 
controversial topic with studies showing conflicting results3-7. 
While the importance of folate in human health is well known, environmental 
factors which may impact folate status are poorly understood. One little known 
factor which may potentially decrease folate status, is exposure to solar ultraviolet 
(UV) radiation, with research showing that UV radiation has the capacity to degrade 
folate in human blood and skin8,9. The recent discovery of an indirect degradation 
pathway, via UVA derived generation of Reactive Oxygen Species (ROS), able to 
oxidise and therefore indirectly degrade 5-Methyltetrahydrofolate (5-MTHF), has 
provided an important biological mechanism for degradation of folate via UV 
radiation10-13. Other mechanisms such as the direct degradation of the synthetic 
form of folate, folic acid in the blood by UVA, and the effect of folate depletion in 
the skin from chronic UV radiation exposure, are also important pathways that 
appear to impact folate status in humans9,14.  
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Due to the wide range of health conditions low folate status is associated with, the 
public health consequences of solar UV radiation induced degradation of folate in 
humans are potentially enormous, especially in a country such as Australia, which 
has high annual UV exposures15. A relationship between UV radiation and folate 
degradation would be a particular concern for conception age females due to the 
important role of folate in the development of the embryonic neural tube in the 
early stages of pregnancy. However despite in vitro findings showing UV’s role in 
the degradation of folates in the human body, there is a dearth of population based 
research in this potentially important area.   
1.2 Contributions of thesis to public health research 
The interaction between UV radiation and folate in the human body is a relatively 
new investigative area, with only a small number of laboratory and epidemiological 
studies being conducted recently. With the critical role that folate plays in multiple 
disease processes, any degradation caused by UV radiation is a cause for concern.   
By examining the impact outdoor exposure has on the folate status of conception 
age females taking folic acid supplements, this hypothesis generating study is the 
first of its kind in Australia to investigate the possible effects of UV radiation on the 
folate status of this vulnerable group. Another key contribution that this thesis 
makes to this area of research includes the assessment of participants’ dietary 
folate intake using a food frequency questionnaire, as this is the major contributor 
for folate status. 
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The methods, materials and research findings from this thesis can be used, 
improved and modified to inform the design of larger studies that will answer the 
question, “Can high UV exposure lead to a decrease in folate status in healthy 
individuals?” Findings from this research and larger follow-on studies will help 
inform public health advice, particularly for recommendations on the suitable UV 
exposures for pregnant mothers or women planning a pregnancy. 
1.3 Publications and presentations associated with thesis 
Borradale D, Kimlin MK. Folate degradation due to ultraviolet radiation: Possible 
implications for human health and nutrition. Nutrition Reviews 2012; vol 70, issue 
7:414-422. 
Poster presentation: Institute of Health and Biomedical Innovation (IHBI) annual 
conference 2012, November 22-23, Radisson Resort, Gold Coast, Australia. 
Oral presentation: AusSun Seminar series 2011, QUT School of Public Health, 
October 17 2011, Kelvin Grove campus QUT. 
Poster presentation: Institute of Health and Biomedical Innovation (IHBI) annual 
conference 2010, November 4-5, Radisson Resort, Gold Coast, Australia. 
1.4 Structure of thesis content 
The first chapter provides an introduction to folate and an overview of the role of 
UV radiation in the degradation of folate. Original contributions that the thesis 
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makes to public health research are then briefly discussed, followed by a section on 
publications and presentations given on the research topic. 
The second chapter is the literature review of the thesis. This chapter provides a 
background to folate and its important role in several diseases. The current 
research literature in UV radiation and its role in the degradation of folate are 
discussed, along with the possible mechanisms of this degradation and key 
limitations of the research to date. As the literature review informs the key research 
needs in the area of UV degradation of folate, the end of this chapter describes the 
key aims, research questions and hypotheses for this thesis. 
The third chapter describes the methodology used in the thesis. The research 
design, recruitment, procedures and materials developed for the project are 
discussed and statistical procedures and tests used in the next four chapters are 
described. 
The fourth chapter is the first of the four results chapters and reports on the 
demographics of the sample. This chapter is mainly focused on descriptive data and 
aims to describe participant demographics and blood folate status of the sample 
over the course of the study. As with all the results chapters, interpretation and 
discussion of results presented are provided at the end of the chapter. 
The fifth chapter provides an in depth reporting and discussion of the dietary intake 
of folate for the participants’ and reports on the effectiveness of the folic acid 
supplementation in increasing the participants folate status. 
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The sixth chapter describes the outdoor exposure of the participants following 
supplementation with folic acid. Two outdoor exposure variables were measured; 
the average daily outdoor exposure in minutes and average daily personal UV 
radiation exposure in Joules. 
The final results chapter reports on the results from the analysis for the main 
research question of the thesis, which was to investigate the relationship between 
folate status and outdoor exposure. An in depth discussion of the results is also 
provided in this chapter which also links the current research to past research in the 
area of folate and UV radiation. 
Chapter 8 provides a conclusion of the findings and provides an overview of the 
major strengths and limitations of the thesis. Suggestions are also made regarding 
possible future research directions for the field. 
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Chapter 2: Literature Review 
2.1 Overview 
 This literature review provides a background into the importance of folate for the 
maintenance of human health followed by an investigation of the major research 
findings in the area of UV and folate degradation. A particular focus of this section is 
how UV degradation of folate may impact health status in humans with a discussion 
on the strengths and weaknesses of the major studies conducted in this important 
field. The major gaps identified in the existing research will be then used to inform 
the research questions and design of the PhD project. 
2.2 Folate and Folic acid 
2.2.1 Folates in food and folic acid  
Folate is found in a wide variety of foods such as fruit, vegetables and legumes as 
well as the synthetic form of folate, folic acid, which is found in supplements and 
also added to foods as a fortificant16. Structurally, folic acid consists of three 
moieties; a fused pteridine ring, a para-amino benzoic acid ring and a glutamate 
amino acid residue (See Figure 2.1)17. Folates found in food differ from folic acid by 
existing in polyglutamyl forms with a tail of glutamic acid residues rather than a 
single residue, in the one carbon species located at the N5 and N10 positions, and in 
the oxidation state of the pteridine ring18. 
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Figure 2.1: Diagram of folic acid showing major structural components* 
*Calvero
19
  
 
Abundant sources of folate include foods such as leafy green vegetables, broccoli, 
cauliflower, oranges and yeast extracts such as vegemite; liver, yeast, and beer also 
provide a source of folate16. The main food group sources of folate for Australians 
are vegetables and legumes (29%) followed closely by cereals and cereal products 
(27%)20.  Folate found in food displays a wide range of bioavailability, ranging from 
between 30-59%, compared with folic acid21,22.  The main factors that affect 
bioavailability are the composition of the food matrix; eg. Minced and chopped 
spinach leaves have a higher bioavailability than whole spinach leaves and degree of 
intestinal deconjugation of polyglutamyl folate and the presence of dietary 
components that may reduce or enhance folate absorption23.  To account for 
differences in higher bioavailability of folic acid compared to food folate, the 
Dietary Folate Equivalents (DFE) have been developed, where 1 DFE = 1 µg food 
folate, or 0.6 µg folic acid added to food as a fortificant or 0.5 µg of folic acid taken 
as a supplement when fasting14, 23. Table 2.1 provides a summary of the folate 
content (as DFE) of selected foods and multivitamin supplements. 
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Many countries fortify foods with folic acid; for example, fortification of flour has 
been mandatory in the United States and Canada since 199824. In Australia, 
mandatory legislation was introduced in 2007 for the fortification of all bread 
making flour, unless it is labelled as organic bread or an organic bread product, with 
2-3 mg of folic acid per kg of flour25. This strategy has increased the folate content 
in bread considerably; prior to mandatory fortification a slice of wholemeal bread 
(30g) provided, on average 10 µg of DFE, compared to an average of 70 µg DFE 
following the introduction of mandatory fortification (see Table 2.1). 
Table: 2.1: Dietary Folate Equivalents (DFEs) of selected foods and supplements 
Food DFEs per 100g Weight in grams (g)/serving to 
provide RDI (400 µg/day) 
Wholemeal bread unfortified (pre- 
2007) 
32 1250 g (approx. 42 slices) 
Wholemeal bread fortified (2007-) 229 175 g (approx. 6 slices) 
Asparagus 133 300 g (approx. 20 spears) 
Spinach 105 381 g (approx.  4 cups) 
Orange 31 1300 g (approx. 12 oranges) 
Lentils 182 220 g (approx. 1 cup) 
Beef Liver 218 183 g 
Vegemite 5791 7 g (2.5 teaspoons) 
Multivitamin supplement 200-500 per capsule/tablet 1-2 capsules/tablets 
(Adapted from Suitor and Bailey
23
, FSANZ
27
) 
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The National Institutes of Health (NIH) in the United States have set the 
Recommended Daily Intake (RDI) in DFEs for folate at 400 µg a day for adults with 
higher levels of 600 µg/day recommended for pregnant women to reduce the risk 
of Neural Tube Defects (NTDs)26. The Australian RDIs are similar, with 400 µg per 
day of folate recommended for people aged 14 years and above and 600 µg per day 
of folate recommended for pregnant women20. The RDIs for children, of age groups 
1-3, 4-8 and 9-13, are 150, 200 and 300 µg per day respectively, irrespective of 
gender20. Table 2.2 provides a summary of the recommended dietary requirements 
for folate and mandatory fortification policy in Australia. 
Table 2.2: Dietary recommendations and mandatory fortification in Australia 
Dietary recommendations20 
 
Group and age (years) Dietary Folate Equivalents: µg/day 
 Estimated Average 
Requirement (EAR) 
Recommended Dietary 
Intake (RDI) 
Children aged  
1-3 
4-8 
9-13 
14-18 
 
 
120 
160 
250 
330 
 
150 
200 
300 
400 
Adults 
18+ 
 
 
320 
 
400 
Pregnancy 
 
 
 
520 
 
600 
Lactation 
 
 
 
450 
 
500 
Fortification policy25 
 
Mandatory fortification 
 
 
-Introduced in September 2009 
-2-3 mg of folic acid added to all bread making flour  
-Exception if labelled organic 
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2.2.2 Folate metabolism 
Folate absorption occurs in the duodenum and upper jejunum of the small intestine 
where polyglutamate forms of folate from foods are hydrolysed by the intestinal 
brush border enzyme, Folypoly-y-Glutamate Carboxypeptidase, to monoglutamate 
forms of folate, prior to entering the intestinal cells via proton coupled folate 
transporters28. Active transport via the Multidrug Resistant Protein-3 (MRP3) then 
transports folate over the basolateral membrane of the intestinal cell to the 
capillary bed where it enters the circulation (see Figure 2.2 for diagram of folate 
absorption)28.  The main circulatory form of folate is 5-MTHF, which is transported 
from the circulation to cells via reduced folate carriers in the majority of cells, or the 
high affinity folate receptor alpha (FR-alpha) in the placenta, choroid plexus and 
proximal tubules of the kidney29. The synthetic folic acid form used in supplements 
is also converted to the active 5-MTHF form, however high doses, >200 µg, result in 
the appearance of unmetabolised folic acid in the bloodstream before its 
conversion to 5-MTHF30. Once transported inside the cell, active tetrahydrofolate 
forms perform many essential functions such as acting as one-carbon carriers for 
the methylation of DNA, proteins and lipids, nucleotide synthesis and amino acid 
metabolism. See Figure 2.2 below for a more detailed explanation of folate cell 
metabolism7.  
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Figure 2.2: Folate absorption and metabolism pathway 
(Modified from Ulrich et al.
7
) 
Cell 
Circulation 
Small intestine Enterocyte 
Key 
SAH: S-Adenosyl Homocysteine  FGCP: Foly-poly-γ-Glutamate Carboxypeptidase 
SAM: S-Adenosyl Methionine   PCFT: Proton Coupled Folate Transporter 
MS:  Methionine Synthase   MDR3: Multidrug Resistant Protein 3 
MTHFR: Methyltetrahydrofolate Reductase    
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Legend for Figure 2.2: Folate absorption and metabolism pathway: 
Transmethylation and remethylation; Folate is important for methylation of DNA 
and other substrates via transfer of methyl groups to form methylated substrates 
and SAH from the universal methyl donor SAM (1 & 2). This cycle is essential in 
homocysteine metabolism, with MS mediated transfer of the methyl group from 5-
MTHF to homocysteine to create the essential amino acid methionine. Deficiencies 
in folate (and also vitamin B12 which acts as a cofactor in MS) can therefore inhibit 
this reaction and lead to the elevated serum homocysteine levels. Nucleotide 
synthesis: Folate is also essential in nucleotide synthesis by acting as a methyl donor 
in its 5,10 Methylene-THF forms for pyrimidine and purine nucleotides (3). Folate’s 
essential role in many areas of cell metabolism, particularly methylation reactions, 
DNA synthesis and amino acid metabolism have resulted in significant interest from 
researchers into how folate status impacts on important diseases such as 
cardiovascular diseases, cancer and dementia, which are described in more detail in 
Section 2.3. 
2.2.3 Determination of folate levels 
The accurate determination of folate status is essential in many clinical settings; eg. 
Obstetrics, and in epidemiological research studies investigating folate or folate 
deficiency related conditions.  Typically two main tests of folate status are used: 
serum folate and erythrocyte folate. Serum folate provides a short-term assessment 
of folate status and thus is determinant of recent folate intake, while erythrocyte 
folate, provides a longer-term assessment of folate status (past 2-3 months 
intake)16. Traditionally, microbiological assays using lactobacillus spp. bacteria have 
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been used to test folate status, although these methods are unable to distinguish 
between the different folate metabolites and detect the presence of unmetabolised 
folic acid in the circulation, thus High Performance Liquid Chromatography (HPLC) is 
needed when data on specific forms of folate are required30,31. Increasingly, 
commercial automated competitive binding methods, typically using folate binding 
protein; as used in the current study, with chemiluminescence detection are used 
to assess folate status in laboratories, however like the microbiological methods 
these are unable to detect unmetabolised folic acid, but do have the advantage of 
being widely accessible and cost effective assays32. Identical assays are used to 
assess both red blood cell and serum folate, although prior to assay, the folate in 
red blood cells requires extraction, typically via lysis of the red blood cells in a 
concentration of ascorbic acid33. The Royal College of Pathologists of Australasia 
have defined normal folate status as 7-45 nmol/L for serum folate and 360-1400 
nmol/L for red blood cell folate34. However, both red blood cell and serum folate 
status cut offs for deficiency are not well defined for health outcomes and various 
researchers have used different cut off levels to define deficiency or ‘low’ folate 
status1,35. An example of various cut offs to define low serum and erythrocyte folate 
is provided in Table 2.31. 
Table 2.3: Classification of low and normal serum and erythrocyte folate levels 
Classification Serum folate (nmol/L
)1
 Erythrocyte folate (nmol/L)
1
 
‘Very low’ <6.8 <370 
‘Moderately low’ 6.8-<11.0 370-<513 
‘Normal’ >11.0 >513 
(Data from Flood et al.
1
) 
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2.3 Folate and disease 
Folate’s key role in many aspects of cellular metabolism, particularly synthesis of 
DNA and one carbon metabolism reactions has led to a high degree of interest from 
researchers into how low folate status impacts human health and wellbeing. The 
following section provides an overview of the evidence for folate’s role in diseases 
such as NTDs, cancer and cardiovascular diseases and also briefly discusses recent 
evidence showing a possible role for folate in cognitive decline. The section 
concludes by investigating research showing possible seasonal and latitude 
differences in some of these diseases that suggest an important link between UV 
radiation exposure and folate status. 
2.3.1 Folate and disease: Neural Tube Defects 
Folate is well known for its role in reducing the risk of NTDs2. NTDs are a form of 
congenital malformation which occurs as a result of a failure of the neural tube to 
close during embryonic development early in pregnancy, with the most common 
forms being Spina Bifida; which primarily affects development of the spinal cord, 
and Anencephaly; which is failure of the cerebral cortex to develop36. The exposure 
of the open neural tube in utero during fetal development, results in neurological 
damage over the term of the pregnancy, with some of the most serious symptoms 
for Spina Bifida, including incontinence of the bowel and bladder and varying 
degrees of paralysis below the level of the spinal lesion37.  Despite the recent 
decreases in the prevalence rate of NTDs, approximately one in every ten thousand 
pregnancies is still affected with a NTD in Australia38. While research data show the 
effectiveness of folic acid in reducing risk of NTDs, relatively little is known about 
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the actual mechanisms in which folic acid prevents NTDs; indeed our knowledge of 
the mechanisms behind NTD development are limited36 
Research trials have consistently shown the benefit of folic acid supplementation in 
reducing the risk of NTDs. The landmark Medical Research Council’s (MRC) vitamin 
study is particularly important; this study (N=1,817) showed 4 mg/day of folic acid 
supplementation commenced one month before conception and continued through 
the first trimester, reduced NTD risk by 72% (95% CI: 0.12-0.71) compared to those 
taking a placebo39. Further trials have shown consistent reductions in NTDs 
following folic acid supplementation; for instance, the introduction 400 µg/day folic 
acid supplementation in two regions in China resulted in significant reductions in 
the rate of NTDs for both regions40. While this was not a randomized controlled 
study it was particularly noteworthy for the large number of participants 
(n=130,142 taking folic acid vs. n=117,689 not taking folic acid) involved and the 
finding that NTDs were reduced in areas with both high and low rates of NTDs40.  
A possible weakness in the existing trial evidence is that the majority of studies 
have focused on participants who have previously experienced a NTD affected 
pregnancy; this places some limitation on the relevance of the evidence with Pitkin 
et al.36 reporting that 90% of NTDs cases involve females who have not had an NTD 
affected pregnancy previously. It is also important to note that NTDs are 
multifactorial diseases and several other genetic and environmental factors are 
known to increase the risk of NTDs, one particularly important factor is a mutation 
in the Methyltetrahydrofolate reductase (MTHFR) gene, which is thought to be 
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responsible for up to a quarter of all NTD occurrences2.  Despite this, folic acid 
supplementation of pregnant females continues to be an important public health 
intervention to reduce risk of NTDs, although of only limited benefit in some 
circumstances, such as unplanned and unexpected pregnancies.  
 Folic acid’s acknowledged role in reducing NTDs and the recognition that education 
programs and supplementation interventions will not reach all women planning 
pregnancy are furthermore, of limited effectiveness for women experiencing 
unplanned pregnancies, has led many countries to introduce widespread folic acid 
fortification in foods as a strategy to further reduce incidence of NTDs23,24,27. Data 
from Canada show that overall prevalence of NTDs was reduced from 15.8 per 
10,000 live births over 1993-1997 to 7.2 per 10,000 live births for 2000-2002, a 
45.6% drop following introduction of both voluntary and mandatory fortification41. 
Data from countries such as Canada strongly influenced the recent introduction of 
mandatory folic acid fortification in bread making flour in Australia, with the 
Australian Institute of Health and Welfare data showing that this is expected to 
prevent between 14 to 49 incidences of NTDs per year in the country38.  While an 
important strategy in reducing prevalence of NTDs, mandatory fortification of food 
products with folic acid has also generated some controversy, particularly due to 
the ability of increased folate intakes to mask vitamin B12 deficiency by effectively 
treating the anaemia associated with B12 deficiency, but not the neuropathy, and 
also due to fears of high intakes of folic acid and possible effects on cancer 
prognosis (see 2.3.3)16. 
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2.3.2 Folate and disease: Cardiovascular disease 
 Folate plays an important role in the metabolism of the amino acid homocysteine 
within cells (See Figure 2.3)42. Since homocysteine is classified as an independent 
risk factor for cardiovascular disease, there has been much research interest in the 
role of folate in possibly reducing cardiovascular disease risk through the lowering 
of total serum homocysteine levels17. 
 
Figure 2.3: Homocysteine metabolism in the cell (Simplified) 
(Modified from Finkelstein and Martin
42
) 
 
Legend for Figure 2.3: Folate’s role in homocysteine metabolism: 
Homocysteine is methylated via Methionine Synthase (MS) with 5-MTHF acting as 
the methyl donor/cofactor in this process. Homocysteine is also important in the 
formation of Cysteine and derivatives via the transulfuration pathway. Low folate 
intakes result in decreased methylation of homocysteine to methionine and, an 
increase in serum homocysteine levels, raised levels of which are classified as an 
independent risk factor for cardiovascular disease17. 
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Observational studies have reported significant increases in cardiovascular disease 
risk as a result of elevated homocysteine, while early studies with folic acid 
supplementation showed much promise by significantly lowering homocysteine 
levels 3,43. Together, this seemed to indicate that folate may play an important role 
in reducing risk of cardiovascular disease. Unfortunately, more recent data from 
randomized control trials have shown a null effect from folate and other B vitamins 
on cardiovascular disease risk; for instance, results from a recent large meta-
analysis (eight trials composed of 37,485 participants) show that homocysteine 
lowering intervention via vitamin B supplementation, including folate, had no 
statistically significant effects on cardiovascular disease risk or mortality4,6. To 
explain the null effect shown by recent evidence, Blum and Smulders28 have 
proposed an interesting hypothesis suggesting that the high levels of folic acid 
supplementation used in homocysteine lowering trials may lead to increased 
inflammation and proliferation, stimulating atherosclerotic plaque growth and 
destabilization. This would have the effect of negating any improvements in 
cardiovascular disease risk from lowering homocysteine levels.  
2.3.3 Folate and disease: Cancer 
Folate’s essential role in DNA synthesis and repair has also made its role in cancer of 
great interest, with epidemiological studies showing that folate appears to provide 
a protective effect on some cancers, eg. prostate, lung and colorectal 7. For 
example, a large prospective analysis of cancer mortality and morbidity in Western 
Australia (N=1,988) showed independent associations between decreased folate 
levels and increased risk of prostate cancer mortality and breast cancer morbidity 
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over 20 years of follow up44. Results from randomized controlled trials have shown 
less promise; for instance, a meta-analysis of three randomized studies (total 
N=7,488; folic acid) conducted by Fife et al.45 showed no decrease in adenoma 
recurrence (adenomas are the precursor of most colorectal cancers), over a three 
year follow up with between 0.5 to 2.5 mg folic acid supplements per day.  It should 
be noted, however, that all of these studies recruited participants with a history of 
adverse health, two of the studies with participants who had a particularly high risk 
of developing colorectal cancer ie. adenomas removed in the past six months or 
previous history of polyps. This is important, as recent research has shown that 
timing of folic acid supplementation prior to, or during pre-neoplastic tumour 
stages is likely to be a highly important factor in determining the effect of folic acid 
supplementation on cancer risk46.  
While the precise mechanisms for protective roles of folate in cancer development 
are unknown, it is postulated that folate may enhance DNA repair and protect 
against cancer initiation46. Folate acting as a cofactor for methylation reactions is 
essential in DNA synthesis and deficiency has been shown to disturb DNA 
integrity47. For instance, states of folate deficiency and depletion may play a role in 
cancer initiation via decreased thymidylate synthase activity, which is dependent on 
5,10-methylene tetrahydrofolate, and subsequent misincorporation of uracil into 
DNA48. This results in the repair and removal of the uracil from the DNA strand, 
increasing the risk of double strand breaks which reduce DNA integrity and increase 
cancer risk49. 
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There is also increasing evidence that too much folic acid may increase risk of some 
cancers. Findings from the Prostate, Lung, Colorectal and Ovarian screening trial 
showed a 20% increased risk in breast cancer development in females taking >400 
µg/day of folic acid supplements compared to those not taking supplements50. 
Extended follow up of participants receiving 1000 µg/day of folic acid 
supplementation over three years in colon and prostate cancer trials has also found 
an increased risk of developing multiple colorectal adenomas and prostate cancers 
51, 52. These results highlight the complexity of tumorigenesis and the divergent role 
of folate. 
Several mechanisms have been proposed to explain folic acid’s possible function in 
promoting cancer progression. These includes effects on immune system functions 
important for killing cancer cells; for example, research undertaken by Troen et al.53 
reported that healthy, postmenopausal women with a diet rich in folate and taking 
folic acid supplements in doses >400 µg per day  had significantly suppressed 
Natural Killer (NK) cell cytotoxicity, with an inverse association between 
unmetabolised folic acid in the blood and NK cytotoxicity. There is also an increasing 
focus on the role of folate in the hypermethylation and subsequent silencing of 
tumor suppressor genes, which are important in the control of cancer initiation and 
promotion54. These mechanisms may help to explain some of the recent findings 
showing a higher risk of developing/recurrence of cancer in people taking folic acid 
supplements who are already considered at high risk of developing cancer.  It is 
important to note that even high intakes of natural folates found in food are rarely 
implicated in increased cancer risk, though the paucity of quantitative folate intake 
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data from diet makes any conclusion regarding the different health effects of folate 
from food versus folic acid difficult46. While there is a lack of consensus in this area, 
the growth of mandatory food fortification with folic acid makes further research 
into the possible health risks of folic acid essential.  
2.3.4 Folate and disease: Cognitive Decline 
Studies have shown that an increase in the concentration of plasma total 
homocysteine is associated with increased risk of dementia and Alzheimer’s 
disease55. While the exact mechanisms of this association are unclear, 
homocysteine is known to be associated with increased regional and whole brain 
atrophy, with homocysteine appearing to be a cause of toxic damage to neurons as 
well as neurovascular damage56. Folate, and vitamins B6 and B12 play an essential 
role in homocysteine metabolism and increased intake of these vitamins, even in 
the absence of deficiency, can lower plasma homocysteine levels57.  Therefore, 
there has been a great deal of recent interest in whether increasing levels of folate, 
as well as vitamins B6 and B12, would result in decreased neurodegeneration in 
people with dementia disorders or indeed reduce or delay risk of developing 
dementia in the first place.  
Research conducted in this area has provided mixed data, with Aisen et al.57 
showing no effect in cognitive decline measures for participants with Alzheimers 
disease taking 5 mg folic acid, 25 mg vitamin B6 and 1 mg B12 per day over 18 
months, compared to the placebo group (treatment group n=220;control group 
n=138). Smith et al.58 has however, showed rate of brain atrophy tested via 
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Magnetic Resonance Imaging, significantly decreased in participants with mild 
cognitive impairment taking 800 µg of folic acid, 500 µg of vitamin B12 and 20 mg 
B6 per day over two years (treatment  group n=85; placebo group n=83). While 
both these studies differed in both the type of cognitive decline displayed by 
patients and measures used to test decline, they demonstrate that careful 
consideration of type and stage of dementia as well as of the measures of cognitive 
decline used, will be particularly important in the design of future studies 
investigating folate and its role in neurodegeneration and cognitive decline. 
2.3.5 Folate and disease: Seasonal effects 
Research has also shown seasonal differences in NTDs, with lower levels of NTDs 
reported during winter compared to summer and seasonal differences in cancer 
diagnosis and mortality have also been the focus of recent research59,60.  While 
these are ecological investigations so no causal link can be determined, the authors 
have hypothesised that folate may play an important role in the observed seasonal 
variation between of these diseases60-62. For instance, seasonal variations in folate 
from these studies show decreased serum folate and red cell folate in summer and 
spring compared to higher levels in winter and autumn seasons where UV radiation 
exposure is less60-62. Cancer provides a particularly interesting example of this 
relationship due to folate’s essential role in cancer metabolism; indeed folate has a 
major role in cancer treatment with the use of chemotherapeutic agents such as 
methotrexate which acts as an anti-folate to reduce DNA synthesis and cancer cell 
proliferation in cancer therapy51. While higher folate status appears to be 
protective in the early stages of carcinogenesis, higher folate status during later 
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stages of carcinogenesis may actually decrease cancer survivability for some types 
of cancer46,59. It is through the theory of lower folate status possibly improving 
cancer survival at certain stages in carcinogenesis, that Steindal et al.59 has 
proposed the hypothesis that cancer mortality is linked to seasonality via UV’s role 
in folate photodegradation. For instance, several Norwegian studies have shown 
that the relative risk of death for some cancers was 20-50% lower for cases if 
diagnosed in summer, compared with winter, after 18 months of follow-up63-66. 
Steindal et al.59 suggest that lower folate status in summer resulting from increased 
solar UV folate degradation is a possible reason for the improved cancer prognosis 
seen in these studies.  
While these studies were primarily investigating the role of vitamin D and 
seasonality in cancer prognosis, the Norwegian data provide an interesting 
alternative hypothesis, particularly considering folate’s important role in cancer. It 
is also important to consider that both hypotheses are not mutually exclusive; for 
instance, both higher vitamin D and lower folate status in summer may contribute 
to the improved cancer prognosis seen in ecological research designs. Further 
investigation in this important area is therefore needed to inform how solar 
induced degradation of blood folate may be a factor in improving prognosis for 
some forms of cancer or preneoplastic tumors. As all seasonal and latitude studies 
are ecological in design, no causal affect can be determined and there exists a 
multitude of other cofactors besides folate that could in fact explain, or at least 
certainly contribute to the relationship between season, latitude and disease 
occurrence seen in these studies. Also the actual mechanisms and clinical 
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significance of UV induced folate degradation is as yet not well defined. Thus, well 
designed laboratory and epidemiological studies are critical to improve our 
understanding of the relationship between UV radiation exposure and folate status 
prior to investigation of its possible contribution to disease risk. 
2.4 Folate and UV radiation: Overview 
With folate’s role in many aspects of human health and data showing a possible 
seasonal link with folate status, environmental factors that may affect folate status 
are of great interest from a health perspective. One of these environmental factors 
is the photosensitivity of folates upon exposure to UV radiation. While there has 
been a recent upsurge of research conducted in the area of UV induced folate 
degradation, interest in this area is not a recent phenomenon, with Branda and 
Eaton67 proposing a relationship between UV sun exposure and the evolution of 
human skin colour in 1978. Branda and Eaton67 proposed that maintenance of 
genetic characteristics such as dark skin colour requires continuous positive 
selection and therefore, there must be strong evolutionary pressures favouring 
retention of highly melanised skin in areas of intense UV radiation. The hypothesis 
is based on the observation that populations with more heavily melanised skin 
evolved close to equatorial areas as darker skin provided these populations with a 
survival advantage by reducing folate and possibly other nutrient photodegradation 
by UV radiation exposure68.  
 Other explanations for the retention of dark skin colour, such as the protection that 
dark skin provides against the carcinogenic effects of UV radiation, are likely not to 
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have impacted reproduction and therefore selection, while micronutrient 
deficiencies, particularly folate, are known to play essential roles in fetal 
development and fertility and are therefore much more likely to drive selection 
pressures55. Indeed, research has shown a lower incidence of NTDs in darker 
skinned individuals, which provides evidence that darker skin may offer some 
protection against UV induced folate degradation69. Since the publication of this 
article, several other authors have also published papers supporting the theory of 
the photoprotective role of melanised skin to reduce micronutrient degradation 
and its resulting impact on the evolution of human skin colour68-71. Similarly, it has 
been hypothesized that lighter skin provided a survival advantage away from the 
equator at higher latitudes, in this case by improving UV induced vitamin D 
synthesis, which is reduced in more heavily melanised populations72.  
2.4.1 Folate and UV radiation: Laboratory studies  
Several experimental studies have proven that folate is vulnerable to UV 
degradation. For instance, in vitro studies have shown that folic acid (the synthetic 
form of folate) is photosensitive to UVA radiation13, 73-77. These studies have shown 
that when folic acid is exposed to UVA, it undergoes photolysis and is cleaved into 
its major photoproducts, p-aminobenzoyl-L-glutamatic acid, 6-formylpterin and 
pterin-6-carboxylic acid76. This is a highly relevant finding from a clinical point of 
view considering folic acid exists as free folic acid in the bloodstream prior to 
conversion to 5-MTHF. Furthermore, UVA has the potential to penetrate the skin 
and degrade folic acid prior to its conversion to 5-MTHF (see Figure 2.5). Laboratory 
studies have also shown that biological metabolites of folate found in the human 
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body such as 5-MTHF are sensitive to UVB (280-320 nm) radiation, but not UVA 
(320-400 nm)10. The absorbance’s of both 5-MTHF and folic acid when exposed to 
different UV wavelengths are shown in Figure 2.4, both UVA and UVB are absorbed 
by folic acid and UVB is absorbed readily by 5-MTHF; however, absorbance in the 
UVA spectrum by 5-MTHF is minimal59. Ultraviolet C radiation (100-280 nm), is 
absorbed by both folic acid and 5-MTHF, although as it is absorbed by the earth’s 
atmosphere and does not reach the earth’s surface to affect the skin10. Based on 
observations from Figure 2.4, UVB would appear to be the main UV wavelength 
responsible for folate degradation; however, this does not take into account the 
fact that UVB does not penetrate deeply enough into the skin to reach the dermal 
circulation and is therefore unlikely to influence blood folate levels directly10. The 
longer wavelength UVA, although able to penetrate the skin to a greater depth and 
reach the dermal circulation, is unable to directly degrade 5-MTHF, resulting in the 
inability of UV radiation to directly impact 5-MTHF levels in blood14.  
 
Figure 2.4: Absorbance’s for UVA and UVB radiation in 5-MTHF and folic acid 
 (Adapted from Steindal et al.
59
) 
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The recent discovery of photosensitisers such as flavins and porphyrins, that have 
the ability to indirectly degrade 5-MTHF during UV radiation exposure, has 
consequently provided a biologically plausible mechanism for in vivo UV 
degradation of folate11, 12. Both flavins and porphyrins are natural photosensitisers 
in human blood which produce Reactive Oxygen Species (ROS), such as singlet 
oxygen, when exposed to UV radiation11,12. It is the production of these ROS that 
has been proposed as a mechanism that leads to the degradation of 5-MTHF to the 
oxidized inactive form methyl 5,6 dihydrofolate12. As UVB radiation will not 
penetrate deeply enough into the dermis to affect circulating photosensitisers, it is 
proposed that it is UVA that indirectly degrades 5-MTHF through the generation 
ROS; particularly singlet oxygen, from photosensitisers (see Figure 2.5)12. Thus, 
combined with laboratory studies showing direct degradation of folic acid by UVA, 
this discovery provides a second, indirect mechanism whereby UVA can potentially 
degrade folate, although epidemiological studies are needed to confirm whether 
UV radiation in vivo via sun exposure or sunbeds can significantly decrease folate 
levels in humans. 
While most of the studies in the area are focused on blood levels of folate; folate 
levels in the skin are particularly vulnerable to degradation by UV radiation, both via 
direct photodegradation and indirect degradation via ROS9,78. The depletion of 
folate in skin may have significant health impacts; Williams et al.9 recently 
conducted an experiment using cultured keratinocytes and showed that 
keratinocytes depleted of folate had a decreased capacity to repair DNA damage 
when exposed to solar simulated light.  Folate depletion in the skin combined with 
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UV radiation exposure appears to increase genomic instability, which is associated 
with early skin carcinogenesis9. This situation was reversed by the addition of folate, 
in the form of folic acid, to keratinocytes which enhanced the repair of DNA damage 
in these cells9. While the capacity of UV radiation to damage skin is not a new 
concept, the direct role of UV radiation in the degradation of folate in the skin, and 
the observation of enhanced photo and oxidative damage in folate depleted cells 
requires further investigation. The  interactions of folate with UV radiation in the 
skin suggests  another pathway leading to depletion of circulatory folate, as blood 
folate needs to replete lost folate in the skin (see Figure 2.5). Further research into 
UV induced folate depletion is therefore needed to further our knowledge of its role 
in carcinogenesis and the potential for decreasing circulatory folate levels.  
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Figure 2.5: Proposed pathways to folate degradation by UV radiation 
 
  
 UVA penetrates to 
dermal circulation 
Oxidation of 
photosensitisers (ie. 
porphyrins and flavins) 
Direct absorption and 
photodegradation of  
free folic acid in blood. 
Production of Reactive 
Oxygen Species (ROS) 
Formation of folic acid 
photoproducts 
ROS oxidize 5MTHF 
and form  
photoproducts 
Reduced folate blood 
levels 
Repletion of folate in 
skin by circulatory 
folate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sun Exposure 
(Ultraviolet radiation 
UVA and UVB) 
Skin Direct and indirect 
photodegradation of 
folate in skin. 
 
Increased skin DNA 
damage if folate not 
repleted. 
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2.4.2 Folate and UV radiation:  Sunbed and solar UV studies  
There have only been a few small population based studies conducted into UV 
induced folate degradation, (summarised in Table 2.4). These include a study by 
Gambichler et al.79 showing that both single and serial exposure to UVA radiation 
via a sunbed did not significantly affect serum folate levels in healthy participants. A 
possible limitation of this study was the small number of volunteers (N=24; with 
only eight volunteers exposed to UVA radiation; although no power calculation was 
reported to interpret whether this sample size was adequate) and the dose of UVA 
radiation, which was not sufficient to photodegrade 5-MTHF-the main form of 
circulatory folate.  The results from Gambichler et al.79 confirm the laboratory data 
showing that 5-MTHF is not vulnerable to direct photodegradation by UVA at this 
dose, and although indirect degradation through ROS generation may have been 
expected, the precise biological UVA dose necessary to generate sufficient ROS for 
5-MTHF degradation is unknown.  
The findings from in vitro studies reported earlier, showing higher UVA absorption 
in folic acid compared to 5-MTHF, led Fukuwatari et al.14 to hypothesise that 
humans taking folic acid supplements would be at increased risk to degradation of 
folate by sunlight (via UVA exposure).  To test this hypothesis, a series of 
experiments were conducted using a sample of Japanese college students aged 
between 21-24 who were asked to bathe in sunlight between 11am to 1pm, while 
also taking 0.25 mg of folic acid supplements at each meal for two days prior to, and 
once on the day of blood testing14. This same methodology was also repeated for 
the students with the exclusion of the sunlight exposure intervention. Folate 
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concentrations were decreased by 27% when participants (n=7) bathed in sunlight, 
while conversely, when participants were not exposed to sunlight, folate 
concentrations remained the same (for participants exposed: plasma folate pre-test 
=38.0±7.2 nmol/L vs. post-test =28.1±4.6 nmol/L)14.  The study also showed no 
difference in plasma folate post sun exposure when folic acid was not taken as 
supplements by participants. This lack of depletion when no folic acid was being 
taken, corresponds to the data collected by Gambichler et al.79 and in vitro studies 
showing no significant absorption and degradation of 5-MTHF by UVA irradiation. 
While there are several limitations in the study by Fukuwatari et al.14, particularly 
the small study numbers and lack of randomisation, data collected from the study 
points to the possibility that people supplementing with folic acid are at greater risk 
of folate degradation than those who are not. This is of particular concern for 
pregnant women, especially with high sun exposure, who often obtain a significant 
proportion of their folate intake from folic acid supplementation17. The data from 
both of these studies also raise questions about the degree of the in vivo impact of 
indirect degradation of 5-MTHF via generation of ROS, as they showed no 
significant change in folate status following UV exposure, with the exception of the 
significant change if folic acid was taken14,79.   
Several studies have also examined the effect of UVB radiation exposure on folate 
status by using psoriasis patients where UVB radiation therapy is often used as a 
treatment80. Narrowband UVB phototherapy was used to investigate the effect of 
UVB on serum and red blood cell folate status in patients with psoriasis by Rose et 
al.81 (N=35); and in a mixed sample of dermatological patients by Cicarma et al.82 
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(N=19), although no significant treatment effect was observed in either of these 
studies. An earlier study by Shaheen et al.83, however reported a significant 
decrease, of 27% in serum folate following exposure of 20 vitiligo patients to 36 
narrowband UVB sessions. All three studies used similar equipment with the UVB 
source provided by standard narrowband UVB bulbs, Philips TL-01 fluorescent 
lamps, which have an emission peak of 311 nm. One likely explanation for the 
differences is the larger number of phototherapy sessions and higher cumulative 
UVB exposure used in the Shaheen et al.71 study to treat the exposure group84. It is 
also worth noting the different types of dermatological conditions used in each of 
these studies may have also affected results, such as via reducing the skin’s 
protective barrier to UV radiation, but little research is available into how any of 
these conditions may impact vulnerability of folate to UV radiation.  
To test the effect of broadband UVB exposure (280-315 nm) on blood folate status, 
a recent study was conducted by Juzeniene et al.31 in which both red blood cell and 
serum folate were measured in both healthy volunteers and psoriasis patients in 
Oslo, Norway. Both broadband UVB exposure from sunbeds and sunlight exposure 
during summer were shown to have no influence on healthy participants, although 
a small decrease in folate level was observed in psoriasis patients following 
broadband UVB exposure31.  Once again small study numbers (N=5 to 13), and the 
lack of measurement of dietary and supplemental folate intake, to allow controlling 
for, in the sample are some limitations. Also, as noted by Juzeniene et al.31, the use 
of HPLC rather than the more standard immunoassay method for analysing red 
blood cell folate would have allowed the observation how UVB and sunlight 
53 | P a g e  
 
affected different folate fractions such as 5-MTHF, folic acid and the oxidised 
methyl 5,6 dihydrofolate. This study, combined with previous research, is important 
as it provides evidence that only very high doses of UVB are required to 
photodegrade 5-MTHF. As UVB is unable to penetrate to the dermal circulation it is 
possible that skin derived depletion of folate (see Figure 2.3) or possibly another 
mechanism; for instance, an increased vulnerability to UVB in people with some 
dermatological conditions is responsible for this degradation.     
Another important factor may involve the antioxidant status of participants. For 
example, a recent study by Joshi et al.85 reported on the effectiveness of several 
antioxidants, including ascorbic acid (vitamin C), and quercetin, in protecting DNA 
and RNA bases against damage by reactive ROS generated via photosensitised 
riboflavin. The same ROS, again derived from photosensitisers such as riboflavin, 
have also been shown to oxidise 5-MTHF, as discussed earlier, thus the possibility 
exists that people with higher levels of antioxidants may be protected from the 
indirect folate degradation pathways illustrated in Figure 2.3, although direct 
degradation of folic acid via UVA would continue to occur. This may be another 
factor as to why little in vivo data has shown a relationship between UV radiation 
exposure and folate status in participants not taking folic acid supplements. 
With so few epidemiological studies conducted, the ability of sun exposure to affect 
folate status in clinically significant levels, that would impact human disease, is 
impossible to ascertain. There is also still conjecture as to whether sun exposure 
impacts folate status. Research in countries with higher UV radiation intensities and 
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exposures may be an important next step, as most of the epidemiological research 
has been conducted in higher latitudes where UV radiation intensities, even in 
summer, are quite low.
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Table 2.4: Published in vivo studies in folate degradation and ultraviolet (UV) radiation exposure 
Author (Country study 
conducted) 
Radiation treatment /cumulative 
dose (unless otherwise specified) 
Blood Testing protocol Study participants Results 
Gambichler et al.
79 
(Germany) 
Ultraviolet-A (UVA) from sunbed 
twice weekly for 3 weeks/96 J cm
2
 
Serum folate tested with 
automated immunoassay 
N=24 healthy participants; 
n=8 participants      
randomised into UVA 
treatment group 
No significant differences in 
serum folate observed 
between exposed and non-
exposed groups 
Shaheen et al. 
83 
(Egypt) 
Narrowband Ultraviolet-B (UVB)  
with 36 exposures/ 76 J/cm
2
 
Serum folate tested by HPLC N=40 vitiligo patients ( n=20 
study group; n=20 control) 
Significant decrease in serum 
folate following UV treatment 
(baseline 18.3 ± 5.9 nmol/L 
vs. 13.4 ± 3.4 nmol/L after 
UV) 
Fukuwatari et al.
14 
(Japan) 
Solar UV from outdoor exposure 
11.00-13.00 for two days in summer/ 
UVA: 12 J/cm
2
 
Serum folate tested with 
microbioassay 
N=7 female students taking   
0.25 mg of folic acid 
supplements at each meal for 
2 days and morning of blood 
test  
Control: same protocol and 
participants but no sun 
exposure on another day 
Significant decrease in serum 
folate following sun exposure 
(38.0 ± 7.2 nmol/L vs. 28.1 ± 
4.6 nmol/L) 
Rose et al. 
81
 
(United Kingdom) 
Narrowband UVB with minimum of 
18 exposures/UVB average 2.3 J cm
2
 
per visit (Note: dose varied 
depending on participants clinical 
response to UVB phototherapy) 
Serum and erythrocyte tested 
with immunoassay 
N=35 psoriasis patients No significant decreases in 
serum or erythrocyte folate 
following UVB exposure 
Cicarma et al. 
82 
(Norway) 
Narrowband UVB from photocabinet 
with a total of 9-15 treatments/2.35-
13.4 J/cm
2
 (Note: dose varied 
depending on participants skin type 
and clinical response to UVB 
phototherapy) 
Serum and erythrocyte folate 
with immunoassay; 
25(OH)D with 
radioimmunoassay 
N=19 dermatological patients Significant increase in 
25(OH)D but no effect on 
blood folate status 
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Juzienne et al.
31 
(Norway) 
Study 1 : Solar UV from outdoor 
exposure/UV not measured 
Study 2: UV from sunbed 4 sessions 
2x 10 min and 2 x 20min 
Study 3: Broadband UVB 
photocabinet single exposure/ UVB 
0.18-0.46 J/cm
2
;UVA 0.04-0.46 J/cm
2 
Study 4: Broadband UVB 
photocabinet 7-22 exposures/ varied 
dose (maximum dose 115-220 
J/cm
2
). 
Serum and erythrocyte folate; 
homocysteine and 25(OH)D 
Study 1: N=17 (4 psoriasis 
patients and 13 healthy 
participants). 
Study 2: N=6 healthy males 
Study 3: N=9 psoriasis 
patients 
Study 4: N=10 psoriasis 
patients 
No statistically significant 
effects of solar or artificial UV 
exposure on blood folates in 
all 4 studies. Slight reduction 
in blood folates reported in 
psoriasis patients. 
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2.5 Limitations in previous research and current research needs 
The question of whether UV radiation can affect folate status in clinically significant 
levels in vivo is of great importance due to the essential role that folate plays in 
maintaining human health. While laboratory findings have allowed us to elucidate 
possible mechanisms of UV radiation induced folate degradation and have pointed 
to possible health effects from UV radiation induced folate degradation, in vivo data 
have generated conflicting results14,29,67,69-71. Additionally, population based studies 
have mainly focused on the use of sunbeds with only a few studies testing the 
impact of UV radiation exposure on folate status. Further complicating matters, is 
the lack of consensus regarding folate reference ranges and the need to measure 
different types of folate due to the varied impacts of UVA and UVB radiation on the 
different forms of folate, such as 5-MTHF and folic acid11,12. However, recent 
findings have shown that UV photo degrades the synthetic folic acid in vivo when 
people are exposed to UV radiation14. This is of great health significance, due to the 
introduction of mandatory folic acid fortification in the food supply of many 
countries, including Australia and the reliance, particularly of pregnant women, on 
folic acid supplementation to provide a significant proportion of their folate needs.  
Larger epidemiological studies are needed so researchers can test the effects of UV 
radiation on the folate status of people. These larger studies need to build on the 
research already conducted in this area and would enable researchers to observe 
any statistically significant population level affects between UV radiation exposure 
and folate status. This combined with a research emphasis on groups who are most 
vulnerable to developing adverse health outcomes from folate deficiency, for 
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example, pregnant women; would provide much needed data into the possible 
health consequences of folate photodegradation. Improving our understanding of 
the various mechanisms of UV radiation induced folate degradation in blood will 
also be important as this would allow the elucidation of the relative contributions of 
direct and indirect UVA mechanisms of photodepletion of folate. The impact of 
folate depletion in the skin by both UVA and UVB radiation and its role in reduced 
DNA repair and subsequent skin cancer development is another area in need of 
further investigation.  
Another important consideration is that to date much of the interest and conduct of 
folate and UV research has been largely confined to Northern Europe and Japan, 
regions where populations experience significantly less UV radiation exposure than 
countries such as Australia. Research into the effects of sunlight exposure on the 
folate status of populations in high UV environments is a priority. Future research 
into this field would also benefit greatly if dietary and supplemental folate intake is 
also collected, as both the type and amount of folate consumed have major 
implications for UV radiation and folate studies. 
Our understanding of the important role folate plays in maintaining human health, 
combined with considerable evidence from in vitro data of UV radiation’s impact on 
folate degradation, suggests that UV radiation induced folate degradation may 
possibly contribute to important diseases such as NTDs and cancer, resulting in 
adverse impacts on human health. Unfortunately, current limits in the 
epidemiological evidence minimise our ability to make informed decisions regarding 
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public health advice for populations, particularly those that may be at heightened 
risk such as pregnant women.  As summarised in the preceding discussion on 
current limitations in the research and in Figure 2.6 below, there is a clear need for 
improved population data to enhance our knowledge of whether UV induced folate 
degradation is a public health concern. 
 
 
 
 
 
 
 
Figure 2.6:  Flowchart illustrating need for improved epidemiological data on UV radiation’s role in 
folate degradation 
 
  
Folate plays an essential role in many 
aspects of human health 
Research into modifiable risk factors that 
affect folate status is particularly 
important for vulnerable groups 
Biologically plausible mechanism exists 
for UV degradation of folate in human 
blood 
 
In vitro data show that folate can be 
degraded by UV radiation 
However, current epidemiological data 
are severely limited in terms of:  
Geographical location 
Lack folate intake data 
Lack of folic acid supplementation  
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2.6 Current project’s role in addressing research needs  
This review has identified several research priorities in the area of folate and UV 
radiation research. Therefore, the current PhD research project aims to address 
four major themes where limitations exist in the current research: 
1. Conduct of study in a country with high UV radiation exposures:  Individuals 
living in Australia have been shown to have particularly high annual UV radiation 
exposures15; thus the setting of this study in the subtropical Brisbane region of 
Australia during the late spring and summer season allows for the investigation of 
the impact of high natural sun exposures on the folate status of participants. 
2. Supplementation of participants with folic acid: As early research findings 
suggest that folic acid, rather than natural folates in foods may be most vulnerable 
to UV degradation, this study builds on this previous research by supplementing 
participants with folic acid. 
3. Conception age female participants: Low folate status is of particular concern to 
conception age females due to risk of NTDs in planned and unplanned pregnancies. 
Additionally folic acid supplementation is an important strategy in reducing risk of 
NTDs in this population, thus the current project focuses on this population group. 
4. Dietary and supplemental folate: This project will also add significantly to the 
field by collecting the dietary and supplemental folate intake of participants using a 
validated questionnaire. As intake of folate is the main contributor of folate status 
collection of this data has been a major limitation of previous studies. 
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2.7 Aims, research questions and hypotheses for project 
The main aim of this research project is to investigate whether conception age 
women with higher sun exposures are at an increased risk of lower folate status 
than women with lower sun exposures. Folic acid supplementation over two weeks 
will be used to increase the participants’ blood folate status, followed by one week 
of sun exposure measurement with a sun diary. Blood folate decreases from 
cessation of supplementation will then be compared with the sun exposure 
patterns of participants’ and other possible confounding variables. Another 
important component of the project is a description of participants’ dietary folate 
intake and how this relates to participants’ blood measures of folate. The aims, 
research questions, hypotheses and the Chapters that these are discussed in the 
thesis are outlined below in Table 2.5. 
Table 2.5: Aims, research questions and hypotheses for the research project 
Aim Research Question Hypothesis Chapter 
discussed 
Primary  
To test the effect of 
outdoor exposure on the 
folate status of 
participants. 
1. Are conception age 
women with a higher 
sun exposure at 
increased risk of 
lowered folate status? 
Women with higher 
sun exposures have a 
significantly lower 
folate status than 
women spending less 
time outdoors. 
Chapters 6 & 7 
Secondary  
To measure the 
effectiveness of folic acid 
supplementation in 
raising the folate status of 
participants. 
2. Does two weeks of 
folic acid 
supplementation 
increase folate status 
in a sample of 
conception age 
females? 
Folic acid 
supplementation 
significantly increased 
the folate status of 
the participants. 
Chapter 4 
To measure and evaluate 
the dietary intake of 
folate in the sample. 
3. Does dietary folate 
intake correlate 
significantly with 
blood measures of 
folate for the sample? 
Dietary folate intake 
correlated 
significantly with 
blood measures of 
folate. 
Chapter 5 
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Chapter 3: Methodology 
3.1 Research design 
3.1.1 Recruitment and screening 
This project used a voluntary recruitment strategy, with awareness facilitated by a 
media campaign in the Brisbane CBD area targeting workers and students. The 
media campaign included a call for participants placed on the QUT main page which 
linked to a QUT news story on the project providing information on the project and 
contact details. Additional awareness and media attention for the study was gained 
with a televised story on the study, which was filmed and aired on the Channel 9 
Queensland nightly news on the 5th October, 2011. The media campaign was 
followed by an email flyer announcing the call for participants through QUT email 
lists (see Appendix A), with the contact details provided for interested potential 
participants. 
Once potential participants had expressed an interest in the project via email or 
phone contact, they were sent the Participant Information Sheet (PIS) and consent 
form (See Appendices B and C respectively) for a more in depth explanation of the 
project. Participants were also asked in the initial recruitment flyer and the PIS 
whether they were hypersensitive to sun, or burn when exposed to sun for short 
periods outside of the intense UV radiation exposure times. In these cases, for 
safety reasons these participants were excluded from the study. The following 
criteria were required for participation in the project: 
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 Female 
 18-50 years of age 
 In good health 
 Not pregnant and trying not to conceive 
 Not sensitive to the effects of low level sunlight exposure 
 Be willing to participate in three short clinic sessions 
 Be willing to take a daily 500 µg folic acid* supplement for two weeks 
*Note: a 500 µg folic acid supplement (provided by Blackmores ®; Warriewood, NSW) was used 
due to the commercial availability of this supplement. 
 
Once screening was completed and participants had read the PIS and consent form, 
a date and time was organised via Outlook calendar for the first clinic appointment. 
Participants were also sent an electronic copy of the Part A Questionnaire which 
they could complete prior to the first clinic. An email reminder was also sent to 
participants one day prior to their appointment.  
3.1.2 Project design 
A short-term longitudinal research study design (three weeks in duration), with folic 
acid supplement intervention, was chosen for the project to investigate whether 
sun exposure was associated with a reduction in the blood levels of folate for 
conception age females, whose levels of folate had been increased by the folic acid 
intervention.  The short-term design provided the best way of measuring and 
controlling the outcome variable (sun exposure) within the limitations of funding 
and time for a PhD project. Data collection for the project was undertaken between 
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the 17th of October to the 16th of November, 2011 with cohorts of participants 
beginning on the week of the 17th October (n=33) and the 24th of October (n=13), 
respectively.  For each participant the project lasted three weeks and involved three 
visits to the clinic at the Institute of Health and Biomedical Innovation for data 
collection (Figure 3.1 provides a flow chart of the project structure).  
At the first visit, completed consent forms and Part A General Health 
Questionnaires were collected and participants were provided with a daily, 
commercial supplement of 500 µg of folic acid and instructed to take one tablet 
daily for the first two weeks of the study. To ensure adherence to supplementation 
participants were asked if they would like a SMS message reminder sent to them for 
the first week of the study, participants were also instructed to keep the folate 
supplement in a highly visible place with other medications or supplements. 
Baseline bloods were then taken for red blood cell and serum folate analysis (Figure 
3.2 provides a timeline of the blood collection visits).  After completion of the first 
visit a booking was made two weeks from the first visit. As in the first booking, an 
email reminder was sent to all participants one day prior to the second and final 
appointments. 
On the second visit, participants completed the Part B Questionnaire and post 
supplementation bloods were taken. Participants were also provided with a copy of 
and instructions on filling out the sun and physical activity diary for the final week 
and instructed to cease taking the folic acid supplement for the sun exposure 
measurement period. The final visit one week later was also booked at this time. 
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On the final visit, the completed sun diaries were collected and the Part C Folate 
Food Frequency Questionnaire (FFQ) was completed. Final bloods were also 
obtained and each participant’s height and weight was measured.  
As a thank you, vouchers were also distributed to each participant who completed 
the study. Each participant was informed that their blood results and an 
explanation of the results would be sent via email once analysis was complete. 
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UV AND FOLATE STUDY 
Recruitment   N=46 
 
Screening 
(Not pregnant or trying to receive, not on cancer or epilepsy meds) 
 
Part A Questionnaire 
 
Visit 1 (Initial): 
Consent Form 
Folic acid supplementation (give Blackmore’s supplements) 
Pathology (serum and RBC Folate) 
 
Folic acid supplementation (Duration: 2 weeks) 
 
Visit 2: 
Part B Questionnaire 
Pathology (serum and RBC Folate) 
Information provided on sun exposure diary 
 
Outdoor Exposure measurement week (Duration: 1 Week) 
 
Visit 3: 
Pathology (serum and RBC Folate) 
Part C Questionnaire 
Thankyou gift 
 
Post out/Email all 3 week folate results 
 
Figure 3.1: Flow chart of study design 
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3.1.3 Study dependent variable 
The dependent variable in this study was the change in participants’ folate status 
between Visit 2 and Visit 3, during the week of measurement for outdoor exposure 
(Figure 3.2). The change in folate status was obtained by calculating the difference 
between these two time points for both serum and red cell folate; ie. serum folate 
visit 2 – serum folate visit 3 = change in serum folate. This change in folate 
therefore represented the depletion of folate status over one week, following 
cessation of two weeks of folic acid supplementation.  
Figure 3.2: Data collection phase of project 
 
3.1.4 Study setting 
Collection of participants’ blood and questionnaire information occurred in two 
clinic rooms designed for conduct of research interviews and pathology collection. 
One room was set up as the room for participants to complete their questionnaires 
and receive information on the study, while a second room was equipped as a 
phlebotomy room with clinic supplies, phlebotomy chair and refrigerated storage 
for blood. 
 
 Folic acid 
supplementation 
Outdoor 
measurement 
week 
Two weeks One  week 
Visit 1: 
Baseline 
Visit 2: Following 
supplementation 
 
Visit 3: One 
week post 
supplementation 
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Analysis of serum folate and separation and analysis of red cell folate occurred at 
Pathology Queensland located at the Royal Brisbane and Women’s hospital on 
Herston Road, Herston. On completion of the study, all participants were emailed 
their folate blood results with an explanation of their levels compared to the 
reference values (see Appendix D). 
3.2 Study components and measures 
3.2.1 Part A: General Information Questionnaire 
The general information questionnaire was the first questionnaire provided to 
participants and collected data on important demographic variables. 
It contains 22 questions based on gathering the following data from participants: 
 Date of birth, country of birth and parents’ ethnicity 
 Education level 
 Employment status 
 Indoor/Outdoor occupation  
 Smoking status 
 Alcohol consumption 
 Health rating 
 Medication chart 
 Supplement usage chart 
 
Collection of these variables is important as they have the potential to act as 
confounders or effect modifiers when investigating relationships between folate 
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status and sun exposure. Many of the questions used in the Part A General Health 
and Information questionnaire have been validated by previous research 
undertaken by Kimlin et al.86 Modifications from the original questionnaire used in 
the AusD study included the addition of two extra alcohol intake questions: How 
often participants consumed more than 6 drinks on one occasion and type of 
alcohol consumed. These extra questions were included due to alcohol’s influence 
on folate status and where supported with a diagram detailing standard drink 
serves for various types of alcohol87. Health questions relating to conditions that 
affect folate status were added (cancer and malabsorption conditions). The 
supplement usage chart was also modified to reflect the focus on folate rather than 
vitamin D (see Appendix E for copy of Part A Questionnaire). 
3.2.2 Part B: Sun Exposure Questionnaire 
The sun exposure questionnaire was provided to participants following folic acid 
supplementation to assess participants’ reaction to the sun when skin is exposed, 
typical sun exposure for the previous month and sun protective behaviours such as 
the use of protective clothing, sunglasses and sunscreen. The sun exposure 
questionnaire provided a measure of each participant’s sun exposure and sun 
protection behaviours prior to measurement of outdoor exposure with the sun 
exposure diary over the measurement week. This allowed comparison with 
participants’ sun exposure during the intervention. It may also enable future 
secondary analysis of the relationship between folate status and sun exposure 
before and during the folic acid supplementation phase of the study. 
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The Part B Questionnaire was a modified version of the sun exposure questionnaire 
used in the multicentre NHMRC-funded AusD project, with the only major change 
being the removal of the vitamin D and calcium FFQ (see Appendix F for copy of 
Part B Questionnaire). 
3.2.3 Part C: Folate Food Frequency Questionnaire 
A validated folate FFQ was utilised to assess participant's intake of folate containing 
foods. The Folate Intake Tool (FIT) is a rapid assessment FFQ developed by Hickling 
et al.88 to provide a fast, reliable and valid tool for assessing folate intake in both 
health promotion settings and epidemiological research studies. Two prototypes of 
the tool were developed by Hickling et al.88: the FIT-A and FIT-B, with FIT-A asking 
participants’ to identify only frequency of folate rich food intake, while FIT-B also 
asked participants’ to identify serving size. Despite the addition of serving size 
information to FIT-B, the FIT-A demonstrated higher relative validity when 
compared to serum folate (N=568; FIT-A r=0.54; FIT-B r=0.49) and improved test-
restest reliability (n=277; FIT-A r=0.75; FIT B r=0.68)88. 
Thus, the FIT-A FFQ was selected over the FIT-B in this project due to its higher 
validity compared to serum folate and test-retest reliability. Additionally the FIT-A 
did not require participants to recall serving sizes, thus reducing time taken for 
participants to complete the questionnaire. Email contact was made with the 
developers of the FIT questionnaire and permission was received to use the FIT-A in 
this PhD project. 
 71 | P a g e  
 
Hickling et al.88 determined which foods to include in the FIT-A based around foods 
on the AUSNUT database containing over 20 µg  folate per/serve, folic acid fortified 
foods or foods determined to be major contributors to folate intake based on 
previous folate intake studies. There are 24 questions in total, with participants 
asked to indicate frequency of consumption (Not at all; once; 2-4 times; 5-6 times; 
everyday; 2+ times a day), over the past week with several questions asking 
participants for specific brands of food used. Minor modifications were made to the 
original FIT-A FFQ for the purposes of this study. These included the removal of 
questions for alcohol and supplement use, as this information was collected 
elsewhere; also a question was added asking participants if the last week’s intake 
was typical of their diet in the last 3 months in order to give some indication of 
participants’ longer term folate intake. (see Appendix G for a copy of the 
questionnaire). 
3.2.4 Calculation of Dietary Folate Equivalents (DFEs) 
Data from the Part C FFQ were used in conjunction with supplement information 
from the Part A Questionnaire to work out each participant’s average daily intake of 
folate products and supplements.  These were reported in DFEs, which correct for 
the increased bioavailability of folic acid supplements over natural folates found in 
food (see Section 2.2.2). Note that the folic acid supplements provided for the two 
weeks of supplementation were not added to the calculated daily DFE as this 
research was focused on the independent effects of dietary and individual 
supplemental folate intake. 
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Calculation of each participant’s average daily folate intake was undertaken using 
data from Food Standards Australia and New Zealand’s NUTTAB 2010 database, 
which included the latest data on the DFE content of food since the recent 
introduction of mandatory folic acid fortification of bread making flour89. As the FIT-
A FFQ was used as the basis for Part C, serving sizes were not measured; thus 
serving sizes were calculated as average serving sizes for each food reported by the 
NUTTAB 2010 database. The folate content of each food item was calculated 
manually for each participant with the total DFEs calculated by the following 
method: 
1. Average daily serving size were estimated by dividing weekly reported 
intakes of food items by 7 (ie. 4 serves a week/ 7 days = 0.57 serves a day). If 
participants reported intake of foods daily, these were reported as 
unadjusted (ie. 1 serve a day = 1 serve a day).  
2. The average folate intake from each food item was then calculated by 
multiplying the folate content of that food by its average daily serving size 
calculated above, ie if the folate content per serve was 100 µg  and 
participant was consuming an average of 0.57 serves per day then 100 µg  X 
0.57 = 57 µg  of folate a day. 
3. The average folate intake for all food items was then summed for each 
participant to estimate their average daily dietary DFEs. 
4. Folate from participants taking supplements with folate were reported as 
DFEs, to take into account the high bioavailability of folic acid (see Section 
2.2.2) and these data was added to average daily DFEs to get a total daily 
DFE estimation for each participant.  
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3.2.5 Sun and Physical Activity Diary 
A seven day sun exposure and physical activity diary was provided to participants at 
the beginning of the intervention week for completion on a daily basis over the 
seven day intervention. The sun and physical activity diary collected information on 
the following participant characteristics over the intervention week: 
 Time outside in the sun 
 Sunscreen use  
 Clothing worn 
 Level of physical activity 
 
Participants were asked to fill in the data above each day and participants were 
given verbal instructions on filling out the diary. Additionally written instructions 
and an example of how to fill the diary out were also provided. Time outside in the 
sun was collected in 15 minute blocks (0, <15, 15-30, 30-45, 45-60 minutes) for each 
hour of daylight 5am to 7pm, while data on clothing were collected again for each 
hour of daylight using a numbered clothing guide for upper body, lower body, head 
wear and foot wear. Participants were also asked about their use of sunscreen and 
application time as well as timing and intensity of physical activity and whether this 
was completed indoors or outdoors (see Appendix H for copy of the Sun and 
Physical Activity Diary). Physical activity was given a rating of 0=none to 3=heavy, 
for each hour of the day, this was then summed to give a physical activity rating for 
that day, with 0 to 4=low activity, 5 to 10=moderate activity and 11 and over= 
heavy activity. The sun and physical activity diary used in the project has been used 
successfully in other research conducted at the AusSun laboratory86.  
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3.2.6 Estimation of participant’s personal outdoor and UV radiation exposure 
Average time outdoors: 
As a measure of outdoor exposure, average daily time outdoors in minutes for each 
participant was calculated. For the measurement week (see Figure 3.1), this was 
calculated by summing total time outdoors in minutes over the week (reported in 
the Sun and Physical Activity Dairy), and dividing this by seven to provide the 
average daily time outdoors for the week. The same strategy was used to 
retrospectively estimate average daily time outdoors prior to the measurement 
week using Questionnaire Part B’s outdoor exposure questions (See Section 2 in 
Appendix F), which asked participants about typical outdoor exposure over a week. 
The average outdoor exposure on weekdays and weekends was also calculated to 
take into account differences in outdoor exposure at these times of the week. Thus 
three values were obtained for the measurement week and prior to the 
measurement week during folic acid supplementation: total average daily outdoor 
exposure for a week, total average daily outdoor exposure for weekdays; and total 
average daily outdoor exposure for weekends. 
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Measurement of personal UV exposure: 
The calculation of personal UV exposure consisted of four elements:  
1. The calculation of UV exposure for each hour outside;  
2. The calculation of participants’ Body Surface Area;  
3. Proportion of skin exposed; and 
4. Calculation of personal UV exposure. 
1. Hourly UV radiation exposure: 
Measurement of environmental UV radiation was undertaken at the AusSun 
Research Laboratories detection station located at QUT Kevin Grove campus 
(latitude: 27  29’ S; longitude: 153  8’ E). A Solar Light Co. 501A Biometer was used 
to detect environmental UV and collects data at five minute intervals over 24 hours. 
To estimate total environmental UV radiation for each hour of sunlight (between 
5am to 7pm) for the sun exposure measurement week, the twelve five minute 
intervals were summed for each hour of exposure to give an hourly UV.  
The environmental UV radiation was then multiplied by the proportion of time the 
participants’ spent outdoors during the hour to calculate an estimate of the 
participants’ UV exposure: 
 
UV for hour (J/m2) x proportion of hour spent outside 
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For example, if total environmental UV was 60 J/m2 between 10-11am and a 
participant spent 30 minutes of that hour outside: 
 
60 J/m2 [UV] X 0.5 [proportion of hour spent outside] =30 J/m2 [UV exposure] 
2. Body Surface Area: 
Body Surface Area (BSA) in m2 was estimated for each participant using the 
Mosteller90 equation: 
 
BSA (m2) = ([Height (cm) x Weight (kg)]/3600)1/2 
3. Proportion of skin exposed: 
Calculation of percentage of skin exposed was based on the “rules of nines” 
described by Dixon et al.91 In this model the head, right and left arms, upper back, 
front of chest, abdomen, right and left upper leg and right and left lower legs are 
each estimated to provide 9% of total body surface area (99% total). From these 
proportions, body coverage area provided by the common items of clothing 
illustrated in the sun and diary questionnaire can be estimated.  
Data from self-report of clothing use was used to calculate proportion of skin 
exposed when participants were outdoors; for example, 45% clothing 
coverage=55% proportion of skin exposed. 
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4. Calculation of hourly estimated personal UV radiation exposure: 
By multiplying all three elements together an estimated hourly personal UV 
exposure could be obtained with the following equation: 
 
UV radiation exposure (J/m2) x BSA (m2) x proportion of skin exposed to sun 
Worked example: 
 
20 J/m2 [UV radiation exposure] x 2.1 m2 [BSA] x 0.55 [proportion of skin exposed] = 
23.1 Joules  
Hourly UV radiation exposures were added to calculate each day’s UV exposure for 
each participant.  Average daily UV radiation exposure for each participant over the 
measurement week was then calculated by summing all seven daily estimated UV 
doses together and dividing this number by seven. 
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3.2.7 Weather data 
Weather data over the period of the study were obtained from the Australian 
Bureau of Meteorology website92,93.  Daily temperature range, mean rainfall and 
hours of sunshine were collected. Sunshine is measured by the Australian Bureau of 
Meteorology as mean hours per day of bright sunshine using the Campbell-Stokes 
sunshine recorder, which uses a spherical glass lens to burn a trace on a specially 
designed card once brightness reaches a pre-determined threshold94. UV Index data 
was obtained from the Australian Radiation Protection and Nuclear safety agency 
website95,96. 
3.2.8 Anthropometry 
Height and weight data were obtained in order to calculate the Body Mass Index 
(BMI) of participants. Participants’ height was measured using a standard portable 
stadiometer (S+M) and rounded to the nearest cm. Weight was recorded to the 
nearest kg and was measured using a set of electronic scales placed on a hard 
surface. All participants were asked to wear light clothing prior to their interviews 
and to take off their shoes during the height and weight measurements. BMI was 
then calculated by hand using the equation: Weight (kg)/Height (m)2 and recorded 
to the nearest 0.1 kg. Measurement error was minimised with the use of the same 
set of scales and stadiometer for all measurements in the sample. Additionally, 
none of this equipment was moved during the data collection phase, thus 
differences in surface types or other factors that could feasibly contribute to 
measurement error were reduced. Inter-rater bias was eliminated by the use of a 
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single observer for all measurements who was trained in the anthropometric 
measurement of subjects. 
3.2.9 Phlebotomy 
Collection of blood from participants was undertaken by a trained phlebotomist, 
Sam Vaartjes, in one of the designated clinic rooms. A standard venipuncture 
technique was used to obtain blood samples which were then collected into 5ml 
EDTA and 5ml STS tubes for red cell folate and serum folate, respectively. Samples 
were stored in the refrigerator at 4  C until transportation to the pathology 
laboratory at the end of each day’s data collection. 
3.2.10 Blood transport 
At the end of each day’s collection, the collected samples of blood were 
transported by road via private vehicle from the Institute of Health and Biomedical 
Innovation to Pathology Queensland at the Royal Brisbane and Women’s Hospital.  
Safety requirements were strictly adhered too according to QUT Guidelines for the 
Transportation of Dangerous Goods, Infectious Substances and Diagnostic 
Specimens.  All blood samples were contained in the primary leak proof receptacle 
that they were collected in (EDTA or STS tubes) and each tube was further packaged 
in a secondary waterproof zip lock bag. All packaged blood samples were placed in a 
small insulated esky type container with two cool packs to keep samples chilled in 
transit. The transport esky was labelled according to IATA Dangerous and Infectious 
goods regulations and also displayed the name of the study and contact details of 
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research team. The transport container was carried by a research assistant while 
the investigator drove. These protocols were also discussed with the pathology 
laboratory to assure that their safety protocols were also being adhered too. Risk 
assessment clearance was obtained from the School of Public Health’s health and 
safety officer and the Head of School, prior to project commencement as per QUT 
regulations. 
3.2.11 Serum and red cell folate blood analysis 
Analysis of both red cell and serum folate for participants was undertaken by a 
commercial laboratory (Pathology Queensland). Prior to analysis, folate from red 
cells was extracted for a ten-fold dilution with a 10 g/L concentration of ascorbic 
acid.  Serum and red cell folate were measured via an automated competitive 
binding assay with chemiluminescence detection (Roche Modular E170 and reagent 
- Folate III for Elecsys and Cobas e analyzers part no. 04476433 190). This test uses 
ruthenium labelled folate binding protein, with folate from the sample competing 
with biotin labelled folate for the binding sites of the protein. Measurements of 
chemiluminescence emissions are then used for detection of the folate, of which 
the concentration is determined via a calibration curve. The inter-assay precision of 
the competitive binding assay used in this study has been reported with a 
coefficient of variation of 16%, compared to standard QuantaPhase II radioassay97. 
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3.3 Data storage and security 
3.3.1 Security of electronic and paper results 
All questionnaire and blood result data from participants were stored in locked 
secure storage at the researcher’s office, and are only accessible via researcher’s 
key. Additionally, participant information electronically entered into the SPSS 
database is only identified by code and participants’ names are not displayed in 
electronic format. The stored questionnaires are only linkable to each participant’s 
coded blood results for these research purposes as these are is needed for sun 
exposure and dietary intake data. Hard copy data will be stored for a maximum of 3 
years for possible future follow up folate studies to test folate metabolites in stored 
blood. Blood results data, re-identifiable via code are stored in a key card access 
only room in at the Kelvin Grove campus with only limited access to several staff 
and postgraduate students. 
3.3.2 Serum folate storage 
If consent was given and following analysis at Pathology Queensland each 
participant’s serum folate was frozen at -80   C and stored in a secure laboratory at 
Kelvin Grove for future research purposes. The rationale for the storage of these 
samples is for research that would involve testing of blood for individual 
metabolites of folate such as 5-MTHF and free folic acid with High Performance 
Liquid Chromatography (HPLC) or Mass Spectrometry (MS) techniques. These data 
would provide more detailed data into how different fractions of folate are affected 
by solar UV. In the present study, due to funding restrictions we were only able to 
test whole blood folates (red cell folate and serum); however, if funding becomes 
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available in the future, testing these samples for folate fractions may be undertaken 
(in which the ethics unit will be advised and an application submitted). 
3.4 Ethics 
An ethics application was submitted to the QUT Ethics Unit and clearance received 
on the 9/5/2011 (Ethics approval no. 1100000933). Several modifications around 
study design and methodology were made to the project to reflect findings from a 
new study in the field and clearance for a variation to project protocols was 
received by the QUT Ethics Unit on the 28/9/2011. All potential participants were 
required to read and sign a written consent form prior to participating in the project 
(see Appendix C). Ethical issues were discussed with potential participants prior to 
signing of the consent form, particularly the voluntary and confidential nature of 
the study. The consent form also provided a separate section where participants 
could indicate their consent for their blood samples to be kept for further research 
into folate levels, if consent was not received for this, participants could still 
participate but their blood samples would be destroyed immediately after analysis 
at Pathology Queensland. Participants were also informed that withdrawal from the 
study could be taken at any time and a withdrawal from consent document would 
be made available (see Appendix I). 
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3.5 Statistical analysis 
3.5.1 Data entry and verification 
Raw data from the participant’s questionnaires, sun and physical activity diary and 
blood results were entered into the Statistical Package for the Social Sciences 
analysis software (SPSS Statistics, Version 19.0. Armonk, NY: IBM Corp. Inc.). Coding 
of categorical variables and setup of the SPSS database was completed prior to the 
beginning of data collection. All missing data were coded as -1, as a discrete missing 
value. Following data entry, random visual checking was performed on the data of 
10 participants to verify accuracy of data entry.  
3.5.2 Data cleaning 
All variables in the dataset were checked for errors using tools provided by the SPSS 
v19 software. Categorical variables were checked for errors by checking the 
frequencies of each variable, with specific emphasis placed on checking the 
minimum and maximum values for values outside the possible range of values and 
the number of valid and missing cases. Any abnormalities were checked against the 
variable codebook.  Continuous variables were also checked for abnormal minimum 
and maximum values and the mean score and standard deviation was also checked 
and any outliers re-examined with original questionnaire data. All abnormal or 
questionable data were checked with the original questionnaire data and modified 
if error was identified in dataset, in there were any cases where questionnaire data 
was also abnormal, participants were to be contacted; however, this did not occur 
due to no errors identified in the original questionnaire data. 
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3.5.3 Exploratory analysis of the data and descriptive statistics 
Frequency tables with counts and percentages were used to describe all analysed 
categorical variables. Descriptive statistics were used to describe the distribution of 
continuous variables via means and standard deviations, with medians and ranges 
also presented.  The dependent variables for the study (change (Δ) in serum and red 
cell folate over the measurement week) were described as continuous variables. 
3.5.4 Analysis of Research Questions 
The overall research question for this project is 'Does exposure to sunlight cause 
blood folate degradation in a sample of conception age females?’ Two main 
research questions were used to guide analysis; Research question one was the 
primary focus of the project, this involved the measurement of sunlight exposure 
with a sun diary over a ‘measurement week’, to test sun exposure’s effect on 
participants’ blood folate status following two weeks of folic acid supplementation. 
Research question two focused on measuring the effectiveness of the studies 
supplementation intervention of 500 µg of folic acid in increasing participants’ 
blood folate status. The third research question concerned measurement of 
participants’ intake of DFEs and correlation of this dietary folate intake with blood 
measures of folate. Two sided tests were used and a probability value (p value) of 
<0.05 was considered significant in the analyses conducted. 
 
Research Question 1: ‘Are conception age women with a higher outdoor exposure 
at increased risk of lowered folate status?’  
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Hypothesis: H1: Women with higher outdoor exposures have significantly lower 
folate status than women spending less time outdoors. 
To investigate associations between outdoor exposures and folate status, the 
change (Δ) in the serum and red cell folate over the measurement week (between 
the cessation of supplementation and final blood test-see Figure 3.1) were 
estimated. The two variables; change in red blood cell folate,  change in serum 
folate were compared to measures of average daily outdoor exposure time in 
minutes, and estimated UV dose in joules over the intervention week, as collected 
by the Sun and Physical Activity Diary. Descriptive statistics and bivariate 
correlations were used to investigate crude associations between the dependent 
and independent variables. Outdoor exposure measures were also converted to 
tertiles for further investigation using one way analysis of variance (ANOVA) tests. 
Multiple linear regression was used to investigate the association between outdoor 
exposure measures and folate status with the addition of other independent 
variables that may have acted as confounders or effect modifiers98. Independent 
variables were included in the model based on previous research studies on 
variables that impact folate status and descriptive and bivariate associations from 
our own data analysis. 
Research Question 2: ‘Does two weeks of folic acid supplementation increase folate 
status in a sample of conception age females?’ 
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Hypothesis: H1: Folic acid supplementation significantly increases the folate status of 
the participants. 
An essential element of this study was to increase participants’ folate status prior to 
the measurement of outdoor exposure so that participants started the 
measurement week with an increased folate reservoir provided by the folic acid 
supplements. Descriptive data (means, medians and ranges) and Wilcoxon signed 
ranks tests were used to compare serum and red cell folate at baseline to levels 
obtained following the two week supplementation period and the subsequent 
measurement week. 
Research Question 3: ‘Does dietary folate intake correlate significantly with blood 
measures of folate for the sample?’ 
Hypothesis: H1: Dietary folate intake correlates significantly with blood measures of 
folate. 
While the focus of this project was based on the role of UV’s effect on the folate 
status of conception age females who had been taking folic acid supplements, a 
secondary aim of the project was to investigate dietary folate intake among the 
sample using information gathered from the validated FFQ. For this, descriptive 
data of participants’ dietary folate intake and contribution of folate containing food 
groups to dietary intake were investigated. Bivariate correlations and scatterplots 
were also used to investigate the relationship between dietary intake of folate and 
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serum and red blood cell folate status and these data were compared to similar 
correlation studies used for validating the FFQ.  
Comparisons of folate intake from the sample to the intakes recommended by the 
NHMRC (EAR) were also undertaken, to compare the samples intake to the 
recommended intakes. 
3.5.5 Statistical assumptions 
Determination of normality  
Normality was determined by descriptive statistics and the following criteria were 
used to determine normal distribution: 
 The mean and median fall within 10% of each other 
 Histogram appears visually normally distributed 
 Skewness falls between -3 and +3 
 Kurtosis falls between -3 and +3 
 The mean +3 SD approximates the maximum value of the variable, while the 
mean -3 SD approximates the minimum value. 
 
If non-normally distributed data were found and this was in violation of the 
assumptions of the statistical test to be used, transformation to normal distribution 
was undertaken by using the transform (log10) function in SPSS. 
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Detection of multicollinearity 
Independent variables were examined for multicollinearity via the correlations table 
in SPSS. Independent variables were considered to display multicollinearity if 
bivariate correlations were above 0.799. If two highly intercorrelated variables were 
observed, a decision was made to keep the one determined to be of the most 
clinical significance. 
Outliers, heteroscedasticity and independence of residuals 
Analysis of multivariable outputs also included visual examination of Normal 
Probability Plots of standardised residuals for reasonably straight diagonal data 
profiles, with major deviations suggesting non-normality. Scatterplots of 
standardised residuals were used to investigate distribution of residuals and 
possible outliers. Outliers were for this analysis identified as cases that had a 
standardised residual of more than 3 or less than -3.  If outliers were found, 
sensitivity analyses were undertaken to ascertain the degree of effect on the 
sample. 
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3.5.6 Sample size calculation 
Sample size for correlation: 
A sample size calculation for the primary research question, ‘Are conception age 
women with a higher outdoor exposure at increased risk of lowered folate status?’ 
was undertaken to assess the expected sample size for a correlation between sun 
exposure and change in serum folate status according to the following standard 
sample size calculation for correlation: 
  (
     
 ( )
  )
 
   
Where: 
α = The alpha level (two sided), the probability of making a Type 1 error  
β= The beta level (two sided), the probability of making a Type 2 error 
C(r) = Correlation coefficient  
N = Sample size 
 
A standard alpha level of 0.05 (A 5% probability of rejecting the null hypothesis 
when it is correct, a Type 1 error) and a power level of 80% (A 20% probability of 
accepting the null hypothesis when it is false, a Type 2 error) were used for this 
analysis. A correlation coefficient of 0.4 (Medium strength relationship) was chosen 
to detect a significant difference between change in blood folate level and the 
independent variables99.  
Therefore using a significance level: α=0.05, a power level of 80% and expected 
correlation coefficient of -0.4 between sun exposure and change in folate status, a 
minimum sample size of 37 was required.  
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Chapter 4: Participant demographics and folate status 
4.1 Introduction 
Chapter 4 presents the demographic characteristics of the sample and provides 
descriptive data on the serum and red blood cell folate status of the sample over 
the study time points. The three time points where blood was taken were as 
follows; at baseline, after two weeks of folic acid supplementation and at the end of 
one week of sun exposure measurement. Importantly, this chapter also answers the 
research question; ‘Does two weeks of folic acid supplementation significantly 
increase folate status in a sample of conception age females?’  
Answering this research question allows the assessment of whether the folic acid 
supplementation was effective at increasing folate status in participants. Where 
possible, reference data obtained from large representative surveys or studies have 
also been provided to offer comparative data for the general Australian female 
population. 
Table 4.1: Aim and research question for Chapter 4 
Aim Research Question Hypothesis 
To measure the effectiveness 
of folic acid supplementation 
in raising the folate status of 
participants 
Does two weeks of folic acid 
supplementation increase 
folate status in a sample of 
conception age females? 
Folic acid supplementation 
significantly increases the 
folate status of participants 
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4.2 Methodology overview 
Demographic data for participants were obtained through Questionnaire Part A at 
the beginning of the study, while information on BMI was obtained at the cessation 
of the study during the participants’ final visit. Serum and red blood cell folate 
samples were obtained via venipuncture method by a trained phlebotomist at each 
visit and were sent to a commercial laboratory for analysis. Refer to Section 3.2, for 
further information regarding collection of demographic information and folate 
testing and analysis. 
4.3 Results 
4.3.1 Participant demographics 
For this research project all forty-six volunteers were female and of childbearing age 
(see Table 4.2). For comparative reasons, data of the median age for the Australian 
female population are included in Table 4.2, with the age of the sample being 8.4 
years younger than the general Australian female population due to the inclusion of 
only childbearing age females in this project. The mean and median BMIs were well 
within the healthy weight range of 18.5-24.9 kg/m2. Participant characteristics by 
country of birth, type of employment, exposure to outdoors and education are also 
reported in Table 4.2. Just over one-third of the sample was from a non-Australian 
country of birth, with this being slightly higher than the national average of just 
over one-quarter of the population being of non-Australian birth. The majority of 
workers classified their employment as mainly indoors, with a small minority  
classifying their employment as involving about half indoor and outdoor work. One 
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third of the participants had completed tertiary education at the bachelor degree 
level (n=16; 35%), while almost one third (29%) of the participants had earned a 
postgraduate degree. This level of tertiary education was higher than the national 
average which reports approximately one-quarter of Australians aged 15-64 attain 
at least a bachelor’s degree, unfortunately specific information on females in this 
age range was unavailable.101                                               
Descriptive data for the general health characteristics of the sample reveal that 
most of the participants were non-smokers; this is comparatively similar to the 
number of Australian females who are reported to be non-smokers in general 
population surveys, see Table 4.2102.  For alcohol intake, just under one third of 
participants reported that they consumed alcohol at least twice a week, while one 
fifth of participants reported undertaking at least one session of risky alcohol 
consumption (6+ drinks per session) in the prior month; this was double the 
number reported in recent population data collected by the Australian Institute of 
Health and Welfare103. Over half of participants reported light physical activity 
levels, with only a six of the participants classified as having a high daily physical 
activity level. BMI was also assessed as a categorical variable to investigate the 
samples distribution across the different BMI categories. Only one sixth of the 
sample had a BMI between 25-29.9 kg/m2 and were therefore classified as 
overweight and only four subjects were classified as obese >30 kg/m2. Therefore 
just over one-quarter of subjects were considered overweight or obese. This 
compares to national health survey data reporting that 55% of Australian adult 
females were overweight or obese104.    
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Table 4.2: Selected participant demographics (N=46) 
Variable (Continuous) Mean(±SD) 
 
Median  
Sample                                           Reference 
Age (Years) 30.2(7.7) 28.5 36.9
105
 
BMI (Body Mass Index) (kg/m
2
) 22.8(4.8) 21.6 N/A 
Variable (Categorical) Sample n(%) Reference % 
Country of Birth 
Australia birth 
Non-Australian birth 
 
 30(65.2) 
 16(34.8) 
 
 74%
100
 
26% 
Employment outdoor exposure 
Mainly indoor 
Half indoors/half outdoors 
 
42(91.3) 
4(8.7) 
 
 
N/A 
Education 
Year 12, certificate or diploma 
Bachelor’s degree 
Postgraduate degree 
    
16(35.6) 
16(35.6) 
13(28.9) 
 
41%
101
 
24%* 
Smoking status 
Current smoker 
Non-smoker 
 
4(8.7) 
42(91.3) 
 
14%
102
 
86% 
How often do you usually consume alcohol? 
Once a week or less 
Two or more times a week 
 
32(69.6) 
14(30.4) 
 
N/A 
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100. Australian Bureau of Statistics: Census, 2012–2013    
101. Australian Bureau Statistics 2011   
102. Australian Institute of Health and Welfare 2011. National Drug Strategy Household Survey report.  
103. Australian Institute of Health and Welfare 2011.National Drug Strategy Household Survey report 2010 
104. Australian Government: Department of Health and Ageing. Overweight and Obesity in Australia. 2007-08 National Health Survey.  
105. Australian Bureau of Statistics 2011. Australian Demographic Statistics 
*Includes both bachelor and postgraduate degree, rest of population (38%) indicated education level was Year 11 or less. 
**Physical activity based on information from sun and physical activity diary (Please refer to Methods section 3.2.5, for more information)
 
Variable (Categorical) 
 
Sample n(%) 
 
Reference % 
 
Risky drinking behaviour (6+ drinks on any one day at 
least monthly) 
 
20% 
 
11%
103
 
Physical activity rating daily average** 
Light <5 
Moderate 5-10 
Heavy 11+ 
 
 25(54) 
15(33) 
6(13) 
 
 
N/A 
Body Mass Index (kg/m
2
) 
<24.9 
25-29.9 
>30 
 
35(76.1) 
7(15.2) 
4(8.7) 
 
45%
104
 
30.9% 
24.0% 
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4.3.2 Folate status of participants 
The folate status of the sample was measured at baseline, following two weeks of 
supplementation with folic acid, and after one week of sun exposure measurement. 
Examination of the serum folate over the three time points showed a increase in 
levels following the two weeks of folic acid supplementation compared to the 
baseline level (Table 4.3). There was a median increase of 8.8 nmol/L, following the 
two weeks of supplementation; this corresponds with a statistically significant 29% 
increase in serum folate status for the sample. This level, then decreased by a 
median of 4.0 nmol/L, a statistically significant reduction of 11%, over the sun 
exposure measurement week following cessation of the folic acid supplements, see 
Table 4.3.  Notably, the extent of this association is less obvious for the red blood 
cell folate with only a 10% increase in red cell folate over the two weeks of 
supplementation, this increase not being statistically significant (Table 4.3). It is also 
apparent that there was only a slight drop off in red blood cell levels following 
supplementation, corresponding to a non-significant decrease of 0.7% (Table 4.3). 
Therefore while changes from baseline to the end of folic acid supplementation and 
following the sun exposure measurement week were significant for serum folate 
(p=<0.01); the changes in red cell folate for both time points were not significant.  
Wilcoxon signed rank tests of medians were used to test for the changes in folate 
status for this analysis. 
Table 4.3 includes reference values for determining adequate folate status as 
defined by Flood et al.1. Comparison of these reference levels to the median serum 
and red cell folate status of the sample at baseline shows that status was largely 
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adequate, although the serum folate range at baseline (7.8-76.7 nmol/L) indicates 
at least one participant was below the 11.1 nmol/L level considered the adequacy 
cut-off for serum folate1. Also included for comparative purposes are population 
data on the folate status of females aged 20-59 years, obtained from the US 
National Health and Nutrition Examination Survey (NHANES) 2005-2006106. Baseline 
serum folate status is similar between both groups, while baseline red cell folate 
status is considerably higher in the present sample. 
Table 4.3: Participant dependent variables (N=46) 
 
Variable Average Reference 
Blood folates Mean (SD) 
(nmol/L) 
Median 
+ minimum 
and maximum 
(nmol/L) 
p-value Reference 
level
1
 
Reference 
population 
nmol/L 
(USA) 
(Median)
106
 
RBC (Baseline) 1005(157) 
 
971 
(642-1380) 
 >513 
 
614 
Red Blood Cell 
(RBC) (2 weeks 
supplementation) 
1056(206) 1066 
(681-1660) 
*0.08   
Red Blood Cell 
(RBC) (1 week post 
supplementation) 
1058(154)  1058 
(745-1469) 
**0.74   
Serum (Baseline) 30.2 (11.3) 30.5 
(7.8-76.7) 
 >11.0 27.0 
Serum (2 weeks 
supplementation) 
46.7 (23.9) 39.3 
(13.5-120.9) 
*<0.01   
Serum (1 week 
post 
supplementation) 
34.1(10.1) 35.3 
(12.5-55.2) 
**<0.01   
Values are significant at p <0.05 
1
Flood et al. Prevalence of low serum folate and vitamin B12 in an older Australian population 
106
McDowell et al. Blood folate Levels: the latest National Health and Nutrition Examination Survey (NHANES) 
results (USA general population) 
*Comparison of blood folate at Baseline to following two weeks of folic acid supplementation (Paired sample 
Wilcoxon signed rank tests) 
**Comparison of blood folate following two weeks of folic acid supplementation to one week after cessation of 
folic acid (Paired sample Wilcoxon signed rank tests ) 
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 4.4 Discussion 
The demographics of the sample reveal a representative distribution of 
characteristics across several of the demographic variables. Median age of the 
sample population was 28.5 years, with participants’ age ranging from 18-47 years, 
corresponding to a wide age range of conception age adult females. Country of 
birth was very similar in the sample compared to Australian female adult population 
and smoking status was also similar to that observed in the general 
population100,102.   
There were several notable differences in some of the demographic measures when 
compared to population survey data from the Australian Institute of Health and 
Welfare and Australian Bureau of Statistics; for instance, higher education levels 
were reported in the present sample compared to the general Australian female 
adult population104. This is likely a result of the high proportion of university, and 
staff, and students taking part in the study and may also reflect the younger 
population targeted. The BMI of the sample was below national averages for 
females in Australia, with approximately half the rate of overweight and obesity as 
reported by the national average104. Risky alcohol intake of six or more drinks per 
day in the last month was however, higher than reported in the recent National 
Drug Strategy Household Survey for females over 18 years of age102. Mainly light or 
moderate physical activity was reported, likely reflecting the recruitment of largely 
indoor workers with non-physically intensive job roles. While comparisons to 
population demographics are useful, it is important to note that direct comparisons 
with population statistics are often difficult, due to lack of information on specific 
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age clusters in the data; for instance, demographic information on similarly aged 
female samples was difficult to source for comparative purposes for variables such 
as BMI, alcohol intake and education. 
In an important finding for this study, serum folate levels in participants increased 
significantly (29%; p=<0.01) following supplementation, with the data also showing 
a significant drop off in levels following the cessation of supplementation (-11%; 
p=<0.01). This is partly due to serum folate being rapidly metabolised by the body, 
thus changes that occur over only small timeframes are significantly reflected in 
serum folate status16.   
As red cell folate reflects storage levels of folate, significant changes were not seen 
for this over the short time points tested, reflecting the slower increase in red cell 
folate levels compared to serum folate as previously observed in a 24 week folic 
acid metabolic trial conducted by Lamers et al107.  This can be also be hypothesised 
as a possible cause of the largely similar levels of red cell folate after the sun 
exposure measurement week, when supplementation had been ceased for a week, 
ie. Uptake of folic acid provided by supplements may have been continuing into red 
blood cells, thus little to no decrease was observed. 
The finding of a significant increase of serum and red cell folate levels after two 
weeks of folic acid supplementation informs one of the research questions of this 
project; ‘Did two weeks of folic acid supplementation increase folate status in a 
sample of conception age females?’ As this increase was observed, we can accept 
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our hypothesis from our second research question, for serum folate, that folic acid 
supplementation significantly increased serum folate levels, but not red blood cell 
folate after two weeks of supplementation. The observation of a significant 
decrease in serum folate following one week of supplementation cessation (during 
which independent variables such as sun exposure were measured), is also an 
important finding for the primary research question; ‘Are conception age women 
with a higher sun exposure at increased risk of lowered folate status?’ addressed in 
Chapter 7. 
The majority of the participants displayed adequate serum and red cell folate status 
as defined by Flood et al.1 (>11.1 nmol/L and >513 nmol/L, respectively), with all 
participants having adequate red cell folate status and a single participant being 
defined as moderately low (6.8 to<11.0 nmol/L) at 7.8 nmol/L in serum folate, 
although this individual was not considered deficient (<6.8 nmol/L)32. After two 
weeks of supplementation all participants were assessed as having an adequate 
folate status. This finding adds to recent data showing a low rate of inadequate 
folate status in the general population108. Of note, the participant with low folate 
status at baseline was made aware of this level at the end of the study and it was 
suggested that they visit their General Practitioner for further advice. 
Participants in this study displayed similar baseline serum folate status to the 
comparative group of women aged from 20-59 years from the US data used as a 
reference106. However, red cell folate at baseline was much higher in this sample 
compared to the US sample. A major factor explaining this difference would 
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certainly be due to the comparison of a small, highly educated and largely healthy 
sample of females against the much larger and generalised sample of females (aged 
20-59 years) in the US sample. While comparison with an Australian referent group 
would have been optimal, the folate status of Australian childbearing women from 
a similar and large publicly available dataset was not available for comparative 
purposes. Despite this, comparison of our data to the US data from NHANES is 
highly useful, due to the similar age ranges and same gender of the sample. Also 
important for comparative purposes, is that similar folic fortification strategies are 
used in the US and Australia23,24,106.  
While the observation of a largely adequate folate status is important in this 
population, it is critical to note that the reference levels used by Flood et al.1 are 
used to define adequacy in the general population.  The much higher red blood cell 
folate level of >906 nmol/L has been shown to be related to the lowest risk of NTDs, 
and has been recommended as optimal to reduce risk of NTDs pregnant women109. 
Approximately 25% of the women in the current sample were below this level; as 
discussed in the preceding paragraph, our sample had a relatively high red cell 
status compared to the US referent group. Thus, the possibility exists that a 
significant proportion of women in Australia may not be reaching the optimal red 
cell folate status early in pregnancy for prevention of NTDs, if taking into 
consideration the slow increase in red cell folate concentration when individuals are 
supplemented110. Indeed a recent study has shown that doses of 800 µg/d of folic 
acid (rather than the currently recommended 500 µg/d) may be needed to reach 
the optimal status of 906nmol/L within the first four weeks of pregnancy for healthy 
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women111. Larger studies investigating the folate status of conception age females 
are really needed now that fortification has been introduced in Australia to assess 
whether current supplementation recommendations are adequate. 
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Chapter 5: Dietary intake of folate and effect of supplementation on 
blood folates 
5.1 Introduction 
In the following chapter, the descriptive data from the FFQ, which was used to 
collect and measure participants’ dietary intake of folate, is reported and discussed. 
Bivariate correlations between blood folate status and dietary folate intake are also 
evaluated which are used to answer the research question; ‘Does dietary folate 
intake correlate significantly with blood measures of folate for the sample?’ (Table 
5.1). Where possible, data from other studies and surveys that have reported on 
dietary folate intake in populations are also included for comparative purposes. 
Table 5.1: Aim and research question for Chapter 4 
Aim 
 
Research Question Hypothesis 
To measure and evaluate the 
dietary intake of folate in the 
sample 
 
Does dietary folate intake 
correlate significantly with 
blood measures of folate? 
 
Dietary folate intake correlates 
significantly with blood 
measures of folate 
 
 
5.2 Methodology Overview 
A validated FFQ88 was used to estimate participants’ dietary folate intake. 
Calculation of individual participant’s folate intake from the FFQ was undertaken 
using the NUTTAB 2010 database89, which provides a comprehensive list of the 
folate content in a variety of foods. Folate is reported as DFEs, which use a 
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conversion factor to take into account the higher bioavailability of folic acid, 
compared to folate found naturally in foods.  Further information on dietary folate 
assessment and calculation of participants’ dietary folate intake is provided in 
sections 3.2.3 and 3.2.4. 
5.3 Results 
The mean and median intake of folate, as DFEs for participants’ are reported below 
(Table 5.2). Mean intake, prior to supplementation, is well above the Estimated 
Average Requirements (EAR) of 320 µg/d for Australian adults, (see discussion for 
reasoning of using EAR rather than Recommended Dietary Intakes (RDI). The 
median and range of dietary intakes, are also included; these reveal that 
participants in the sample had a high degree of variation in folate intake. For 
comparative purposes, data of the DFE intake from a study of Australian females 
(N=127) conducted by Hickling et al.88 was also included. This demonstrates the 
much lower mean dietary intake (127.7.7 µg/d lower) observed by Hickiling et al.88 
compared to the current sample.  
Figure 5.1 presents a histogram of the distribution of DFE intake among participants 
at baseline prior to supplementation. Noteworthy are the nine participants’ (20%) 
with very low DFE intakes under 200 µg/d and the four participants’ (8.7% of 
sample) that display high DFE intakes over 800 µg/d..  Also, although not shown as a 
category on the histogram below due to the need to keep consistent category sizes, 
34% of participants were reported to have a DFE intake under 320 µg/d, which is 
the established EAR for folate described previously.  
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Table 5.2: Dietary Folate Equivalents (DFEs), intake of sample before and during folic acid 
supplementation (N=46). 
Variable Mean (±SD) µg/d Median (min and 
max) µg/d 
Reference Mean (±SD) 
µg/d
88
 
DFEs*  414.7(231.1) 354.5(75.9-1048.9) 287(129) 
88.
 Hickling et al. A rapid dietary assessment tool to determine intake of folate was developed and validated.  
*DFEs prior to supplementation. In order to calculate DFEs with supplements add 500µg 
 
 
 
Figure 5.1 Average Dietary Folate Equivalent (DFE) intake of participants prior to supplementation 
(N=45) 
 
The percentage of contribution for food groups to the daily average DFE intake are 
represented in Figure 5.2. Breads and cereals, which are fortified with folic acid, 
provided one quarter (25.8%) of participant’s dietary folate intake, while fruit and 
vegetables provided almost half of the participant’s folate intake (45.4%). The 
‘Other’ food category comprised dairy foods, nuts and nut products, vegemite, liver 
products and other sources of folate. Data from the National Nutrition Survey 
(NNS)112 on the percentage contribution of foods from the breads and cereals, fruit 
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and vegetables and the other food categories are also included for comparative 
purposes (Figure 5.2). 
 
Figure 5.2: Contribution of foods to average Daily DFEs  
*National Nutrition Survey 1995
112
 
 
Table 5.3 summarises correlations between the DFE intake and blood folates. At 
baseline prior to supplementation, both serum and red cell folate were significantly 
correlated with DFE, this relationship being particularly evident for serum folate 
with a high Pearson correlation coefficient.  Figures 5.3 and 5.4 provide a visual 
representation of these relationships using scatterplots, with the significant 
upwards association obvious in serum and red cell folate status at baseline as 
dietary intake of folate increases.  Examination of the data reveals an obvious 
outlier in Figure 5.3, with this participant having a particularly high serum folate 
status. When excluded from the correlation, the relationship between dietary 
intake and serum folate at baseline was decreased (r= .39,:p=0.08), but still showed 
a positive trend. Correlations between dietary and supplemental intake of folate 
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and blood folate following the two weeks of supplementation are also reported in 
Table 5.3; however, in this case correlations were not significant. A significant 
correlation was observed between DFE intake and red blood cell folate, at one week 
post supplementation, while the correlation between DFE intake and serum folate 
at this time was not observed to be significant.  
Table 5.3: Correlations of blood folate at three time points with Dietary Folate Equivalents  
 Blood folates Pearson correlation p-value 
Baseline 
DFEs baseline 
 
Serum Folate 
RBC Folate 
.52 
.41 
<0.01* 
<0.01* 
Two weeks supplementation 
DFEs with supplements Serum Folate 
RBC Folate 
.22 
.26 
0.15 
0.09 
One week post-supplementation 
DFEs* 
 
Serum Folate 
RBC Folate 
.28 
.37 
0.06 
0.01* 
*Significant at p=0.05 
**As both DFEs prior to and during supplementation differed by the 500 µg  folate supplement for each 
participant, correlations were the same for both DFE without supplements and with supplements 
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Figure 5.3: Total DFEs and correlation with serum folate (Baseline) (N=45) 
*Pearson’s correlation r 
 
 
Figure 5.4: Total DFEs and correlation with RBC folate (Baseline) (N=45) 
*Pearson’s correlation r 
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5.4 Discussion 
Comparisons at the descriptive level in this chapter reveal that the mean dietary 
intake of folate for this sample; 414 µg/d, was well above the 287 µg/d mean intake 
reported in a study of 127 Australian females by Hickling et al.88. Several reasons 
may exist for this, including differences in the age range of the samples; ie. 
Conception age females were recruited for the current study (aged 18-50 years), 
while females aged 33-83 years where used for the study conducted by Hickling et 
al.88. Notably, the fact that Hickling et al.88 conducted their study prior to the 
introduction of mandatory fortification of bread making flour with folic acid is also 
important. Data from the US, which has introduced a similar mandatory fortification 
strategy, show significant increases in folate status following this introduction, so 
this is likely a major factor108. Unfortunately, while studies on the impact of folic 
acid fortification have been conducted in relation to its impact on blood folate 
levels (see previous chapter), no correspondingly large scale studies have been 
conducted on changes that this fortification has had to dietary folate intake in 
Australia. Of course, differences in other demographic characteristics such as 
socioeconomic status resulting from the comparison of two relatively small samples 
would also likely impact differences. As the same rapid folate FFQ was used by both 
studies, with the exception of updated food database information (NUTTAB 2010)89, 
to take into account the folic acid fortification changes in the current study, 
differences due to the measurement tool used were minimised. 
The mean folate intake was also above the EAR of folate for adults of 320 µg/d in 
the current study. The EAR represents the estimated requirement to meet the 
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requirements of half of the healthy individuals in a specific group and is used to 
assess adequacy of intake in groups20. It was for this reason that EARs were used 
rather than the RDI, which are more suitably used for assessing individual intake. 
While the mean intake was well above the EAR for the sample, investigation of the 
spread of the data via a histogram (Figure 5.1) and the observation of the median 
and range, revealed a negative skew towards lower intakes, with several very high 
intakes inflating the mean. Approximately one-third of the participants’ had intakes 
below 320 µg/d (34%), with nine of these participants (20%), having intakes below 
200 µg/d. Participants did have higher intakes than the earlier comparative data 
reported by Hickling et al.88, which showed that over 60% of their female sample 
was under the recommended 320 µg/d EAR for folate. 
The proportion of participants not achieving the EAR may reflect some difficulty of 
achieving adequacy of folate intake on diet alone even with mandatory folic acid 
fortification being introduced. Achieving the RDI of 400 µg/d for individuals would 
thus be challenging for many.  This may also reflect a diet quality problem as there 
are a wide variety of rich folate sources available, particularly in fruit, vegetables, 
breads, cereals and legumes. Indeed, judging from the high contributions for folate 
from fortified breads, and fruit and vegetables in this sample (see Figure 5.2), 
people with diets rich in these foods may be of much reduced risk of not meeting 
folate requirements. Also with red cell and serum folate reported to be largely 
sufficient in the previous chapter and in previous Australian population research, 
despite lower then recommended intakes of folate, one may argue such high levels 
of recommended intake could be called into question113. Metabolic balance studies, 
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have however, shown that intakes of 400 µg/d DFEs in comparison to intakes of 200 
µg/d DFEs do significantly reduce the number of individuals with low red cell and 
plasma folate status as well as reduce plasma homocysteine levels20. Also, as 
reference levels for folate are still poorly defined, the high folate intake 
recommendations, while considering safe upper limits; may act as a safety net due 
to uncertainties on optimal folate intakes and status for health maintenance and 
disease prevention.  
Data on the contribution of dietary folate intake provided by the major folate 
containing food groups of breads and cereals, and fruit and vegetables, was also 
reported, and compared with survey data from the NNS. Breads and cereals 
contributed approximately 25% to total folate DFEs before the supplementation 
phase of the project, this being very similar to the contribution of 27% reported by 
the data from the NNS112. Fruit and vegetables, including legumes, also provided a 
similar contribution to DFEs as the comparative data from the NNS, with this food 
group providing participants from the current study 45% of their DFEs vs. 39% for 
participants in the NNS112.  Unfortunately as data from the NNS was collected in 
1995, there is an immense need for more up to date national data on nutrient 
intakes, particularly in regard to folate due to the introduction of mandatory folate 
fortification of the food supply. Updated data reflecting current intakes of folate in 
the national population will hopefully be forthcoming in the Australian Health 
Survey 2011/2013.  
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Correlations of average daily DFEs and both serum and red cell folate were 
significant prior to supplementation. The observed correlation (r=.52) between 
serum folate and DFEs was similar to that reported by Hickling et al.88 (r=.49) in 
their validation study of the same FFQ used in this study. Thus, prior to 
supplementation with 500 µg  of folic acid, participants’ blood levels of folate  
correlated highly with DFEs, so we can accept the hypothesis from the third 
research question that intake of DFEs correlates significantly with blood measures 
of folate, in this case prior to supplementation at baseline. The finding of these 
strong correlations between serum and red cell folate and dietary intake of folate 
provides further validity of the FFQ tool developed by Hickling et al.88.    
Correlations of DFEs following supplementation period of two weeks however, were 
not significant (Table 5.3). This may be reflected as one of the limitations of using 
the single FFQ over the course of the study: the FFQ was administered at the end of 
the study and reflected normal intakes of food over the past three weeks and thus 
was not sensitive to the short term changes in folate intake that occurred during 
the study. This is mainly reflected in the serum folate status which can be affected 
by relatively short term changes in dietary intake1,35. Interestingly, red blood cell 
folate also showed a significant correlation with DFEs one week after folic acid 
supplementation was ceased, while serum folate did not show a significant 
association with DFEs at this time. Future research in this area may therefore 
benefit from the use of a three day weighed food record, or 24 hour food recalls, 
just prior to measurement of serum folate to improve the precision of the data. 
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Chapter 6: Sun exposure, sun protection behaviours and clothing 
6.1 Introduction 
This chapter describes the sun exposure and sun protection characteristics of 
subjects in the sample. Data for sun exposure as time outdoors in minutes are 
presented for the measurement week following supplementation. For comparative 
purposes, data on time outdoors in minutes during the two week supplementation 
period, which occurred prior to the outdoor measurement week, is also presented. 
Additionally, the UV radiation exposure of participants in both Joules/m2 (J/m2) and 
total Joules is also reported for the measurement week. Definitions of the three sun 
exposure measures used in the thesis are provided in Table 6.1.  The chapter also 
defines the relationships between sun exposure and sun protection measures to 
test whether changes in outdoor exposure are related to changes in sun protection 
measures.  
Table 6.1: Table of definitions 
Sun exposure definitions Description 
Time outdoors (minutes) Average daily time outdoors in minutes 
Environmental UV radiation exposure 
(Joules/m
2
) 
Average daily environmental UV radiation 
exposure as Joules per m
2
 of body surface area 
Estimated personal UV radiation  (Joules) Average daily estimated total environmental UV 
exposure in Joules 
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6.2 Methodological overview 
Sun exposure and sun protection data were collected via a seven day sun and 
physical activity diary, which participants were required to complete during the 
measurement week following cessation of supplementation. Participants started 
this measurement period at staggered times following the 31st of October due to 
the rolling recruitment design described in Section 3.1.2, with participants 
beginning the measurement phase in two cohorts on the week of 31st October 
(n=33) or 6th November (n=13). Information on participants’ sun exposure was also 
collected over the two week period of supplementation via a survey, Questionnaire 
Part B, for comparative purposes. Environmental UV radiation exposure as J/m2 was 
measured via a Solar Light 501A biometer installed at QUT Kelvin Grove campus. 
Data for temperature and hours of bright sunshine over the study period were 
obtained from the Australian Government’s Bureau of Meteorology website. For 
more information on these measurement tools and methodology please see section 
3.2 which describes the Part B questionnaire, sun exposure diary calculation of 
outdoor exposure weather data in further detail. 
6.3 Results 
6.3.1 Weather conditions during the study period  
Average daily maximum temperatures (  C) and daily hours of bright sunshine over 
the entire study period from the 17th October to 16th November, 2012 are 
summarised in Table 6.2. There was an average of just over nine hours of daily 
sunshine during the study and minimum and maximum average daily temperatures 
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were 18.2  C to 26.8  C.  Additional information on weather conditions over the study 
period are provided in Figure 6.2 which shows a graphical summary of the 
maximum temperatures and hours of sunshine for each day over the study period.  
Over the measurement period for the two groups of participants (31st Oct-16th 
Nov), only two days, the 31st Oct and 5th November, had less than eight hours of 
sunshine per day, with the remaining days having between 9-13 hours of daily 
sunshine. An upward trend in temperature towards the end of the data collection 
period can also be observed.  More detailed daily weather information over the 
study period, including daily UV index values can be found in Appendix J. 
Table 6.2: Summary of weather conditions over study period (17
th
 Oct-16
th
 Nov 2012) 
 Average over study period 
              Sunshine(Hours) 9.1 (3.5) 
              Min  em    C) 
              Ma   em    C) 
18.2 (±2.2) 
26.8 (±2.3) 
 
 
Figure 6.1: Description of daily sun in hours and maximum temperatures over study period 
*Sunshine and temperature data obtained from the Australian Bureau of Meteorology
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6.3.2 Description of time outdoors and UV radiation exposure 
Descriptive data for time outdoors in minutes and UV radiation exposure are 
presented in Table 6.3. Differences in the median daily time outdoors (minutes) 
shows that there was a 15 minute decrease in outdoor exposure during the one 
week measurement period compared to the preceding two week supplementation 
period.  The variation in ranges also suggests more variation in the outdoor 
exposure patterns for participants during the supplement period compared to the 
exposures during the measurement period. Average daily environmental UVR 
exposure in J/m2 for the measurement period is also reported in Table 6.3. As 
observed with the reported time outdoors, the environmental UV radiation 
exposure (J/m2) showed wide variations in range, reflecting the broad variations of 
time spent outdoors for individuals in this sample. 
Table 6.3: Participants’ average time outdoors and environmental UV radiation exposure (N=45) 
 
Further information on the distribution of the environmental UV radiation 
exposures is presented in Figure 6.2 using a histogram. This figure provides a visual 
Variable Median (Range) 
Average daily time outdoors during supplementation 
(minutes) 
107 41-379 
Average daily time outdoors measurement week 
(minutes) 
92 15-231 
Average daily  environmental UV measurement week  
(J/m2) 
456 70-1680 
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representation for the distribution of environmental UV in the sample.   Nine of the 
participants (20%) received environmental UV exposures at the lowest category of 
reported UV (0-200 J/m2) while two of the participants received the highest 
category of UV exposure (1601-1800 J/m2).  
 
Figure 6.2: Average daily participant UV radiation exposures (N=45) 
 
Table 6.4 describes the relative contributions of weekdays and weekends to the 
environmental UV exposure (J/m2) for the measurement week. Notably, there was 
an increase in sun exposure during the weekend period compared with weekdays, 
reflecting the modest increase in sun exposure usually associated with weekends.  
Weekend days UV exposure contributed to over one-third to the total weekly UV 
exposure. These data reflects a modest increase in UV radiation exposure over the 
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weekend period compared to weekdays, with participants on average having 8.3% 
more UV exposure on weekends compared to weekdays 
The percentage of the total available environmental UV in J/m2 received by 
participants is also described; for example, if a participant spent all of their time 
outside for the week, they would have received 100% of the total available 
environmental UV for that week (Table 6.4). Participants on average received less 
than one tenth of the available environmental UV exposure (6%), over the course of 
the exposure week, with the range of total available environmental UV radiation 
received by participants reflecting the range of outdoor exposures between the 
participants.  
Table 6.4: Percentage contributions of environmental UV radiation (J/m
2
) over week 
Variable Median   Range 
 
Weekdays contribution to  
environmental UV radiation 
 
 
65% 
 
 13-100% 
 
Weekends contribution to  
environmental UV radiation 
 
 
35% 
 
 0-87.0% 
 
Percentage of total available 
environmental UV received 
 
 
 
6% 
 
 
 1-27% 
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6.3.3 Outdoor time and environmental UV radiation by time of day 
Average daily time outdoors in minutes for the time periods of early morning (5am-
9am), late morning (9am-12pm), early afternoon (12pm-3pm) and late 
afternoon/early evening (3-7pm) were measured (See Figure 6.3). A trend towards 
higher outdoor exposures in the later afternoon period and evening can be 
observed (approximately 30 minutes on average in the period 3-7pm), with the 
lowest outdoor exposures reported during the late morning period (approximately 
20 minutes on average).  
Figure 6.4 presents data on the average estimated environmental UV radiation 
(J/m2) exposure by time period for participants. The figure provides an interesting 
comparison to Figure 6.3, illustrating that, despite the similar or even lower times 
spent outdoors by participants during the high UV intensity times between 9am-
3pm, actual exposure to UV is still much higher. 
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Figure 6.3: Average daily outdoor exposure (minutes) for each time period of day during 
measurement week (N=45) 
Error bars indicate standard deviation 
 
 
Figure 6.4: Average environmental UV radiation exposure (J/m
2
) for each time period of day during 
measurement week (N=45) 
Error bars indicate standard deviation 
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6.3.4 Sun protection behaviours and association with outdoor time and 
environmental UV radiation exposure 
Two thirds of the participants used a sunscreen or a moisturiser containing at least 
a SPF 15+ protection factor sunscreen during the measurement week (see Table 6.5 
below).  To investigate any possible relationships between the use of sunscreen and 
sun exposure, independent samples t-tests were used.  However, no significant 
associations were found between the either time spent outdoors in minutes or 
environmental UV radiation in J/m2 and sunscreen use. Thus for this sample, 
participant’s use of sunscreen was not associated with their degree of outdoor 
exposure. 
Table 6.5: Sunscreen use and association with average time outdoors and average environmental 
UV radiation exposure (J/m
2
) (N=45) 
  Sunscreen Use 
 
   Total N (%) Association with 
outdoor exposure 
 
Outdoor Time 
in mins 
 
Sunscreen use 
Yes 
No 
 
 
 
29(64.4) 
16(35.6) 
 
 
t(43)=0.68; p=0.50 
 
Environmental UV 
radiation exposure 
J/m2 
 
Sunscreen use 
Yes 
No 
 
 
 
29(64.4) 
16(35.6) 
 
 
t(43)=-1.07;p=0.29 
 
Significant associations were observed between percentage of skin exposed, and 
the outdoor exposure measures of outdoor time in minutes and environmental UV 
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radiation (J/m2) exposure.  Figures 6.5 and 6.6 demonstrate the significant positive 
correlation between percentage of skin exposed and average reported time 
outdoors at and between environmental UV radiation exposure and percentage of 
skin exposed. Both of these associations show increased outdoor exposures are 
significantly associated with decreased clothing coverage. 
 
 
 
Figure 6.5: Correlation between percentage of skin exposed and average daily time outdoors 
(N=45) 
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Figure 6.6: Correlation between average percentage skin of exposed and average daily 
environmental UV (N-45) 
 
 
6.3.5 Estimated UV radiation exposure and percentage of skin exposed as an 
integrated variable 
While the percentage of skin exposed revealed a strong significant correlation with 
environmental UV radiation exposure, examination of Figure 6.6 shows that a 
proportion of participants with over 40% skin exposure reported relatively low 
exposures to environmental UV radiation (<600 J/m2). This suggests that 
environmental UV radiation exposure (J/m2), by itself, may not most accurately 
assess the UV radiation exposure of the participants due to the differences in skin 
coverage from clothing. To account for these variations and create a variable to 
measure UV radiation exposure more accurately, a variable taking into account 
both UV exposure and percentage skin exposed was created, the daily personal UV 
exposure, (see Chapter 3). The distribution of the daily personal UV radiation 
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reports total Joules (J) of UV, and comparison with the distribution of 
environmental UV radiation exposure in J/m2 from Figure 6.2 shows a quite 
different distribution of exposures over the sample. Importantly there is a smaller 
number of participants having the higher UV radiation exposures (>800 J) when 
percentage skin exposed is taken into account. Correspondingly, more participants 
were now classified as having personal UV radiation exposures in the lowest 
category (0-201 J). Participants’ median daily total personal UV radiation and 
minimum and maximum values received are also reported in Figure 6.7. 
 
Figure 6.7: Frequency of estimated daily UV radiation exposure in Joules (N=45) 
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6.3.6 Summary of sun exposure measures and association with demographic 
variables 
Associations between the sun exposure measures of estimated daily personal UV 
radiation exposure and average daily time outdoors and demographic 
characteristics of participants are represented in Table 6.6. No significant 
associations between the sun exposure measures and demographic variables were 
observed. 
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Table 6.6: Association of sun exposure measures and demographic characteristics of participants (N=45) 
 
Estimated daily personal UV exposure (Joules)     Time outdoors (Minutes) 
Continuous Variable S earman’s rho Continuous Variable S earman’s rho 
Age (n=45) R=-.09; p=0.52 Age (n=45) R=-.09;p=0.54 
Dietary Folate Equivalents (DFEs) (n=45) R=.11; p=0.49 DFEs (n=45) R= .09; p=0.54 
Dichotomous Variable Independent samples t test Dichotomous Variable Independent samples t test  
 
Country of Birth 
Australia  (n=29) 
Non-Australia (n=16) 
t(43)=-.90; p value=.38 
 
Country of Birth 
Australia (n=29) 
Non-Australia (n=16) 
t(43)=-1.45; p value=.15 
Education 
Year 12 (n=15) 
Bachelor’s Degree/or Postgraduate 
degree (n=29) 
t(42)=-.88; p value=.38 Education 
Year 12 (n=15) 
Bachelor’s Degree/or Postgraduate 
degree (n=29) 
t(42)=-.28; p value=.78 
Smoking 
Yes (n=4) 
No (n=41) 
t(43)=.86; p value=.38 
 
Smoking 
Yes (n=4) 
No (n=41) 
t(43)=1.32; p value=.19 
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Estimated daily personal UV exposure (Joules)     Time outdoors (Minutes) 
Dichotomous Variable Independent samples t test Dichotomous Variable Independent samples t test  
Usual Alcohol Intake 
Once a week or less (n=31) 
Twice a week or more (n=14) 
t(43)=-.60; p value=.95 Usual Alcohol Intake 
Once a week or less (n=31) 
Twice a week or more (n=14) 
t(43)=-.59; p value=.59 
Number of std. drinks when drinking 
Two or less (n=22) 
More than two (n=18) 
t(38)=-1.84; p value=.07 Number of std. drinks when drinking 
Two or less (n=22) 
More than two (n=18) 
t(38)=-.09; p value=.93 
Multivitamin Supplements 
Yes (n=15) 
No (n=30) 
t(43)=.69; p value=.49 Multivitamin Supplements 
Yes (n=15) 
No (n=30) 
t(43)=.14; p value=.89 
Sunscreen use 
Yes (n=26) 
No (n=17) 
t(41)=1.20; p value=.24 
 
Sunscreen use 
Yes (n=26) 
No (n=17) 
t(41)=1.52; p value=.14 
Physical Activity 
Lowest (n=24) 
Highest (n=21) 
t(43)=-1.13; p value= .27 Physical Activity 
Lowest (n=24) 
Highest (n=21) 
t(43)=-1.03; p value=.31 
Body Mass Index (BMI) 
<25 (n=35) 
>25 (n=10) 
 
t(43)=-1.21; p value=.23 
Body Mass Index (BMI) 
<25 (n=35) 
>25 (n=10) 
 
t(43)=-.56; p value=.58 
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6.4 Discussion 
Weather conditions over the course of the study were largely fine with average 
temperatures of 18.2  C to 26.8   C and average daily sunshine of 9.1 hours.  Over the 
dates when participants were completing their sun diaries (31st Oct-16 Nov), the 
majority of days were also fine, with 15 of the 17 days over the period having 
between 9 and 13 hours of bright sunshine. While generally consistent, there was a 
gradually observed increase in temperature and hours of sunshine towards the end 
of the measurement phase, during the time participants who started this phase in 
the second week, were completing their sun diaries. Thus, the week participants 
begun the sun exposure measurement phase of the study is an important 
independent variable for inclusion into analysis in the following chapter.  It is 
important to note that the late spring setting of this study, in the high UV 
environment of Brisbane, Australia, provides a significant contribution to the field 
as other population research in this area has been conducted at higher latitudes14, 
or with artificial sources of UV radiation31,79,81-83. Therefore a significant gap in the 
literature has previously been how high levels of natural UV radiation exposure 
effect folate status in a population.   The use of a free living sample, exposed to 
natural UV radiation in a high UV environment is thus a major strength of the 
current project. 
Data were also collected on sun exposure in the two weeks prior to the 
measurement week. A mean daily decrease of 15 minutes was observed in time 
spent outdoors for participants during the measurement phase compared to the 
supplementation phase of the study. Investigation of the ranges shows that at least 
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some of this variation was increased by several particularly high outdoor exposures 
during the supplemental phase. Examination of weather differences between the 
two phases of the project reveals that there was an increase in maximum 
temperature and daily average hours of sun during the measurement phase of the 
study. This may have been a factor in the reduced sun exposure during this phase; 
for instance, as the sample was relatively well-educated, participants may have an 
increased knowledge about reducing sun exposure than the general public and 
possibly reduced outdoor activities as a response to increased temperatures and UV 
radiation intensity.  
 A second important and likely contributor for these observed differences is 
probably due to the use of a diary in the measurement phase vs. survey assessment 
in the supplementation phase for sun exposure. Differences between sun exposure 
assessed via diary and survey have been described previously in lifesavers114, where 
diaries have shown superior correlation to surveys in regards to sun exposure 
assessed via the ‘gold standard’ measurement of personal UV radiation dosimeters, 
with surveys overestimating sun exposures compared to dosimetry and diaries.  It is 
important to note however, that while both surveys and diaries tend to 
overestimate sun exposure, they have generally shown good correlations with 
dosimeter data, with a study of N=124 volunteers by Chodick et al.115 
demonstrating that self-reported sun exposure from diaries had a high degree of 
agreement with objective sun exposure as measured by UV dosimetry badges. 
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Environmental UV radiation exposure in J/m2 was calculated for participants using 
the information from the sun diary and biometer data. These data correspond to 
the total environmental UV radiation in J/m2 received on a flat plain measured by 
the biometer on the roof at QUT, when participants indicated they were outside on 
their sun exposure diary. While these data do not provide a dose, they do provide 
an estimation of the intensity of the UV radiation participants were exposed to 
when outside during the measurement week. Environmental UV radiation exposure 
thus accounts for a key limitation of outdoor time in minutes, in that, it estimates 
the intensity of the UV radiation exposure depending on time of day outdoors, 
rather than just providing a quantification of the time spent outside. 
The distribution of environmental UV radiation shown in Figure 6.2 reinforces the 
wide variety of sun exposures experienced by this group, with average daily 
environmental UV radiation exposures ranging from 69.5 to 1680.7 J/m2 per day 
(median 456 J/m2). While the sample was skewed towards lower levels of exposure 
(<600 J/m2), n=14 (30%) of the participants were exposed to very high 
environmental UV radiation levels of over 1,000 J/m2 during their measurement 
week.  Comparatively, UV radiation exposures measured as Standard Erythemal 
Doses (1 SED=100 J/m2) from a study conducted in Brisbane (N=54) using dosimeter 
badges, reported median exposures of 3.0, 8.0 and 10.0 SEDs  in November for a 
sample of adolescents, home workers and outdoor workers, respectively116. While 
this study used dosimeters, rather than measurement of environmental UV 
radiation, the corresponding daily medians of between 300 and 1,000 J/m2, 
compare well to the current studies median UV radiation exposure of 456 J/m2. 
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Environmental UV radiation was also used to compare weekend and weekday sun 
exposure, with weekend environmental UV radiation exposure being higher than 
the weekday exposure for participants’. Participants’ weekend exposures increased 
by an average of 8.3%, for a total weekly contribution on weekends of 36.9%. The 
increase in weekend UV radiation exposure is relatively modest compared to data 
from Parisi et al.116, which reported that weekends contributed to an average of 
47% of the total annual UV radiation exposures for a mixed sample of outdoor and 
indoor workers in South East Queensland. Also reported was the percentage of 
total available environmental UV radiation received, with participants’ receiving a 
median of 6.3% (Range: 1-27%) of daily UV radiation available. Studies with outdoor 
workers in Queensland during spring have comparably shown median 
environmental UV radiation exposures of 26% of total available UV radiation, 
reflecting the major differences of outdoor vs. indoor occupation on available 
environmental UV radiation exposures117. 
Due to the increasing intensity of UV radiation intensity during the middle of the 
day, particularly between 9am-3pm, the time of day that outdoor exposure occurs 
is important for assessing participants’ UV radiation exposure118. In this sample, a 
pattern of time spent outdoors in minutes was observed whereby decreased time 
was spent outdoors during the period of 9am-12pm and increased time was spent 
outdoors during 3pm-7pm. Due to the sample consisting of university staff and 
students, primarily engaged in indoor work, this likely corresponds to work and 
study related activities indoors during much of the day and increased outdoor 
activities after the workday has finished. 
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However, when investigating data from environmental UV radiation exposure, in 
J/m2, there is a substantial increase in exposure during the periods 9am-12pm and 
12pm-3pm due to the increased intensity of UV radiation during these periods. 
Appendix K shows the UV Index range (the UV Index is based on environmental UV 
radiation levels) throughout a typical day and this provides a good example of how 
even with lower exposure times, UV radiation exposure can increase enormously 
during the middle of the day118. Thus, despite participants having lower time 
outdoors on average they still received their highest environmental UV radiation 
exposures during the middle of the day (9am-3pm), due to the intensity of the UV 
radiation levels at this time. 
An important factor to consider was whether participants’ use of sunscreens or 
their average clothing coverage over the measurement week modified their sun 
exposure behaviours. While the use of sunscreen was not statistically associated 
with an increase or decrease in average outdoor time or environmental UV 
radiation exposure; strong, significant correlations were shown between decreased 
percentage of skin exposed and increasing sun exposures measured both in 
minutes, outdoors and environmental UV radiation exposure. This important 
observation shows that there was a trend towards the use of less clothing coverage 
for participants who spent more time outdoors, the reverse of public health advice 
from the Cancer Council Queensland, which recommends choosing clothes that 
cover as much of the skin as possible to protect against sun damage119. This finding 
is worth further investigation, particularly due to the public health implications 
regarding skin cancer risk. Recent data from the Cancer Council Queensland 
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indicates that 21,000 Queenslanders are diagnosed with skin cancer resulting in 
7,000 deaths each year, with sun exposure being a major preventable risk factor121. 
While campaigns such as SunSmart have been shown to increase awareness of sun 
exposure risks and promote sun protection measures, for instance, in Victoria, 
improved data are needed about the sun exposure habits of particular population 
groups in Queensland and the effectiveness of current health promotion 
campaigns121. While the current study uses a small population sample, the data 
clearly shows decreased protective clothing use among participants’ with higher 
sun exposures and no association with sunscreen use; ie. Participants’ who did not 
use sunscreen were just as likely to spend as much time outside as those who did 
use sunscreen. Recent research on adolescents has shown that strong desires for a 
tan or ‘color’ can lead to decreased sun protection behaviours among adolescents, 
whether a similar affect is also present in young adult women or other factors are 
involved requires further investigation122,123.  It is clearly a worrying finding in a 
group of younger women residing in a high UV radiation environment and larger 
studies are really needed to investigate sun protective behaviours and attitudes 
among this age group. 
While a useful measure of crude UV radiation exposure, the average environmental 
UV radiation exposure is limited when considering the strong likelihood of effect 
modification from percentage of skin exposed. In comparison, the estimated 
personal UV radiation in Joules, reported in Section 6.5, takes into account each 
participant’s body surface area and percentage skin exposed as well as their 
exposure to environmental UV radiation over the time the participant was 
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outdoors, from the sun diary information. With the strong correlation between 
increased outdoor exposure and decreased clothing coverage in participants this 
has the ability to strongly modify participant UV radiation exposures. For instance, 
using daily average environmental UV radiation J/m2, the highest participant’s UV 
exposure is 27 times greater than the lowest participant’s exposure, (see Table 6.2, 
minimum to maximum comparison). However,  by taking into account percentage 
skin exposed, the estimated daily average personal UVR (in joules) of the highest 
participant is 196 times greater than the lowest participant (see Figure 6.8), due to 
a much greater percentage skin exposed. 
While the daily average personal UV radiation in Joules allows us to control for 
participant body surface area and percentage skin exposed, there are several 
limitations. Like environmental UV radiation in J/m2 it is reliant on the same UV 
radiation data collected via the biometer on a flat roof at QUT.  This horizontal 
measurement does not take into account the geometry of the body which contains 
many vertical and angular surfaces, where only diffuse sun exposure will occur, thus 
overestimation is likely124. A second limitation likely to cause overestimation is the 
lack of data on shade seeking activities when outdoors. While both of these 
limitations can be overcome by personal dosimetry such as polysulphone badges, 
this was beyond the scope of this project.  
In this chapter, descriptive data of the weather conditions over the study duration 
and descriptive and bivariate data of participants’ sun exposure and sun behaviours 
have been presented. An understanding of the sun exposure characteristics of the 
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sample is essential to inform selection of variables for use in testing our primary 
hypothesis for the relationship between folate degradation and sun exposure in the 
following chapter.  In this respect, the development of the measure, personal UV 
radiation exposure in Joules, is particularly important, as it produces a variable 
which estimates participants’ UV radiation exposures while taking into account the 
percentage of skin exposed to the sun. The investigation of participants’ sun 
exposure and sun protective measures in this chapter has also resulted in the 
finding of a strong association between increased sun exposure and decreased sun 
protective behaviour. While not a focus of this particular research study, this is 
highly important observation from a public health perspective and warrants further 
investigation. 
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Chapter 7: Associations between outdoor exposure and folate status 
in conception age females 
7.1 Introduction 
The following chapter aims to answer the main research question for the study: 
‘Are conception age women with a higher sun exposure at increased risk of lowered 
folate status?’ 
The first section of this chapter describes the dependent variables for the study: the 
change in serum and red blood cell folate levels, measured over the sun exposure 
measurement week. Bivariate associations between change in folate status and the 
sun exposure measures of average daily outdoor time in minutes and personal UV 
radiation exposure in Joules (as discussed in the previous chapter), are then 
investigated. Possible associations between the change in blood folates and other 
independent variables that may act as confounders or effect modifiers for the 
primary research question are also explored. Modelling of the data using multiple 
linear regression models are used to test how effectively sun exposure measures 
and other independent variables explain the change in folate status for the sample. 
The final section of the chapter consists of a discussion of the findings and how 
these relate to previous research, as well as the public health implications of any 
findings. Table 7.1, below, defines the aim, research question and hypothesis which 
are the focus of this chapter. 
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Table 7.1: Aim and research question for Chapter 7 
Aim Research Question  Hypothesis 
To test the effect of outdoor 
exposure on the folate status 
of participants 
 
Are conception age women 
with higher sun exposure at 
increased risk of lowered folate 
status? 
 
Women with higher sun 
exposures have a significantly 
increased degradation of folate 
then participants’ spending less 
time outdoors 
 
 
7.2 Methodological overview 
The collection of demographic, dietary, sun exposure and protective sun behaviour 
variables that form the independent variables for this project are described briefly 
in earlier results chapters, while Chapter 3 provides more detailed information on 
their collection. The dependent variable, change in serum and change in red cell 
folate was calculated by subtracting serum or red cell folate status taken at Time 3 
(following the measurement week) from the corresponding blood test taken at 
Time 2, following two weeks of supplementation. Thus the change in blood folate 
status represented the difference between these two times. 
7.3 Results 
7.3.1 Description of the change (Δ) in serum and red cell folate status over sun 
exposure measurement period (Time 2 to Time 3). 
The change in serum and red cell folate in the week following cessation of folic acid 
supplementation is shown below in Table 7.2. A mean decrease in serum folate can 
be observed from the day when supplementation was ceased, to one week after 
the cessation of folic acid supplementation. Whilst less, a decrease can also be 
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discerned for median serum folate over this time period following cessation of folic 
acid supplementation. Red cell folate was observed to have minimal changes 
following cessation of folic acid supplementation. 
The distribution of change in serum and red cell folate is presented in histograms 
shown in Figures 7.1 and 7.2. These figures provide a useful representation of the 
distribution of the change in the blood measures of folate over the week, with the 
majority of participants (n=32; 71%) having decreasing serum folate levels over this 
time period, while just over half of participants (n=26; 58%) had an increase red cell 
folate over the same time period. The figures also reveal that the data are 
somewhat skewed towards the negative values, this is especially apparent for 
change in serum folate status, resulting in decision to use of Spearman’s rho 
correlation in the bivariate analysis for the dependent variable of change in serum 
folate status. 
Table 7.2: Description of change in serum and red cell folate (over 1 week measurement period) 
(N=45) 
 Mean (SD) Median (min to max) 
 
Change in serum folate 
(nmol/L) 
 
-12.6 (22.8) 
 
 
      -4.0 (-68.4 to 29.9) 
Change in red blood cell folate 
(nmol/L) 
 
 
2.3 (170.7) 
 
     -8.0 (-424.5 to 282.5) 
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Figure 7.1: Histogram of change in serum folate (nmol/L) over measurement week (N=45) 
 
 
Figure 7.2: Histogram of change in red cell folate (nmol/L) over measurement week (N=45) 
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7.3.2 Bivariate relationship between change in blood folate and outdoor exposure 
measures-correlations. 
 
The correlations between the sun exposure measures of UV radiation personal dose 
and average daily time outdoors and the dependent variable change in serum and 
red cell folate status over the measurement week are presented in Table 7.3. Serum 
folate change is significantly correlated with both personal UV radiation exposure in 
Joules and average daily time outdoors in minutes. Both sun exposure measures 
have an inverse correlation with change in serum folate, indicating that higher 
levels of sun exposure were correlated with an significantly increased rate of serum 
folate decline, over the measurement week. Furthermore, both personal UV 
radiation and time outdoors displayed very similar correlations and significance 
levels (both p=<0.01). Spearman’s rho correlation was used to test these 
associations due to the skewing of the dataset. In contrast, no significant 
correlations suggesting an association were observed between change in red cell 
folate and personal UV radiation exposure, or average daily time outdoors. 
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Table 7.3: Correlations between change in serum and red cell folate and sun exposure measures of 
Personal UV radiation exposure (Joules) and time outdoors (minutes) (N=45) 
 
 Correlation  P-value 
Change in Serum Folate 
 
         Personal UV radiation (Joules) 
 
         Time Outdoors (minutes) 
        (Spearman rho) 
 
-.437 
 
-.439 
 
 
<0.01* 
 
<0.01* 
Change in Red Cell Folate 
 
         Personal UV radiation (Joules) 
 
         Time Outdoors (minutes) 
 
              (Pearson r) 
 
.109 
 
-.039 
 
 
0.47 
 
0.79 
*Significant at p=<0.05 
 
7.3.3 Bivariate associations between dependent variables (change in serum and 
red cell folate) and independent variables 
Associations at the bivariate level between independent variables and change in 
serum and red cell folate status are presented in Table 7.4. For these analyses, the 
multiple category variables of education, usual alcohol intake, number of drinks 
consumed when drinking alcohol, tanning tendency of the skin, skin reaction to the 
sun and physical activity were collapsed into two category dichotomous variables. 
This was undertaken for two major reasons: to increase category sample sizes due 
to the small size of the samples; and also to facilitate their inclusion into 
multivariable regression models.  
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The dependent variable, change in serum folate, was significantly associated with 
physical activity (lowest vs. highest) and current smoking (yes/no).  Non-significant 
trends (p=<0.2) were also observed with week of recruitment (Week 1/Week 2) and 
Tanning tendency (Light to no tan/Dark to medium tan). No association with change 
in serum folate and the continuous variables of age, BMI or DFEs were observed; 
also measures of alcohol intake were not associated with change in serum folate 
status in participants.  The dependent variable of change in red cell folate was not 
significantly associated with any of the independent variables, but change in red cell 
folate did show trends (p=<0.2) with the week of recruitment, skin reaction with 
sun and sunscreen use.
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Table 7.4 Associations between change in serum and red cell folate and independent variables (N=45) 
 
Change in serum folate Change in red cell folate 
Continuous Variable 
 
Spearman’s rho 
Change serum folate 
Continuous Variable 
 
Pearson r   
Change red cell folate 
Age (n=45) R=-.060; p=0.69 Age (n=45) R=-.013; p=0.94 
BMI (n=45) R=.-.091; p=0.55 BMI (n=45) R=.183; p=0.23 
DFEs (n=45) R=-.062; p=0.69 DFEs (n=45) R=.032; p=0.84 
Dichotomous Variable Independent samples t test of change in 
serum folate 
Dichotomous Variable Independent samples t test of change in red 
cell folate 
Country of Birth 
Australia  (n=28) 
Non-Australia (n=14) 
 
t(43)=.73; p value=0.47 
Country of Birth 
Australia (n=29) 
Non-Australia (n=16) 
 
t(43)=.40; p value=0.69 
Education 
Year 12 (n=14) 
Bachelor’s Degree/or 
Postgraduate degree (n=27) 
 
t(42)=.38; p value=0.71 
Education 
Year 12 (n=15) 
Bachelor’s Degree/or Postgraduate 
degree (n=29) 
 
t(42)=-.95; p value=0.35 
Smoking 
Yes (n=4) 
No (n=38) 
 
t(43)=-2.54; p value=0 .02* 
Smoking 
Yes (n=41) 
No (n=4) 
 
t(43)=1.29; p value=0.20 
Usual Alcohol Intake 
Once a week or less (n=29) 
Twice a week or more (n=13) 
 
t(43)=.53; p value=0.60 
Usual Alcohol Intake 
Once a week or less (n=31) 
Twice a week or more (n=14) 
t(43)=.20; p value=0.84 
Number of std. drinks when 
drinking 
Two or less (n=20) 
More than two (n=17) 
 
 
 
t(38)=-.24; p value=0.82 
Number of std. drinks when drinking 
Two or less (n=22) 
More than two (n=18) 
 
 
 
t(38)=-.48; p value=0.63 
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*Significant at p=<0.05 
Multivitamin Supplements 
Yes (n=11) 
No (n=31) 
 
t(43)=-1.14; p value=0.27 
Multivitamin Supplements 
Yes (n=13) 
No (n=32) 
 
t(43)=-.66; p value=0.51 
Skin reaction to sun 
Burn < 1 Hour (n=25) 
Burn > 1Hour (n=16) 
 
t(42)=.12; p value=0 .91 
Skin reaction to sun 
Burn < 1 Hour  (n=26) 
Burn > 1Hour  (n=18) 
 
t(42)=1.46; p value=0.15 
Tanning sun 
Light or no tan (n=21) 
Medium or dark tan (n=20) 
 
t(42)=1.69; p value=0 .09 
Tanning sun 
Light or no tan (n=21) 
Medium or dark tan (n=23) 
 
t(42)=-1.17; p value=0.25 
Sunscreen use 
Yes (n=31) 
No (n=10) 
 
t(42)=.82; p value=0 .42 
Sunscreen use 
Yes (n=28) 
No (n=16) 
 
t(43)=1.29; p value=0.20 
Physical Activity 
Lowest (n=24) 
Highest (n=21) 
t(43)=2.49; p value=0 .02* Physical Activity 
Lowest (n=24) 
Highest (n=21) 
t(43)=1.01;p value=0.32 
Oral Contraceptive use 
Yes (n=11) 
No (n=34) 
 
t(43)=-82; p value= 0.42 
Oral Contraceptive use 
Yes (n=11) 
No (n=34) 
 
t(43)=0.08; p value=0.93 
Week of recruitment 
Week 1 (n=33) 
Week 2 (n=12) 
 
t(43)=1.41; p value=0 .17 
 
Week of recruitment 
Week 1(n=33) 
Week 2 (n=12) 
 
t(43)=-1.94; p value=0 .06 
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7.3.4 Multivariable linear regression analysis of association between dependent 
variables (change in serum and red cell folate) and independent variables 
Multiple linear regression was used to investigate the predictive capacity of the sun 
exposure measures (personal UV radiation and average outdoor exposure time) on 
change in serum and red cell folate. Inclusion of other independent variables into 
the models was based on whether they were shown to be significantly associated 
with change in serum or red cell folate or showed non-significant trends (p=< 0.2). 
All models were checked for assumptions (multicollinearity, regression standardised 
residuals and homogeneity of variances) using scatterplots, histograms and plots of 
regression standardised residuals generated via SPSS v.19. High multicollinearity 
between the independent sun exposure variables of personal UV radiation 
exposure and outdoor time meant that separate models were used for each of 
these independent variables. Investigations of standardised residuals also indicated 
that the data did not violate the assumptions (less than -3 or more than +3 
standardised residuals)99. 
1. Change in serum folate (personal UV radiation exposure as sun exposure variable) 
(Table 7.5) 
A multivariable regression to assess the predictive effect of personal UV exposure in 
Joules on the dependent variable, change in serum folate levels was undertaken. 
Other independent variables that showed associations with change in serum folate 
at the bivariate level: physical activity, week of recruitment, smoking, tanning 
tendency of skin and use of multivitamins were also included. This model produced 
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a statistically significant adjusted R2. Only personal UV dose was a significant 
predictor of change in serum folate over the measurement week, while physical 
activity and week of measurement showed non-significant trends as predictors.  
To improve model fit, the independent variables not showing trends (p=<0.2); 
smoking, tanning and multivitamin supplements, were removed from the first 
model to produce a second model. With the removal of non-trending variables, this 
second model, which was also statistically significant, produced a more robust 
adjusted R2 than the previous model. Both personal UV radiation exposure in Joules 
and physical activity were significant predictors of change in serum folate over the 
measurement week, while week of measurement showed a non-significant trend. 
Thus, higher personal UV exposure and the highest category of physical activity 
were associated with significant decreases in serum folate over the measurement 
week. Model 2 explained 32.8% of the variance in change in serum folate over the 
measurement week, with personal UV exposure in Joules being the largest 
contributor to this by explaining 20% of the variance (by squaring the part 
correlation for personal UV radiation exposure). Examination of the unstandardized 
coefficients in model 2 also allows us to estimate that for every Joule of UV 
exposure increase there was a .026 nmol/L decrease in serum folate in this sample, 
corresponding to a 2.6nmol/L decrease for every 100 Joules of UV exposure, 
although these estimates must be interpreted with caution due to the only modest 
variance of the model. 
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2. Change in serum folate (outdoor time exposure as sun exposure variable) (Table 
7.6) 
A multivariable regression model was also used assess the predictive effect of 
outdoor time in minutes on the dependent variable, change in serum folate levels.  
As with the model for personal UV exposure, independent variables that showed 
associations with change in serum folate at the bivariate level: physical activity, 
week of recruitment, smoking, tanning tendency of skin and use of multivitamins 
were included. The first model produced a statistically significant adjusted R2 (See 
Table 7.6). As with the previous model only the sun exposure measure, in this case, 
time outdoors in minutes was a significant predictor of change in serum folate over 
the measurement week, while only physical activity showed non-significant trends 
as a predictor.  
To improve model fit, the independent variables not showing trends (p=<0.2); 
smoking, tanning and multivitamin supplements, were removed from the first 
model to produce a second model. An exception to this was that week of 
measurement was kept as an independent variable and entered into model as it 
showed borderline trend and was also added in the previous model. With the 
removal of non-trending variables, this second model produced slightly more 
predictive capacity with its statistically significant adjusted R2. As observed in the 
previous model, the sun exposure predictor, in this case average daily outdoor time 
in minutes, was a significant predictor of change in serum folate over the 
measurement week, although not quite as strong as a predictor as personal UV 
dose. Physical activity was also a significant predictor of change in serum folate. 
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Thus, mirroring the results presented in Table 7.5, both average daily time outdoors 
and the highest category of physical activity were associated with significant 
decreases in serum folate over the measurement week. Week of measurement also 
again showed a non-significant trend with change in serum folate.  
Model 2 explained 28.8% of the variance in change in serum folate over the 
measurement week, with the outdoor time in minutes being the largest contributor 
to this by explaining 16% of the variance (by squaring the part correlation for time 
outdoors). Examination of the unstandardized coefficients in model 2 allows us to 
estimate that for every minute of daily outdoor exposure increase there was a 
0.16nmol/L decrease in serum folate in this sample, corresponding to a 9.6 nmol/L 
decrease for every extra 60 minutes spent outdoors daily. Again, this must however 
be interpreted with caution due to the only modest variance of the model. 
3. Change in red blood cell folate (Table 7.7) 
While not showing significance with sun exposure variables at the bivariate level, 
two separate multiple regressions were also undertaken on the dependent variable 
change in red blood cell folate. This was in order to observe any changes to the 
relationship between sun exposure measures and change in red blood cell folate 
when other independent variables were included in the analysis. In the first model, 
personal UV radiation exposure in Joules was selected as the sun exposure variable, 
while other independent variables were selected based on bivariate trends. The 
model was not significant, with the predictor of interest, personal UV radiation 
exposure showing no association with change in red cell folate. The other 
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independent variables included in the model also were not significant.  The 
association between daily average outdoor time in minutes and change in red cell 
folate was tested in the next model, although once again this model was not 
significant. Outdoor exposure in minutes, although showing a stronger association 
then personal UV radiation exposure, did not reach significance. The independent 
variables of tanning and smoking showed some correlation with change in red cell 
folate; however, these also were not significant. Thus, sun exposure does not 
appear to be a predictor of change in red cell folate over the measurement week. 
 
 149 | P a g e  
 
Table 7.5: Multivariable regression model: change in serum folate (personal UV radiation exposure as sun exposure variable) (N=45) 
Model 1 
 
Model 2 
Independent  
Variables 
Unstandardised  
Coefficients 
 Independent  
Variables 
Unstandardised  
Coefficients 
 
 
 
Constant 
 
Personal UV (Joules) 
 
Tanning sun 
 
Physical Activity 
 
Smoking 
 
Multivitamin 
Supplements 
 
Week of 
measurement 
 
B 
 
-5.06 
 
-.03 
 
.45 
 
-12.13 
 
7.94 
 
6.43 
 
 
-9.61 
SE B 
 
23.47 
 
.01 
 
5.25 
 
6.17 
 
10.66 
 
6.96 
 
 
6.59 
β 
 
 
 
-.44 
 
.01 
 
-.27 
 
.10 
 
.13 
 
 
-.19 
 
Significance 
 
 
 
.003* 
 
.933 
 
.057 
 
.461 
 
.362 
 
 
.154 
 
 
Constant 
 
Personal UV (Joules) 
 
Physical Activity 
 
Week of 
Recruitment 
 
B 
 
16.553 
 
-.026 
 
-12.809 
 
-10.179 
SE B 
 
9.125 
 
.007 
 
5.682 
 
6.317 
β 
 
 
 
-.454 
 
-.283 
 
-.199 
Significance 
 
 
 
.001* 
 
.030* 
 
.115 
Part 
Corr. 
 
 
-.448 
 
-.279 
 
-.199 
Significance of model 
(ANOVA): 
 
.003* Significance of 
model (ANOVA): 
 
<.001*  
Adjusted R
2
:
 
 
.300 Adjusted R
2 
 
.328  
*Significant at p=<0.05 
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Table 7.6: Multivariable regression model: change in serum folate (outdoor time exposure as sun exposure variable) (N=45) 
Model 1 
 
Model 2 
Independent  
Variables 
 
Unstandardised  
Coefficients 
 Independent  
Variables 
 
Unstandardised  
Coefficients 
 
 
 
Constant 
 
Outdoor Time 
exposure 
(minutes) 
 
Tanning sun 
 
Physical Activity 
 
Smoking 
 
Multivitamin 
Supplements 
 
Week of measurement 
 
B 
 
4.95 
 
-.15 
 
 
-1.76 
 
-12.57 
 
6.415 
 
5.44 
 
 
-8.23 
SE B 
 
24.6 
 
.06 
 
 
5.26 
 
6.36 
 
11.12 
 
7.15 
 
 
6.79 
β 
 
 
 
-.38 
 
 
-.05 
 
-.28 
 
.08 
 
.11 
 
 
-.161 
Significance 
 
 
 
.010* 
 
 
.740 
 
.055 
 
.567 
 
.452 
 
 
.233 
 
 
Constant 
 
Outdoor Time exposure 
(minutes) 
 
Physical Activity 
 
Week of measurement 
B 
 
20.79 
 
-.16 
 
 
-13.47 
 
-8.65 
 
SE B 
 
9.96 
 
.05 
 
 
5.83 
 
6.52 
β 
 
 
 
-.41 
 
 
-.29 
 
-.17 
Significance 
 
 
 
.003* 
 
 
.026* 
 
.192 
Part  
Corr. 
 
 
-.404 
 
 
-.294 
 
-.169 
Significance of model 
(ANOVA): 
 
 
.007* 
Significance of model 
(ANOVA): 
 
 
<.001* 
 
Adjusted R
2
:
 
 
.256 Adjusted R
2
:
 
 
.288  
*Significant at p=<0.05 
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Table 7.7 Multivariable regression model: change in red blood cell folate (N=45) 
Personal UV radiation exposure in Joules 
 
Outdoor time in minutes 
Independent  
Variables 
 
Unstandardised  
Coefficients 
 Independent  
Variables 
 
Unstandardised  
Coefficients 
 
 
 
Constant 
 
Personal UV (Joules) 
 
Week of measurement 
 
Smoking 
 
BMI 
 
Sunscreen Use 
 
Tanning sun 
 
 
B 
 
-98.33 
 
-.02 
 
84.49 
 
-168.03 
 
5.38 
 
-60.49 
 
84.32 
SE B 
 
234.79 
 
.07 
 
59.58 
 
106.66 
 
5.44 
 
62.25 
 
55.48 
β 
 
 
 
-.04 
 
.22 
 
-.25 
 
.15 
 
-.15 
 
.25 
Significance 
 
 
 
.79 
 
.17 
 
.12 
 
.33 
 
.34 
 
.14 
 
 
Constant 
 
Outdoor Time exposure 
(minutes) 
 
Week of measurement 
 
Smoking 
 
BMI 
 
Sunscreen Use 
 
Tanning sun 
 
B 
 
-31.72 
 
-.60 
 
 
84.98 
 
-193.79 
 
5.34 
 
-67.66 
 
99.64 
SE B 
 
234.83 
 
.454 
 
 
54.23 
 
105.57 
 
5.21 
 
61.05 
 
52.61 
β 
 
 
 
-.20 
 
 
.22 
 
-.29 
 
.15 
 
-.17 
 
.292 
Significance 
 
 
 
.19 
 
 
.15 
 
.07 
 
.31 
 
.28 
 
.07 
Significance of model 
(ANOVA): 
 
.108 
 
Significance of model 
(ANOVA): 
 
.059 
 
Adjusted R
2
:
 
 
.111 Adjusted R
2
:
 
 
.149 
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7.4 Discussion 
This chapter has focused on the analysis of the association between the sun 
exposure variables (personal UV radiation exposure in Joules and outdoor exposure 
time in minutes) and the change in folate status over the week following cessation 
of supplementation. Thus, the chapter aims to address the main research question 
for the project, ‘Does sun exposure affect folate status in conception age females 
following folic acid supplementation?’  
At the descriptive level, median serum folate was reduced over the measurement 
week (-4.0 nmol/L), while median red cell folate showed only minimal change (-8.0 
nmol/L). It is important to note that folate concentration is much higher in red 
blood cells compared to serum, thus, while a decrease of 4.0 nmol/L in serum folate 
is quite significant, an 8.0 nmol/L decrease in red cell folate is only modest, relative 
to its concentration.  While both red cell and serum folate showed a decrease over 
the measurement period, there was some variation observed, with a number of 
participants actually increasing their serum folate levels in the week after cessation 
of supplementation.  
At the bivariate level, significant negative correlations were observed between 
change in serum folate and both average daily outdoor time in minutes and 
personal UV exposure in Joules, with a high degree of similarity between the 
correlations of both of the sun exposure variables. These modest to strong 
correlations indicate participants with higher sun exposures also experienced more 
pronounced decreases in serum folate over the measurement week. Significant 
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correlations were not found however between change in red cell folate and the sun 
exposure measures. This finding is not surprising due to the relative (average) 
stability red cell folate over short periods of time, for instance; during the 
measurement week, with only a small average decrease observed. As reported in 
Chapter 4, red cell folate reflects long term folate status and is less sensitive to 
short term changes in folate status compared to serum folate.16  
Besides the sun exposure measures, only physical activity and smoking were 
observed to have significant associations with change in serum folate. Participants 
with higher physical activity had significantly decreased serum folate over the 
measurement week, while non-smokers also had increased serum folate 
degradation compared to those who smoked. None of the variables analysed were 
shown to be significantly associated with red cell folate. The finding that age was 
not associated with change in folate status is expected, as while research has shown 
that older people, particularly those over 80 years of age are at increased risk of 
folate deficiency1, this sample was composed of relatively young individuals (18-47). 
Participant’s intake of folate (DFEs) was not correlated with change of folate status 
over the measurement week.  It is important to note that while participants were 
asked if the dietary intake represented their normal diet, a limitation of this project 
was the lack of a food diary to provide a more accurate account of folate intake and 
timing of the intake of folate rich foods over the measurement week; however, this 
would have introduced an increased burden on participants (see limitations in 
Chapter 8). 
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Alcohol consumption has a negative influence on folate, by reducing absorption and 
interfering with folate metabolism in the liver, thus measurement of alcohol intake 
is important in folate studies87. In this sample however, participants who were 
classified as having a higher alcohol consumption (two or more drinks a week or 
intake of alcohol more than twice a week) did not have any significant differences in 
folate degradation over the measurement week, compared to participant’s with 
lower alcohol intakes. This lack of association is perhaps not surprising, as many 
early studies investigating the association between alcohol consumption and folate 
status have focused on alcoholic subjects125-127. In a more recent crossover study 
design to assess the impact of moderate alcohol consumption on folate status 
postmenopausal women (N=53), were given no alcohol, 15 grams (one standard 
drink) and 30 grams (two standard drinks) of alcohol a day over three eight week 
crossover treatments128. While differences were noted in serum folate between any 
of the groups over the course of this crossover study, these were not statistically 
significant; although vitamin B12 levels were significantly reduced in participants’ 
consuming 30 grams of alcohol per day, compared to those consuming no alcohol 
(p=0.03). Data also presented in Table 7.4 show no association between 
participants who usually drink more than two drinks per occasion, and changes in 
folate status. This adds further evidence that alcohol intake in this sample was not a 
significant contributor to the decrease in folate over the measurement week. 
Participants’ BMI was not significantly associated with change in serum or red blood 
cell folate over the measurement week. This is not particularly surprising, due to 
the majority of subjects being classified as within the healthy BMI range for this 
 155 | P a g e  
 
sample (see Chapter 4). Of interest though, is recent research that has shown 
significant associations between serum folate pharmacokinetics and BMI, in which 
women of childbearing age with BMIs >30kg/m2 (n=16) were reported to have 
significantly lower folate uptake (p=0.001) compared to normal weight controls 
(n=16)129. Any future research into UV and folate, where the sample has a wider 
range of BMIs, should consider this association within their analyses. 
The multivariable linear regression models for change in serum folate over the 
measurement week were highly significant, with both personal UV radiation 
exposure and average daily outdoor time showing significant associations with 
change in serum folate over the measurement week. Furthermore, personal UV 
radiation exposure and average daily outdoor time were the major predictors of 
change in serum folate in the model, by explaining 20% and 16% of the variance, 
respectively. Also of interest, the model for personal UV exposure in Joules predicts 
that for each 100 Joules of UV exposure there is a decrease of 2.6 nmol/L of serum 
folate in the week following cessation of folic acid supplementation. Perhaps more 
practically, at least from a public health point of view, is that the independent 
variable, daily outdoor time in minutes, predicted that an extra hour of sun 
exposure for each day of the week was associated with a 9.6 nmol/L decrease in 
folate, in the week following cessation of the folic acid supplement for this sample. 
This high rate of depletion in folate levels is not unprecedented, with Fukuwatari et 
al.14, recently reporting a drop of 9.8 nmol/L in serum folate for Japanese students, 
who had been taking folic acid supplements two days prior and on the day of 
exposure, following two hours of sun exposure. Both the current sample and the 
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Japanese sample are not highly representative samples and consequently, an 
important next step would be to assess whether similar results could be replicated 
on a larger more representative sample.  Also, as suggested the predictive analysis 
must be interpreted with caution due to the only modest variance that the model 
explains. 
The results from the multivariable models suggest a strong association exists 
between degree of sun exposure and decrease in serum folate status, thus we can 
accept the hypothesis that the participants with higher sun exposures had  
significantly increased folate degradation over the measurement week then 
participants’ spending less time outdoors. Due to the observational nature of the 
study, we cannot state that sun exposure is the actual cause for the increased folate 
degradation in those with higher sun exposure and the small study size also 
increases our risk of Type-2 error. However, the finding of a strong association 
between the sun exposure variables and change in folate status adds evidence that 
sun exposure may play an important role in folate degradation, particularly when 
other variables shown to affect folate status such as dietary intake of folate and 
alcohol were also taken into account and no significant associations were found 
between these variables and folate degradation over the measurement week.  
While the current study has shown a significant association and in vitro evidence 
has shown the effect of UV radiation on folate degradation11,12, other in vivo 
evidence is inconsistent14,29,67,69-71. This inconsistency may in part be due to the 
varying study designs used, ie. studies by Rose et al.81 and Cicarma et al.82 which 
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showed no significant effect were sunbed studies using only narrowband UVB 
radiation. This is a major limitation of these studies, as UVB radiation (280-315nm) 
will not penetrate to the dermal circulation; rather, it is longer wavelength UVA 
radiation (315-400nm), which has been shown to penetrate to the circulatory 
regions in the dermis of skin, that most likely affects folate status in humans 12,14. A 
benefit of the present study was that participants were exposed to natural solar 
radiation and thus the whole spectrum of UV radiation, including UVA, reaching the 
earth’s surface. Therefore the combination of UVA penetration down to the dermal 
circulation and biological mechanisms such as indirect degradation of 5-MTHF and 
skin folate degradation (see Chapter 2, Figure 2.5) via UVA radiation, provide 
biologically plausible mechanisms for the observation of the strong association 
between increased sun exposure and decreases in serum folate status observed in 
this study. This thesis therefore adds further evidence to research showing that UV 
may degrade folate in humans. 
Increased physical activity was also significantly associated with change in folate 
status. As with all variables tested, examination for multicollinearity was 
undertaken and physical activity was not correlated with sun exposure or the other 
included variables, thus in this model it appears to be an independent predictor, 
with higher physical activity levels associated with increased folate degradation 
over the measurement week. The need for increased B vitamins for people with 
high physical activity, due to higher metabolic demands has been raised 
previously130, although research has not shown significantly lowered folate status in 
athletes compared to inactive controls131. Data are however weak in this area and 
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there is a paucity of research on whether B-vitamin needs for physically active 
people are higher than less inactive people. This could be a possible cause of this 
association, or it could be a random association.  An obvious association may be 
that people who were more physically active, had a lower dietary intake of folate 
and following cessation of supplementation depleted faster than less active 
individuals due to decreased intake, although no associations between these 
variables were observed during multicollinearity analysis. The multivariable analysis 
also indicated that participants who began the sun diary measurement in the 
second week showed a trend towards decreased serum and red cell folate 
compared to those from the first week; however, this did not reach significance. 
Increasing temperatures and hours of sunshine in the measurement week may have 
contributed to this weak association.  
At least some of the unexplained variance for change in serum folate over the 
measurement week would have almost certainly been due to changes in folate 
metabolism following cessation of the folic acid supplementation and the 
subsequent drop in folate intake. Although our understanding of folate metabolism 
is still limited, several degradation products have been identified with pathways for 
excretion via the urine and the bile132,133. Importantly, folate catabolism has been 
reported to vary widely among individuals and there is some evidence that 
increases in urinary excretion of intact 5-MTHF (the main component of serum 
folate) occur when levels reach above 45 nmol/L133. Thus, individual variation for 
metabolism of folate, particularly following supplementation would almost certainly 
be a major cause of the unexplained variation in change in folate status over the 
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measurement week among participants.  Genetic factors, such as inborn errors of 
folate metabolism are also important considerations and may have contributed to 
these variations; for instance, recent research shows that the most common 
polymorphism of the Methyltetrahydrofolate Reductase enzyme (MTHFR) 677C>T, 
present in 10-15% of the population, is associated with decreased serum and red 
blood folate in European populations133. The measurement of folic acid degradation 
products shown to be increased following UV radiation exposure (such as pterin-6-
carboxylic acid) may assist future studies by providing a biochemical measure 
capable of assessing degradation more specifically attributable to UV degradation. 
In contrast to the change in serum folate, results from the multivariable analysis for 
the change in red cell folate revealed no significant predictive capacity for the sun 
exposure measures of average time outdoors in minutes or personal UV radiation 
exposure in Joules. This is not surprising, considering the lack of associations 
observed due to the fact that red blood cell folate reflects long term folate status 
and thus would unlikely be sensitive to sun exposure measured over one week. It is 
interesting to note that research that has reported effects of sun exposure on folate 
degradation rate, exclusively shows this relationship with serum folate, but this may 
be due to the short term nature of the studies and the widespread use of serum 
folate rather than red blood cell folate as a test for folate status14,83. Longer term 
studies using UV sunbed exposures have tested red blood cell folate but have 
shown no significant degradation, although as eluded to earlier, these have used 
particular UV wavelengths over a narrower band then natural solar UV 
radiation31,81,82. Studies of red blood cell folate status would be useful, however, in 
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testing vulnerability to folate degradation if sun exposure was assessed over a 
longer period of time.  
While there was a significant drop in average serum folate following cessation of 
the supplementation and this showed a strong correlation with degree of sun 
exposure, no participants were classified as deficient (<7 nmol/L) based on the 
criteria outlined by the Royal College of Pathologists34. Also, with the exception of 
one participant, who was considered to have low serum folate at baseline (7.8 
nmol/L), all of the remaining participants where above the cut-off point defining a 
normal range for serum folate (>11.0 nmol/L)1. On a population scale, data from 
analysis of blood folate levels in 20.592 Australian individuals collected from 2007 
to 2010, report a 31% increase in mean serum folate since introduction of 
mandatory folic acid fortification in food, and very low population rates of folate 
deficiency (2.1%) based on serum folate levels108.  Thus, an appropriate question is, 
‘If folate deficiency is not highly prevalent in the population, is the possible effect of 
sun exposure on enhancing the rate of folate degradation a clinically significant 
problem?’ 
There are several reasons why research into the effects of UV radiation on folate 
status is still an important undertaking, despite low reported population levels of 
deficiency. Whilst the use of folic acid supplementation, and now the introduction 
of mandatory fortification of bread making flour has been highly successful in 
reducing the prevalence of folate deficiency and reducing the rate of NTDs32,108, the 
possible ability of UV radiation to affect folate levels in humans, means that specific 
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subgroups of the population may still be at risk. This is particularly true for people 
with chronically high sun exposures, for instance; outdoor workers, who do not take 
recommended precautions when exposed to solar UV radiation. Both in vitro and in 
vivo evidence and the results of the current study, indicate that UV degradation of  
folate may be of cause for concern in individuals with high sun exposure and low 
sun protective behaviours, although casual evidence is required for this relationship 
to be confirmed11,12,14,83. 
A second area of concern is that reference levels for folate are not well defined with 
researchers frequently using different reference ranges to define deficiency and 
normal ranges1,35. Also with the lack of knowledge of folate’s role in chronic 
diseases such as cancer, cardiovascular and neurodegenerative diseases, defining 
cut-off levels presently for the best outcomes with these diseases is not possible.   
Another important factor, linked to the first, may be timing of sun exposure 
following folic acid supplementation. High doses of folic acid supplements (>200 µg) 
result in the appearance of unmetabolised folic acid in the circulation one to two 
hours after intake (prior to conversion to 5-MTHF via Dihydrofolate Reductase) and 
studies have shown that folic acid, but not 5-MTHF is vulnerable to direct UVA 
degradation13,30,73-77.  Additionally, as reported earlier, Fukuwatari et al.14 recently 
reported that students exposed to sun immediately after folic acid supplementation 
showed significant decreases in folate levels, indicating, in vivo, that folic acid in 
high doses may be particularly vulnerable to degradation in the several hours 
following taking of supplement-thus reducing effectiveness of supplementation.  
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People with very high sun exposures and low sun protective measures, as observed 
with several of the participants in the current study would be particularly 
vulnerable to this type of degradation. While this direct degradation pathway is 
beyond the ability of the present study to analyse, as measurement of sun exposure 
occurred one week following this cessation of folic acid supplementation, there is 
the prospect that degradation of folic acid, prior to conversion to 5-MTHF in the 
pathway outlined above, occurred soon after supplementation was ceased in 
participants’ with high sun exposure. Possible other mechanisms for the 
degradation of folate in the current study include degradation via indirect 
mechanisms through UVA generation of ROS and folate skin depletion as illustrated 
in Figure 2.59,11,12,78.  
While in depth exploration of possible UV dependent folate metabolic pathways  is 
beyond the scope of the current project, further investigation of the ability of folic 
acid to be degraded prior to conversion to circulatory 5-MTHF form, is required as 
this has the ability to affect the potency of folic acid interventions. This has 
important implications for public health, as people with high chronic sun exposures, 
who do not make adequate use of protective strategies, or have natural protection 
such as highly melanised skin69, to protect from sun exposure, may be at increased 
risk of UVA derived degradation of folic acid. This may reduce the effectiveness of 
current folic acid fortification strategies-which are aimed particularly at conception 
age females. Similarly, for pregnant women, high sun exposures may also reduce 
effectiveness of folic acid supplementation, an important and highly successful 
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intervention to reduce risk of NTDs17,39,40, with possible consequences for fetal 
developmental health, especially if intake of folate rich foods is poor.   
This chapter has shown that a strong association exists between degree of outdoor 
exposure and folate degradation in a sample of conception age females. This 
relationship remained even after other variables significant at, or showing trends at 
the bivariate level, were added to the multivariable model. Additionally, while 
folate deficiency is not widespread in the population based on current definitions, 
this research adds significantly to the literature by showing that people with 
particularly high sun exposures in a high UV radiation environment may be at 
increased risk of folate degradation. This is a particularly important finding in 
conception age women due to the risk of NTDs during embryonic and fetal 
development during pregnancy. Further research using larger samples and 
randomised controlled trials are needed to provide causal evidence of the effect of 
UV radiation on degradation of folate status in the population.  
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Chapter 8: Conclusions 
8.1 Overview of findings 
Chapter 4 
Chapter 4 reported on the demographic characteristics of the sample and provided 
data on the blood folate status of participants’ over the three time points of the 
study. The major significant finding from Chapter 4, was that both serum and red 
cell folate levels in participants’ increased following supplementation, with the data 
also showing a rapid and significant drop off in serum, but not red blood cell levels 
following the cessation of supplementation. The observation of the significant 
increase in folate status following supplementation was important, as a key 
component of the study was to increase participants’ folate status prior to the sun 
exposure measurement week.  
Chapter 5 
In Chapter 5, dietary intake of folate and correlations between folate status and 
dietary folate intake were reported. Significant findings for this chapter included 
data showing average that dietary intake of folate for this sample was above the 
recommended EAR for population groups; however, 34% of participants still had 
intakes below this level. There was also a significant correlation observed between 
dietary intake of folate and both serum and red blood cell folate status. This 
association resulted in the acceptance of the hypothesis that intake of dietary folate 
was significantly associated with blood measures of folate in this sample. This 
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finding also provided further validation of the rapid folate FFQ developed by 
Hickling et al.88 
Chapter 6 
Chapter 6 explored the sun exposure and sun protection characteristics of the 
participants. Significant findings included correlations observed between 
participants with higher sun exposures and less skin coverage by clothing, which has 
implications for sun safety public health messages. Also explained is the creation of 
the daily personal UV radiation exposure variable, which takes into account both 
exposures to environmental UV radiation and the percentage of skin exposed. 
Chapter 7 
In Chapter 7, descriptive, bivariate and multivariable analysis of the relationship 
between change in blood folate status and the sun exposure variables is 
undertaken. Multivariable modelling of the dependent variable, change in serum 
folate over the measurement week, revealed strong inverse associations with the 
independent sun exposures of personal UV radiation exposure in Joules and time 
outdoors in minutes. Conversely, no significant associations between red cell folate 
and outdoor exposure measures were observed. The hypothesis for our main 
research question; that women with higher sun exposures have significantly 
increased degradation of folate then women spending less time outdoors, is thus 
accepted for serum folate status. This finding has important public health 
consequences, as people with high sun exposures may potentially reduce the 
efficacy of folic acid supplementation and fortification in raising folate status. Table 
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8.1 provides a summary of the key findings for each of the research questions posed 
in the thesis. 
Table 8.1: Summary of key findings for the research questions in thesis 
 
Aim Research Question Key Finding 
Primary 
 
To test the effect of outdoor 
exposure on the folate status of 
participants. 
1. Are women of 
childbearing age 
women with a higher 
sun exposure at 
increased risk of 
lowered folate status? 
 
Women of childbearing age with higher 
sun exposures were found to have 
significantly increased degradation of 
serum folate over the measurement 
week compared to those with lower 
exposures.  
 
Secondary 
 
To measure the effectiveness 
of folic acid supplementation in 
raising the folate status of 
participants 
2. Does two weeks of 
folic acid 
supplementation 
increase folate status 
in a sample of 
childbearing age 
women? 
 
A significant increase in both serum and 
red blood cell folate was observed in 
the sample, following two weeks of 
supplementation with folic acid. 
To measure and evaluate the 
dietary intake of folate in the 
sample. 
3. Does dietary folate 
intake correlate 
significantly with blood 
measures of folate for 
the sample? 
 
Dietary folate intake correlated 
significantly with blood measures of 
folate at baseline. 
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8.2 Conclusion and significance of the Thesis 
This research was conducted on a sample of conception age females aged between 
18-47 years, with the key aim of answering the research question; “Are conception 
age women with a higher sun exposure at increased risk of lowered folate status?” 
Participants recruited from the Queensland University of Technology were 
supplemented for two weeks with 500 µg of folic acid to increase blood folate 
levels. This was followed by one week of sun exposure assessment using a sun and 
physical activity diary to assess the association between rate of folate degradation 
and sun exposure as well as confounders such as dietary intake of folate. 
Participants’ red blood cell and serum folate was tested at baseline, following the 
two weeks of supplementation and at the end of the one week sun exposure week.  
The need for research on UV-induced folate degradation 
Folate is essential in many aspects of health, thus research into environmental 
factors that may impact folate status, such as UV radiation, are of great importance.    
Currently, there is a paucity of population research in the area of solar UV radiation 
induced folate degradation. Improved data on the role of sun exposure in the 
depletion of folate levels is particularly relevant to the Australian population as due 
to the high population sun exposures, Australians would be amongst the highest 
risk for UV degradation of blood folate levels15. This is the first population study to 
investigate the effects of UV radiation exposure on folate levels of a sample of 
participants in Australia. It also builds on international research by being the first 
population study to investigate the association of natural outdoor UV radiation 
 168 | P a g e  
 
exposure (as opposed to artificial sources of UV) and folate degradation in 
conception age females.  
Project findings 
Results from this study suggest an association exists between degree of sun 
exposure measured as both time outdoors in minutes and personal UV radiation 
exposure in Joules, and decrease in serum folate status. Thus, we can accept the 
hypothesis that the females in this sample with higher sun exposures had 
significantly lower folate status than women spending less time outdoors. This adds 
significantly to evidence suggesting that people, who have had their folate levels 
raised by folic acid, are at increased risk of a higher degree of folate degradation 
following high levels of sun exposure, potentially reducing the efficacy of folic acid 
supplementation. In contrast to the strong association between serum folate and 
sun exposure, no significant relationship was observed between the sun exposure 
variables and red cell folate, this is likely due to the long-term nature of red blood 
cell folate turnover and short term duration and measurement of variables in this 
study.  
Public health significance of project  
Earlier studies, combined with the findings from this project, indicate that the 
health consequences for the association between UV radiation exposure and folate 
status, may be most pronounced for individuals with high sun exposure and poor 
sun protection measure usage. This has consequences for public health, as high sun 
exposures, without adequate use of protective strategies to protect from sun 
exposure, may increase UVA derived degradation of folic acid, reducing the 
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effectiveness of current folic acid fortification strategies aimed particularly at 
conception age females. Similarly, for pregnant women, high sun exposures may 
also reduce effectiveness of folic acid supplementation with possible consequences 
for fetal developmental health, especially if intake of folate rich foods is poor.   
The finding of a strong association between sun exposure and decreased use of sun 
protective clothing in this sample is also highly significant from a public health 
perspective, particularly with the high rate of skin cancer in Queensland120. With 
sun protection messages encouraging people to cover up when heading outdoors, 
most importantly during the high intensity UV time periods of 9am-3pm, further 
investigation of sun exposure behaviours amongst this population group is 
warranted.  
Innovation of project 
The use of a FFQ was an important addition to the research, as intake of folate is 
the main contributor of folate status. Furthermore the lack of collection of dietary 
folate data has been a major limitation of previous studies. The collection of dietary 
and supplemental folate intake data is particularly important in conception age 
women due to risk of NTD and the description of folate intake and its relationship 
between blood folate levels in participants formed an important part of this project. 
This thesis has also provided further validation of the FFQ developed by Hickling et 
al.88 by finding strong correlations between baseline serum and red cell folate 
status and intake of dietary folate as measured by the FFQ.The present thesis 
provides a strong case for continued investigation in this field with a larger more 
representative sample or preferably the establishment of a small well designed 
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randomized controlled trial to provide data on any casual association between UV 
radiation exposure and folate degradation in the human body. 
8.3 Strengths and Limitations of project 
Strengths: 
Australian setting in high natural UV radiation environment 
The setting of this study during the late spring season (17th October-16th November) 
and in the city of Brisbane (153.0  E, 27.3  S), which has high UV intensity, 
particularly during this period of the year was a major strength of this study95,96. 
Most previous studies29,79,81-83 have involved the use of sunbed or solar lamp 
exposures, which while allowing more control over dose received, are frequently 
limited to specific wavelengths, or due to ethical reasons only practical for 
participants who already require therapeutic use of artificial UV sources, such as 
psoriasis patients. While important for demonstrating the role of UV radiation in 
folate degradation, these factors severely limit the generalisability of the data to 
wider populations outside the specific groups who use artificial sources of UV 
irradiation. Additionally, the few previous studies in the area of natural UV 
degradation of folate have been undertaken in areas of higher latitude, ie. 
Fukuwatari and colleagues14 conducted their important study in Japan, which has a 
lower UV intensity then the location of the current project. The current project, 
focusing on the study of a sample of participants in Brisbane, has added enormously 
to the field as it has addressed these two key weaknesses: the investigation of both 
the impact of natural environmental sun exposure and the measure of this sun 
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exposure in a high UV radiation environment to investigate its impact on the folate 
status of participants.  
Conception age women and folic acid supplementation 
Low folate status is of particular concern to conception age females due to risk of 
NTDs in planned and unplanned pregnancies. This study has been the first 
investigation, to the author’s knowledge, to study the effects of sun exposure on 
the folate status for this particular group. Additionally, the inclusion of folic acid 
supplementation was a key component of the study for raising participants’ folate 
status prior to the measurement week. This study also raised an important issue: 
with folic acid intake increased in the population by the introduction of mandatory 
fortification in bread making flour, the possibility of exposure to an environmental 
factor that may reduce the effectiveness of the strategy of raising blood folate 
status via folic acid fortification is of concern, particularly to this population group. 
Use of FFQ to assess dietary folate 
Collection of the dietary and supplemental folate intake of participants using a 
validated FFQ was a major strength of this study as few other studies have collected 
this information. As dietary intake of folate is the main contributor of folate a lack 
of collection of this data has inhibited the interpretability of past research 
investigating the relationship between folate status and UV radiation exposure. 
 172 | P a g e  
 
Weaknesses: 
Small numbers and convenience sample 
The two major limitations of this study were the small numbers of participants 
recruited (N=46) and the convenience nature of the sample. The convenience 
sample introduces some selection bias, ie. Females volunteering for this study were 
more likely more concerned and educated about folate status then a fully 
representative sample. However, despite these weaknesses, this research adds 
significantly to the in vivo data. Only one other population based study investigating 
the effect of natural UV radiation exposure on the folate status of a population 
taking folic acid supplementation has been conducted, to the author’s knowledge. 
This study, conducted by Fukuwatari et al.14 involved only seven participants over a 
two day period. 
Measurement of folate and alcohol intake 
While the addition of assessment of dietary folate intake via a FFQ was an 
important addition to this research area, a seven day food and alcohol intake diary 
may have allowed improved measurement of intake over the measurement week. 
Both the dietary folate and alcohol intake, as assessed, related to ‘normal’ intake 
over the study period; however, these measures may not have accurately measured 
atypical intake during the measurement week. For instance, an alcohol binge during 
the measurement week or an unusually high intake of folate rich food products may 
have impacted the rate of folate degradation. The introduction of such a diary as 
well as the existing sun and physical activity diary would have, however, 
significantly increased participant burden. 
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8.4 Future research directions 
Several major themes for continued research in this area have been identified:  
1. The clear need for causal data on the relationship between UV radiation and 
folate status; 
2. The role of timing between folic acid intake and UV radiation exposure and 
its effect on folate status; and 
3. The use of more sensitive measurements of blood folate, such as free folic 
acid and photoproducts of folate catabolism. 
Given the small size of the study and use of a convenience sample, future 
observational studies investigating the association between UV radiation exposure 
and folate status should focus on a research design with larger numbers of 
participants and more representative sample recruitment. A randomised research 
design that would assist in establishing causality would therefore be most 
beneficial. The current project and the research conducted by Fukuwatari et al.14 
have shown that a significant effect can be established in regard to UV degradation 
of folate with only relatively small sample sizes and over timeframes of several days 
to weeks; thus a small, well designed Randomised Controlled Trial with adequate 
statistical power would further the field greatly. 
Any future research should also consider the role of the timing of sun exposure 
following folic acid supplementation. While UVA radiation had previously been 
shown to be responsible for direct degradation of folic acid in vitro, this was only 
recently demonstrated to have an effect in vivo13,14,30,73-77. The degradation of folic 
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acid in its unmetabolised form, prior to conversion has the potential to reduce the 
effectiveness of folic acid supplementation. A study design that could identify peak 
unmetabolised folic acid in the blood in a representative sample of participants and 
the vulnerability of this to UV-induced degradation, would improve immensely on 
the knowledge that we have in this area.  Results from such a study would be 
particularly important for individuals with high sun exposures and are particularly 
reliant on supplements to provide folate status. Also, with the introduction of 
mandatory folic acid supplementation in Australia, the identification of an 
environmental exposure that may affect folic acids efficacy would be of important 
public health significance. 
Future studies may also benefit from the measurement of the free unmetabolised 
form of folic acid in the blood and assessment of folic acid degradation 
photoproducts via techniques such as HPLC30,31. The use of more specific blood 
measures of folate would allow a highly accurate measurement of the degree of 
folate degradation related specifically to UV-induced degradation.  
Other future topics of research in this area that could further the field include; an 
emphasis on how skin colour, ethnicity and BMI affect the association between UV 
and folate status, observational studies investigating whether sun exposure is linked 
to differences in folate status in pregnant women and whether gender affects the 
association between folate status and UV exposure. Future use of personal UV 
dosimeters for sun exposure measurement and dietary folate intake measures, such 
as a food diary, would also benefit future research in this area. 
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                                                                                  Have you heard about the vitamin folate? Did you know folate levels in your blood may be affected by how much sun exposure you are getting?  
Volunteers are required for a study!  Researchers at the Queensland University of Technology are looking for healthy females to participate in a study that will compare the affect of everyday folate exposure on the B-vitamin folate. Folate is important in many areas of human health, particularly in reducing risk of neural tube defects such as spina bifida. We need to understand factors that effect folate levels, so that we can help to prevent these serious health issues.   
Criteria for participation: -Female -18-45 years of age -In good health  -Not pregnant and trying not to conceive -Primarily indoor activity/work (ie. less then 2 hours outside exposure during most days) -Be willing to participate in 3 short clinic sessions, take a daily folate supplement for two weeks (there are no risks for taking the folate supplement) and possibly undertake 2 X half an hour daily walking sessions for a week.   
Benefits to you: -Assessment and receive report of your folate status  -Receive coffee voucher on completion of study -Receive a pedometer on completion of the study -Go in a draw to win iPad2   
Are you interested? If you are interested in participating or would like more information, please contact: David Borradale david.borradale@qut.edu.au 0405 804 680    This study has been approved by the Queensland University of Technology Human Research Ethics Commitee ( Approval no. TBA) 
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PARTICIPANT INFORMATION FOR QUT RESEARCH PROJECT 
Investigating the association between sun exposure  
and folate degradation in the human body 
QUT Ethics Approval Number 1100000933 
RESEARCH TEAM 
 Institute of Health and Biomedical innovation (IHBI) – QUT  
Principal Researcher: David Borradale – PhD researcher 
Associate Researcher: Professor Michael Kimlin – Supervisor 
DESCRIPTION 
This project is being undertaken as part of a PhD project for Mr. David Borradale. The project is funded by the Queensland 
University of Technology’s School of Public Health. The funding body will not have access to the data obtained during the project. 
Purpose of this project  
This research study aims to investigate whether ultraviolet radiation from the sun affects folate levels in Australian adult females. 
The information provided below provides some background for the project and a brief summary of what the project entails. 
Folate and folic acid 
Folate is a water-soluble B-vitamin essential in many aspects of health in the human body, including healthy blood formation and 
the prevention of Neural Tube Defects such as spina bifida in babies. More recently research has suggested a role for folate in both 
cardiovascular disease and cancer prevention, although research into these areas is ongoing. We obtain our folate from our food 
with green leafy vegetables, legumes and oranges being particularly good sources. Folic acid is the form of folate used in 
supplements and added to some foods such as bread-making flour. 
Ultraviolet Radiation from the sun 
Ultraviolet radiation (UV) from the sun exists in three forms: UVA, UVB and UVC, with only UVA and UVB reaching the earth’s 
surface. Excessive UV radiation from sun exposure via the sun is a major cause of various skin cancers, however inadequate sun 
exposure can cause low vitamin D levels as UV is needed to produce vitamin D in the skin. Sunlight is the main source of vitamin D 
for humans as food only provides a minimal amount of daily requirements. Vitamin D is important for prevention of bone diseases 
such as rickets in children and osteoporosis in older adults, while recent research has also shown that vitamin D may also have 
important roles in the prevention of several cancers, cardiovascular diseases and autoimmune diseases. 
How are folate and UV from the sun linked? 
Studies have shown that some forms of folate, particularly folic acid, are destroyed by ultraviolet radiation penetrating the skin, 
however very little data exists in regard to how sun exposure affects folate levels in the human body. This is a big gap in the 
research due to the high sun exposure of Australians in general and the role that folate plays in numerous health outcomes. 
What is the study about? 
This project aims to test whether there is a relationship between participants’ UV exposure and folate status when taking folic acid 
supplements. Thus this project aims to answer the question: 
 “Does increased solar UV exposure increase risk of folate breakdown for females on folic acid supplementation?” 
This project will be undertaken by recruiting 60 females. Adult females are an important population for folate studies due to the 
nature of folate deficiency in increasing the risk of Neural Tube Defects in babies 
PARTICIPATION 
Your participation in this project is voluntary. If you do agree to participate, you can withdraw from participation at any time during the 
project without comment or penalty. Your decision to participate will in no way impact upon your current or future relationship with 
QUT (for example your grades). 
This is a three-week study and three short clinic visits at IHBI’s clinic rooms are required.  
The initial visit will involve an introduction to the study, a brief questionnaire about health status, an assessment for skin colour to 
check for vulnerability to sun exposure and blood test to test for baseline folate status. Participants will also be provided with a 
blister pack of commercial (Blackmore’s) 500 mcg (micrograms) folic acid supplements (500 mcg of folic acid is the standard dose 
of this supplement found in pharmacies, supermarkets and health food shops) and will be asked to take 1 tablet each day for the 
following two weeks, email reminders will be sent out to remind participants to take their tablets. 
In the second clinic visit, two weeks later, a blood to test for folate levels after supplementation with folic acid. Participants will be 
randomized into a restricted sun exposure group and an increased sun exposure group: 
For restricted outdoor exposure, participants are asked to minimize outdoor exposure, when outdoor exposure is necessary 
participants are asked to cover up with long sleeves, long pants and hat, a sun and activity diary will be provided to self monitor 
exposure. 
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For participants asked to increase outdoor exposure, an activity program of 2 X 30 minute walks in the morning and afternoon will 
be prescribed during times of low UV intensity, outside of the peak UV intensity hours of 10am- 3pm. Participant outdoor 
exposure will be self monitored via a sun and activity diary. 
On the final visit to the clinic, participants will be asked for a final blood sample, sun exposure diaries will be collected and a short 
folate food frequency questionnaire will be administered. Participants will receive a $25 Coles/Myer gift card, which will be 
redeemable at all participating stores.  
EXPECTED BENEFITS 
It is expected that this project will not directly benefit you. However, it may benefit the future health of the population through 
improved understanding of the interaction of the UV environment and folate degradation. Participants will receive their folate 
results with an explanation of the reference levels used for folate tests. 
RISKS 
There are minimal risks associated with your participation in this project. These include bleeding and/or minor bruising at the blood 
collection site, occasionally multiple punctures to locate veins, and temporary dizziness or fainting. In the very unlikely event that 
you experience one of the above side effects, prompt medical assistance will be provided.  
Solar ultraviolet radiation exposure risks are controlled in this study through the following methods: 
 Sun exposure for participants asked to increase sun exposure will occur outside peak UV Index times of between 10am 
and 3pm. 
 The collection of data in Spring rather then Summer. 
 The small 1 week exposure window being used. 
 A skin color check to exclude people with high risk of sun damage (eg. very pale skin). 
There are no risks associated with taking 500mcg of folic acid daily. 
QUT provides for limited free counseling for research participants of QUT projects who may experience discomfort or distress as a 
result of their participation in the research.  Should you wish to access this service please contact the Clinic Receptionist of the 
QUT Psychology Clinic on 3138 0999.  Please indicate to the receptionist that you are a research participant. 
CONFIDENTIALITY 
All comments and responses will be treated confidentially.  The names of individual persons are not required in any of the responses. 
The privacy of all volunteers in this research program is taken very seriously. When you fill out a questionnaire or donate a sample 
of blood to this study we will make every effort to protect your privacy. 
 All your questionnaires and samples will be stored securely in such a way that they cannot immediately be identified as 
having come from you. They will be labeled with a unique barcode number so that they do not get confused with 
questionnaires or samples from someone else. 
 Any identifying information (your full name, address etc.) will be stored separately from the samples and information you 
provide. Access to this identifying information is restricted to a small number of senior members of the study team. 
 No information that could easily be used to identify you or your family will be included in any report on the results of the 
study. 
CONSENT TO PARTICIPATE 
The return of the completed consent form at the time of the first interview is accepted as an indication of your consent to participate in 
this project. 
QUESTIONS / FURTHER INFORMATION ABOUT THE PROJECT 
Please contact the researcher team members to have any questions answered or if you require further information. 
David Borradale – PhD researcher Professor Michael Kimlin – Supervisor 
Inst itute of  Health  and Biomedica l  innovat ion  ( IHBI)  –  QUT 
Phone:  3138 0400 Phone:  3138 5802 
Email:  david.borradale@qut.edu.au  Email:  m.kimlin@qut.edu.au  
CONCERNS / COMPLAINTS REGARDING THE CONDUCT OF THE PROJECT 
QUT is committed to researcher integrity and the ethical conduct of research projects.  However, if you do have any concerns or 
complaints about the ethical conduct of the project you may contact the QUT Research Ethics Unit on 3138 5123 or email 
ethicscontact@qut.edu.au. The Research Ethics Unit is not connected with the research project and can facilitate a resolution to your 
concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your information. 
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CONSENT FORM FOR QUT RESEARCH PROJECT 
Investigating the association between sun exposure  
and folate degradation in the human body 
QUT Ethics Approval Number 1100000933 
RESEARCH TEAM 
David Borradale – PhD researcher Professor Michael Kimlin – Supervisor 
Inst itute of  Health  and Biomedica l  innovat ion  ( IHBI)  –  QUT 
Phone:  3138 0400 Phone:  3138 5802 
Email:  david.borradale@qut.edu.au  Email:  m.kimlin@qut.edu.au  
STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
 have read and understood the information document regarding this project 
 have had any questions answered to your satisfaction 
 understand that if you have any additional questions you can contact the research team 
 understand that you are free to withdraw at any time, without comment or penalty 
 understand that you can contact the Research Ethics Unit on 3138 5123 or email 
ethicscontact@qut.edu.au if you have concerns about the ethical conduct of the project 
 agree to participate in the project 
 
  I do consent to my blood sample being stored for at QUT for up to 3 years where it may be used for 
extended research and DNA testing to examine genetic factors associated with folate. 
  I do not consent to my blood sample being stored for at QUT for up to 3 years where it may be used 
for extended research and DNA testing to examine genetic factors associated with folate. 
 
 
Name  
Signature  
Date   
 
 
Please return this sheet to the investigator. 
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Dear ……….., 
 
The following table contains your blood results from the Folate and UV Study: 
 
 Baseline After 2 weeks 
supplementation 
After intervention  
Serum Folate* 
Reference range: 
(values over 7nmol/L 
are considered normal) 
 
….. nmol/L 
 
 …. nmol/L 
 
 …..nmol/L 
 
Red Cell Folate** 
Reference range: 
(values over 900nmol/L 
are considered normal) 
 
….. nmol/L 
 
 …. nmol/L 
 
 …. nmol/L 
 
 
*Serum folate levels are a test of short term circulatory folate levels, therefore these are 
rapidly increased by high folate foods and supplements. 
 
**Red cell folate levels test the concentration and folate within red blood cells and provide a 
longer term measure of folate status (ie. They are not as rapidly affected by short term dietary 
changes as serum folate). 
 
 
 
Your results indicate adequate folate status for the duration of the study.  
 
 
 
Thanks again for taking part in this study and if you have any questions please do not 
hesitate in contacting me, 
 
Best regards, 
David 
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Part A: 
General Information Questionnaire 
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Date:      
First Name:      
Surname:      
      
1. What is your date of birth?      
2. In what country where you born?      
3. If you where not born in Australia, in what year did you come to live in Australia?      
4. What is your PARENTS ETHNIC ORIGIN (that is, the place where most of their ancestors came 
from) and the COUNTRY THEY WERE BORN IN 
Parent Country of birth Ethnic Origin (Please select  
the ONE that best describes 
your mother 
 
Mother       Australian 
 
Other please describe 
      
 
Father       Australian 
 
Other please describe 
      
 
 
5. What is the highest technical, professional or academic qualification that you have completed? 
(Please cross one of the boxes below) 
☐�Did not complete primary school ☐�Trade/Apprenticeship 
☐�Primary school ☐�Certificate or diploma 
☐�Some high school ☐�Bachelor’s degree 
☐�Year 12 senior certificate ☐�Postgraduate degree 
 
 
 
 
 
Insert ID label here 
SECTION 1: GENERAL QUESTIONS ABOUT YOU 
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6. Which of the following best describes the occupation you had for the longest period? 
(Please cross one of the boxes below) 
☐�Manager or administrator 
 
☐�Professional (eg. Engineer, doctor, teacher, nurse, police, technical officer)�
 
☐�Tradesperson (eg. Carpenter, electrician, plumber, mechanic, etc.)�
 
☐�Clerk (eg. typist, receptionist, data processor etc.)��
 
☐�Salesperson or personal service worker (eg. sales rep, teller, insurance rep, etc.)�
 
☐�Plant or machine operator or driver (eg. taxi driver, bus driver)�
 
☐�Farmer�
 
☐�Labourer or related worker (eg. trade assistant, factory hand, construction, mining, agricultural)� 
☐�Member of defence forces (army, navy air forces)�
 
☐�Other (please state)������
 
 
7. Which of the following best describes your current employment status? 
(Please cross one of the boxes below) 
☐�Unemployed 
☐�Home duties 
☐�Part-time work - employed/self-employed 
☐�Full-time work - employed/self-employed 
☐�Student 
☐�Sole parent pension 
☐�Disability pension  
☐ Retired  
☐�Other (please state)      
 
8. Which of the following best describes your current, main occupation?  
(Please cross one of the boxes below) 
☐�Mainly indoors (e.g. office worker) 
☐�Half indoors and half outdoors (e.g. physical education teacher)  
☐�Mainly outdoors (e.g. gardener)  
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9. Which of the following best describes your smoking status?�
☐ I smoke daily  
☐ I smoke occasionally  
☐    I don’t smoke now, but I used to   
☐    I tried a few times but never smoked regularly 
☐    I’ve never smoked   
☐ Unsure/Don’t know/Can’t remember 
 
10. The following questions ask about your consumption of alcohol: 
 
How often do you have a drink containing alcohol?  
 
☐Never (go to question 14)             ☐Monthly or less     ☐Once a week or less                    
 
                                        ☐2-4 times a week           ☐5 or more a week 
 
11. How many standard drinks do you have on a typical day when you are drinking? (Please use 
diagram on next page to determine standard drink size). 
 
☐ 1  ☐ 2        ☐ 3 or 4       ☐ 5 or 6          ☐ 7 or more 
 
12. How often do you have 6 or more standard drinks on one occasion? 
 
☐ Never ☐Less than monthly ☐Monthly ☐Weekly      ☐Daily or almost daily 
 
13. What is the main alcoholic drink consumed? 
 
☐ Spirits (ie. vodka, whisky, scotch, gin)     ☐ Beer ☐ Wine ☐ Fortified wine 
 
☐ Whatever is available ☐ A mix of all types  
       
      Standard Drinks Diagram 
      
SECTION 2: SMOKING AND ALCOHOL CONSUMPTION 
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14. How would you rate your general health over the PAST MONTH? 
☐Excellent   ☐Fair    
☐ Very good              ☐Poor  
☐ Good                      ☐Very poor   
15. Have you been diagnosed with any disease that causes malabsorption? (ie. coeliacs disease, 
tropical sprue, inflammatory bowel diseases, short bowel syndrome)? 
☐ Yes   ☐ No (Please go to Question 17) 
16. If so what is the name of this condition? 
Click here to enter text. 
17. Have you ever been diagnosed with cancer? 
☐ Yes   ☐ No (Please go to the medication chart on the next page) 
18. If so what is the name of the cancer you were diagnosed with and what month and year were 
you last diagnosed with this type of cancer? 
Click here to enter text. 
 
 
 
 
 
 
 
 
 
 
SECTION 3: GENERAL HEALTH INFORMATION 
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19. The following chart is a medication chart, please fill out with any medications (not vitamin 
supplements) that you are currently taking: 
Name of 
medication  
 
Strength of 
medication on 
packet 
Quantity taken 
each time 
Form of 
medication 
How often do you usually 
take it? 
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant�
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
  
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to 
enter text. 
Click here to 
enter text. 
Click here to 
enter text. 
☐Tablet 
☐Capsule�
☐Liquid 
☐Patch�
☐Spray 
☐Injection 
☐Implant 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
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The following questions ask about several supplements you may take or have been prescribed. It 
will help you to have your supplements with you so you can fill out the supplement chart on the 
following page. 
20. During the PAST MONTH, did you take any MULTIVITAMIN SUPPLEMENTS? (Please cross one box) 
 
☐Yes      Be sure to enter details into supplement chart below 
☐ No      Continue on to supplement chart below 
 
21. During the PAST MONTH, did you take any FOLATE SUPPLEMENTS? (Please cross one box) 
 
☐Yes       Be sure to enter details into supplement chart below 
☐No        Continue on to supplement chart below 
 
22. During the PAST MONTH, did you take any B12 SUPPLEMENTS? (Please cross one box) 
 
☐Yes Be sure to enter details into supplement chart below 
☐No          Continue on to supplement chart below 
 
Name and brand of 
multivitamin 
supplement 
 
Strength of folic acid 
and vitamin B12 on 
packet 
Quantity taken each 
time (eg. 2 tablets) 
How often do you usually 
take it? 
(eg. 3 times per week) 
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
                  
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
             
Name and brand of 
folic acid supplement 
 
Strength of folic acid 
on packet 
Quantity taken each 
time 
How often do you usually 
take it? 
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
 
SECTION 4: SUPPLEMENTS 
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Name and brand of 
vitamin B12 
supplement 
 
Strength of vitamin 
B12 on packet 
Quantity taken each 
time 
How often do you usually 
take it? 
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
Click here to enter 
text. 
Click here to enter 
text. 
Click here to enter 
text. 
                                  ☐Day 
              Times per  ☐Week 
                                  ☐Month 
                                  ☐Year 
 
 
 
THANKYOU FOR COMPLETING THIS QUESTIONNAIRE 
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Part B: 
Sun Exposure Questionnaire 
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Date:      
First Name:      
Surname:      
1. How does your skin react when you sit in the sun in your current area of residence, in the middle of 
the day, for the first time in summer, without sunscreen? (please cross one box) 
 
☐ Never Burn 
☐ Burn after more than 2 hours sun exposure 
☐ Burn after 1-2 hours 
☐ Burn after 1/2-1 hour 
☐ Burn within half an hour 
 
2. At the end of summer or after a two week holiday in the sun, what kind of tan would you have? 
(please cross one box) 
 
☐ A dark tan 
☐ A medium tan 
☐ Light tan 
☐ Practically no tan 
 
3. How does your skin react when you go out in the sun in your current area of residence, for one hour 
in the middle of the day, for the first time in summer, without sunscreen? (please cross one box) 
 
☐ Burn then peel 
☐ Burn then tan 
☐ Tan only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID Number 
SECTION 1: YOUR SKIN AND THE SUN 
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Please cross the box that reflects your outside sun exposure for each time period ( ie: cross the 15-30 minute 
box if usually spend between 15-30 minutes approximately outside on Mondays between 5-6am) 
 
4a. A typical MONDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
 
4b. A typical TUESDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
SECTION 2: TIME SPENT IN THE SUN 
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4c. A typical WEDNESDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
 
4d. A typical THURSDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
 
 
 
P a g e210P a g e191
 
4e. A typical FRIDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
 
4f. A typical SATURDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
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4g. A typical SUNDAY in the PAST MONTH (Cross one response for EACH time period) 
Length of time spent outside 
 Never <15 minutes 15-30 minutes 30-45 minutes 45-60 minutes 
Morning (am) 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
7-8 ☐ ☐ ☐ ☐ ☐ 
8-9 ☐ ☐ ☐ ☐ ☐ 
9-10 ☐ ☐ ☐ ☐ ☐ 
10-11 ☐ ☐ ☐ ☐ ☐ 
11-12 ☐ ☐ ☐ ☐ ☐ 
Afternoon (pm) 
12-1 ☐ ☐ ☐ ☐ ☐ 
1-2 ☐ ☐ ☐ ☐ ☐ 
2-3 ☐ ☐ ☐ ☐ ☐ 
3-4 ☐ ☐ ☐ ☐ ☐ 
4-5 ☐ ☐ ☐ ☐ ☐ 
5-6 ☐ ☐ ☐ ☐ ☐ 
6-7 ☐ ☐ ☐ ☐ ☐ 
 
5. We are interested in the CLOTHING AND SUN PROTECTION that you have worn in the 
PAST MONTH. During the past month, when outside, did you..... 
 
 Never/Rarely Less than half the 
time 
More than half the 
time 
Almost 
always/always 
Wear a  broad-
brimmed hat? 
 
☐ ☐ ☐ ☐ 
Wear a cap? 
 
☐ ☐ ☐ ☐ 
Wear any other 
head covering? 
 
☐ ☐ ☐ ☐ 
Wear a shirt with 
long sleeves? 
 
☐ ☐ ☐ ☐ 
Wear long trousers 
or clothing that covers 
all 
or most of your legs? 
 
☐ ☐ ☐ ☐ 
Wear sunglasses? 
 
☐ ☐ ☐ ☐ 
 
 
SECTION 3: SUN PROTECTIVE BEHAVIOUR 
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6. Have you used sunscreen in the PAST MONTH? 
☐ Yes (please go to next question) 
☐ No (Thankyou for completing this questionnaire) 
 
7. What is the sun-protection factor (SPF) of the sunscreen that you have used most often? (eg. SPF30+). 
Consider any product you may use that have an SPF, including daily moisturiser or make-up products. 
 
Sunscreen SPF:  Click here to enter text. 
 
Daily moisturiser SPF: Click here to enter text. 
 
Make up SPF: Click here to enter text. 
 
8. Over the PAST MONTH, how often on average have you used any of the products described in 7? 
 
☐ Every Day  
☐ 5-7 days a week  
☐ 3-4 days week  
☐ 1-2 days week  
☐ Less than once a week 
 
9. On days that you have used sunscreen in the PAST MONTH, how often did you apply it? 
 
Click here to enter text.   Times per Day  
 
Where do you normally apply your sunscreen?  (PLEASE be as specific as possible ie. back of upper arms, 
back of lower legs etc.) 
 
Click here to enter text. 
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Part C: 
Folate Food Frequency Questionnaire 
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Name: Click here to enter text. 
Date: Click here to enter text. 
Instructions: 
This questionnaire is designed to estimate your usual pattern of food intake of certain types of foods. 
Think about the food and drinks you have consumed over the past two weeks. 
HOW OFTEN? 
How often have you eaten each of the following food. Tick one box for each food. 
WHAT BRAND AND TYPE? 
For some of the foods listed you are asked to write a particular brand and type that you have eaten this 
week. 
If you can’t remember the brand or type then please look at the colour photos provided. These photos 
do not include every option but may help you to remember the brand or product. If you have eaten two 
types or brands of a particular food then please write the brand type that you eaten most often. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID Number 
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Folate Dietary Intake Questionnaire 
 
Over the last week how many times have you eaten…… 
                      Not at all             Once        2-4 times        5-6 times        Everyday      2+ times a day 
Breakfast cereal                      ☐                ☐             ☐                 ☐                 ☐                ☐ 
What brand and type? (eg. Sanitarium weetbix): 
Click here to enter text. 
 
Wheatgerm or Wheatbran   ☐                ☐             ☐                 ☐                 ☐                ☐ 
Milk on your cereal                ☐                ☐             ☐                 ☐                 ☐                ☐ 
What brand and type of milk? (eg. Pura light start): 
Click here to enter text. 
 
Breakfast bar                           ☐                ☐             ☐                 ☐                 ☐                ☐ 
What brand and type? (eg. Keloggs LCMs): 
Click here to enter text. 
 
Bread that was bought          ☐                ☐             ☐                 ☐                 ☐                ☐ 
from a shop (includes bread 
rolls, flat breads, crumpets,  
muffins, bagels and damper) 
 
What brand and type? (eg.Sunblest white): 
Click here to enter text.  
 
 
Bread that was made at          ☐                ☐             ☐                 ☐                 ☐                ☐ 
home (includes bread rolls, 
flat breads, crumpets,  
muffins, bagels and damper) 
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Over the last week how many times have you eaten or drunk…… 
           Not at all         Once       2-4 times         5-6 times          Everyday     2+ times a day 
Vegemite or marmite                         ☐                ☐             ☐                 ☐                 ☐                ☐ 
Peanut Butter                                       ☐                ☐             ☐                 ☐                 ☐                ☐ 
Pate                                                        ☐                ☐             ☐                 ☐                 ☐                ☐ 
an Orange                                             ☐                ☐             ☐                 ☐                 ☐                ☐ 
another type of fruit                           ☐                ☐             ☐                 ☐                 ☐                ☐ 
Fruit or vegetable juice                      ☐                ☐             ☐                 ☐                 ☐                ☐  
What brand and type of fruit or vegetable juice? (eg. Berri orange juice): 
Click here to enter text. 
 
Cheese                                                ☐                ☐             ☐                 ☐                 ☐                ☐ 
Salad (salad includes mixed            ☐                ☐             ☐                 ☐                 ☐                ☐ 
green vegetables and other 
mixtures of raw vegetable) 
 
Cooked green vegetables                ☐                ☐             ☐                 ☐                 ☐                ☐ 
fresh or frozen 
(eg. broccoli, spinach) 
 
Tinned or canned vegetables          ☐                ☐             ☐                 ☐                 ☐                ☐ 
(includes baked beans and  
Other tinned beans and peas) 
 
Peanuts or other nuts                      ☐                ☐             ☐                 ☐                 ☐                ☐ 
 
 
Liver                                                    ☐                ☐             ☐                 ☐                 ☐                ☐ 
 
 
 
Thank you for your time 
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Appendix J: Withdrawl of consent for study 
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WITHDRAWAL OF CONSENT FOR QUT RESEARCH PROJECT 
 
“Investigating the association between sun exposure and folate degradation 
in the human body” 
QUT Ethics Approval Number 1100000933 
 
RESEARCH TEAM CONTACTS 
David Borradale, PhD researcher Professor Michael Kimlin 
Institute of Health and Biomedical innovation Institute of Health and Biomedical innovation 
Phone:  3138 0400 Phone:  3138 5802 
Email:  david.borradale@qut.edu.au  Email:  m.kimlin@qut.edu.au  
I hereby wish to WITHDRAW my consent to participate in the research project named above. 
I understand that this withdrawal WILL NOT jeopardise my relationship with Queensland University of Technology. 
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Appendix K: Daily UV index values and weather over study period  
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Appendix L: The UV index 
 
 
 
 
 
 
 
 
 
 
1
K: Daily UV index values and weather over study period  
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    The UV Index 
            
 
Source: Australian Government, Bureau of Meteorology. About the UV Index [Online document]. 
Available at: http://www.bom.gov.au/uv/about_uv_index.shtml 
 
